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ABSTRACT 
M O T I V A T I O N A N D THE PLACEBO RESPONSE 
BENJAMIN JON WHALLEY 
Predicting individual differences in placebo responding has proved hard. Predictions 
f r o m dispositional or personality variables are unreliable for two reasons: first, be-
cause dispositional predictions fail to account for situational variability, and second, 
because the dimensions identified in popular dispositional models are mter-individual 
variables, and may not map on to infra-individual structures and processes involved 
i n placebo effects. This thesis describes a new psychological mechanism of placebo 
responding—motivational concordance—which links placebos w i t h established research 
on human values and goal-striving. Progress towards goals, particularly goals which 
are self-actuahsing, is associated wi th positive emotional states. Findings presented 
here support the view that when rituaUsed behaviour associated wi th taking a placebo 
substance is concordant w i t h high-level or self-defining goals then participants expe-
rience therapeutic benefits. Thus, goals represent enduring dispositions which may 
interact w i t h features of the situation in predictable ways to produce placebo responses. 
This motivational account avoid a number of problems associated wi th alternative 
expectancy-based accounts, in particular the proximal causes of placebo responses in 
complex situations. This report presents data that support the motivational concordance 
account i n a number o f ways: Placebo responding is found to be temporally consistent 
but contextually specific; people respond to a placebo consistently, but only when 
contextual features of its presentation are held constant (Chapter 2). Motivational 
dispositions predict responses to a complementary therapy, rephcating an earlier finding 
(Chapter 3). Trait predictions are found to be moderated by the motivational context 
of the placebo ritual (Chapter 5). Chapter 6 demonstrates that motivational-affective 
benefits of placebos can occur 'at one remove'; temper tantrums i n young children were 
reduced when carers performed a motivationally-concordant placebo ritual. Finally, data 
f r o m Chapter 7 suggest that motivational concordance may generalise to traits other than 
spirituality, and to other treatments including conventional medical therapies. 
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Chapter 1 
Introduction 
I f scientific paradigms were to be evaluated only by their fruitfulness, then 
biomedicine in the twentieth-century must be judged extraordinarily suc-
cessful (Kuhn, 1962). However the work reported here concerns a range of 
phenomena that have posed theoretical, practical and ethical problems for 
practitioners of conventional medicine: placebo effects. Placebo effects are 
difficult to explain within a conventional biomedical paradigm because of a 
background assumption of the specificity of disease aetiology. Placebo effects 
are characterised by equifinality, and even where specific biological mecha-
nisms are identified, for instance the role played by endogenous opiates in 
placebo analgesia, the same results may be obtained by multiple methods. 
Red or blue pills, injections, alternative therapies, or surgery may all generate 
equivalent physiological responses. Only a psychological account of the 
mechanisms of placebo responding can provide a satisfactory explanation 
of these phenomena, and make predictions regarding when, why, and for 
whom, placebos w i l l be effective. 
1 
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1.1 Overview 
Placebo effects are difficult to explain within a conventional biomedical paradigm 
because of a number of background assumptions made: that diseases may be identified 
by specific cellular pathologies; that scientists must identify diseases by observing 
and describing the relevant biochemical processes at the cellular level; and that when 
appropriate treatments are developed they wi l l effect direct changes in these processes. 
These background assumptions have proved extremely f ru i t fu l for diseases where specific 
pathology exists and has been identified—most notably the treatment of infectious 
disease, immunization and surgery. However, to the extent that placebo effects exist 
and are chnically-meaningful all three of these assumptions require further specification 
and qualification, and this difficulty has lead many wi th in the mainstream of scientific 
medicine to regard placebo phenomena as an embarrassment, to be treated w i t h derision, 
contempt or outright hostility (Buckalew et al., 1981). I n identifying four reasons why 
placebo effects are unpopular w i t h conventional physicians. Wall notes: 
. . . the very mention of the placebo effect is taken as a hostile questioning 
of the vahdity of the logic on which a therapy is based... we all trust our 
sensation as a reflection of objective reahty and yet the placebo changes the 
sensation without affecting the objective reality. (Wall, 1992). 
Epistemological concerns notwithstanding, extensive efforts have been made to identify 
the neural and chemical processes by which placebos have their effects on the body. It 
appears several physiological mechanisms are involved, including endogenous opiates, 
and the dopamine and immune systems (e.g. Benedetti et al. 2006; CoUoca et al. 
2004; Maier et al. 1994, and also see Stewart-WiUiams and Podd 2004). These research 
efforts are aimed at establishing a form of 'specificity' for placebo effects and thus 
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bringing them within the fold of scientific medicine. However research into these 
physiological processes does not presume to explain the psychological antecedents of 
placebo responses; although exciting this work is at best an incomplete explanation of 
the phenomena. 
1.2 Changing conceptions of placebo effects 
Tracing a strict chronological progression in definitions of the placebo proves remarkably 
difficult, i n part because more sophisticated accounts often fail to transfer f rom interested 
researchers to the medical community at large. However, historical conceptions of 
placebos may be categorised into three primary groups: as flattery or a distraction; as 
an inert comparator; and more recently, as an active therapeutic manoeuvre. 
1.2.1 Placebo as flattery 
The word placebo derives f rom the Latin, T shall please, and became widely known 
from around the 7th century onwards as part of the 'office of the dead' ritual in the 
western church. The first line of Psalm 116, which was repeated by the congregation 
after each passage of prayer, reads 'placebo Domino in regione vivorum' or ' I wi l l please 
the Lord in the land of the living'. This service was initially performed on all souls' 
day for those in purgatory, but was later came to be performed on other days for a 
particular deceased. Wealthy famiUes might distribute both money and food to mourners 
immediately after the ceremony, and over time placebo became the term for a professional 
mourner wi th no connection to or genuine concern for the deceased. Alluding to this 
earlier meaning, later authors used the word to denote a flatterer or sycophant: I n 
Chaucer's The Merchant's Tale, Placebo and Justinus are brothers of the knight January, 
4 CHAPTER 1. I N T R O D U C T I O N 
a 'senex amans' or 'amourous old man'. When January decides to marry the teenage girl 
May, Justinus advises caution. However January only hears Placebo's flattery, is struck 
b l ind soon after the marriage, and is later cuckolded by May and Damyan. 
This early definition of placebo as a flatterer seems to have directed the later use 
i n relation to medicine. The 1811 revision of Quincy's Lexicon-Medicum (cited in 
de Craen et al., 1999) defines placebo as 'an epithet given to any medicine adapted more 
to please than to benefit the patient' and this concords wi th the Oxford dictionary's 
definition f r o m the late 18th century as 'a p i l l , medicine, procedure, etc., prescribed 
more for the psychological benefit to the patient of being given a prescription than for 
any physiological effect' (Oxford, 1993). The use of placebos as a comfort to patients 
survived well into the twentieth century (Shapiro, 1959). As an example, Richard Cabot, 
the eminent professor of Medicine at Harvard, describes being: 
brought up, as I suppose every physician is, to use placebo, bread pUls, water 
subcutaneously, and other devices... How frequently such methods are used 
varies a great deal I suppose w i t h individual practitioners, but I doubt i f there 
is a physician in this room who has not used them and used them pretty 
often...I used to give them by the bushels" (cited in Kaptchuk, 1998, p. 1722). 
Ironically, although a large proportion of medications and medical interventions in 
this period may i n fact have been placebos (in the sense that they were psychologically 
mediated and d i d not have directly-therapeutic physiological effects), doctors of the 
period were clear that while placebos may be of comfort to patients, they had no 
further therapeutic benefits (Kaptchuk, 1998). Few writers before the 1940s identified 
that placebos could actually have curative properties, although many physicians found 
that placebos were a useful diagnostic tool to identify malingering of false reporting of 
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symptoms, a role they may have retained to recent times (Nitzan and Lichtenberg, 2004). 
As a consequence, the 'placebo' is not paired w i t h a 'placebo effect' unt i l the development 
of controlled trials which, although it had roots wi th pioneers in the nineteenth century, 
gathered pace i n the wake of the second world war. 
1.2.2 Inert but powerful! Placebos as methodological controls 
As the logic of the RCT was developed through the 1940s and 1950s, more researchers 
became aware of the placebo effect as an empirical and statistical fact. It became 
common for counterfeit medicines, typically pills indistinguishable f rom the genuine 
pharmaceutical but without biologically active ingredients, to be used as a control for 
the effect of simply being treated. These placebos were, by definition, inert. Early 
proponents of comparative medicine described placebo effects, that is the responses 
observed in patients receiving these fake pills or injections, as substantial, and this 
became an important argument for the use of RCTs, rather than clinical judgement, to 
determine the efficacy of medical interventions. Efficacious treatments were now defined 
as those which could be statistically distinguished from counterfeit treatment. Thus, 
proponents of the new comparative medicine faced a dilemma in defining the placebo. 
Placebo effects had to be substantial to justify the expense and complexity of controlled 
trials where clinical judgement had previously sufficed, but the logic of the controlled 
trial resulted in a narrow and seemingly contradictory definition as, for example in an 
American medical dictionary from 1951 as: 
A n inactive substance or preparation, formerly given to please or gratify 
a patient, now also used in controlled studies to determine the efficacy of 
medicinal substances. (Dorland, 1951) 
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Henry Beecher's paper The Powerful Placebo (1955) was highly influential in establishing 
the clinical significance of placebo effects. The paper employed informal meta-analytic 
methods to estimate the proportion of patients who benefited from placebo in 15 
controlled trials, along w i t h the magnitude of the placebo effects observed. These 
estimates may have understated the variability in responding, and overstated the size 
of the placebo effects observed (de Craen et al., 1999), but the paper was widely read 
and provided an impetus for further basic research, including the search for the placebo 
responder—a person for w h o m placebos would be consistently effective. 
Al though the existence of placebo effects provided a justification for the use of 
controlled trials, large placebo responses made the task of identifying statistically signif-
icant differences between verum and placebo treatments more difficult. Although many 
contextual variables responsible for variation in group-level placebo effect sizes were 
identified (for instance the colour or number of placebo pills, or the improved effects 
of injections compared to orally-administered placebos), identification of a placebo-
responding type' proved elusive (Liberman, 1967) a failure that was frustrating to both 
tr ia l organisers seeking to minimise placebo response rates and clinicians who might 
have practical uses for this information. 
I n addition to these frustrations, the 1960s and 70s saw an increasing regard for 
ethical issues, specifically the requirement for informed consent and the active partic-
ipation of patients in treatment decisions. The paternalism which had characterised 
earlier doctor-patient relationships became increasingly unacceptable. Taken together, 
these factors appear to explain the increasingly pejorative characterisations of placebos 
amongst medical professionals: not only were placebos a nuisance in clinical trials, they 
were deceptive, unethical, and therefore inadmissible, in clinical practice (Wall, 1992). 
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During the 1990s, re-analysis of data from clinical trials prompted a new critique of 
the placebo, wi th some researchers claiming that placebo effects may be entirely illusory, 
and the straightforward result of methodological biases. In reappraising Beechers 
original study (1955), Kienle and Kiene (1997) argued that none of the 15 studies 
used provided direct evidence for placebo effects, and that 'spontaneous improvement, 
fluctuation of symptoms, regression to the mean, additional treatment, conditional 
switching of placebo treatment, scaling bias, irrelevant response variables, answers of 
politeness, experimental subordination, conditioned answers, neurotic or psychotic 
misjudgment, psychosomatic phenomena, [and] misquotation could account for the 
pattern of results (p. 1311). Asbj0rn Hrobjartsson and colleagues (2001 and 2004) 
presented meta-analyses which estimated the average effect sizes observed for placebo 
groups in RCTs. The authors found 'little evidence in general that placebos had powerful 
clinical effects'; that there were 'no significant effects on objective or binary outcomes'; 
and that 'outside the setting of clinical trials, there is no justification for the use of 
placebos' (Hrobjartsson and Gotzsche, 2001, p. 1594). Although the authors have 
been criticised for ignoring the potential for variation in effect sizes between conditions 
(Kirsch and Scoboria, 2002), the conclusions stand as a recent example of the conception 
of placebo as 'inert substance'. 
Finally, it should be noted that the conception of placebos as an inert compara-
tor—akin to the 'chemists' blank' (Shapiro, 1959)—has not been confined to the field 
of medicine. As psychotherapeutic research adopted quantitative methods the terms 
'specific' and 'non-specific' came into common use, w i t h the implication that psychother-
apies, like pharmaceuticals, had both active and placebo components (Caspi, 2002). 
This logic is inherent in 'dismantling' or 'component' studies of psychotherapies (e.g. 
Jacobson et al., 1996). Although the use of the term 'non-specific' as a synonym for 
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placebo is common, the example of psychotherapy neatly highlights the theoretical 
weaknesses inherent in the characterisation of placebos as 'inert' (Kirsch, 1985a, 1986). 
'Non-specific' components of treatment i n psychotherapy are held to be those which are 
not deemed necessary by a particular psychotherapeutic approach—for instance the role 
of 'unconditional positive regard' f rom the therapist in Cognitive Behaviour Therapy. 
However other theoretical approaches may deem these components to be central to 
the treatment process (Rogers, 1946, 1951; Frank and Frank, 1991). I n the absence of 
consensus among theorists, i t is impossible to term any component of a therapy which 
has beneficial effects as 'non-specific', or a placebo (Kirsch, 2005). 
1.2.3 Meaningful: a therapeutic ritual 
I n parallel w i t h the disinterested medical use of placebos as a form of methodological 
control, some researchers have actively engaged in research on placebos i n their own 
right. I n the course of documenting a wide variety of effects that could be generated 
by manipulating the context i n which a therapy was presented, researchers developed 
increasingly sophisticated conceptions of placebo effects. A n important first step towards 
this more nuanced position was a critique of some of the background assumptions held 
by biomedical researchers. Wr i t ing in 1949, Stewart Wol f argued that research into drug 
effects often lacked ecological validity: 
The effect of administration of a drug or other chemical agent on a bit of 
muscle suspended i n a standard solution is predictable and reproducible 
because it depends only on the pharmacologic action of the agent ad-
ministered. The effect of administration of the same agent on an intact 
organism, however, is not necessarily predictable or reproducible . . . Despite 
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this . . . drugs are often dealt wi th as i f the intact organism were comparable 
to the water bath and little interest has been manifest in factors other than 
their pharmacologic action (Wolf, 1950, p. 100) 
Importantly, Wolf's definition of placebo effects does not require 'inert' substances. 
Psychological effects are one of many influences on the 'end state of the organ', and it 
is the researchers' task to study and explain the complex interactions of these influences. 
In reviewing historical and contemporary definitions of the placebo, Liberman (1962) 
offers one of the first definitions to consider the psychological complexity inherent i n 
placebo effects: 
The effects of a placebo may be quite physical and objective, like the action 
of the adrenal gland or the secretion of gastric juice; however, these effects 
are mediated by the brain and are dependent upon the individual's ability to 
comprehend the cultural symbols (such as piUs, hospitals, injections, and so 
forth) which give meaning to the doctor-patient relationship. The modern 
placebo is an inert substance that does not affect the physiology or chemistry 
of the body directly. A lactose tablet or an injection of water or saline 
usually serves this purpose. But the placebo is no modern invention and 
its frequency of use is not l imited to lactose tablets and saline-filled syringes. 
(Liberman, 1962, p. 761) 
This definition contains several important elements: First, placebo effects may have 
objective, specific effects on physiological functioning. Second, the placebo need not 
be inert, although it should not directly affect the physiological function of interest. 
Third, the effect of the placebo is psychologically-mediated, and depends upon the 
meaning of the substance or procedure used. Later writers, drawing on anthropological 
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and cultural-historical perspectives, similarly emphasise the importance of meaning 
in placebo situations (Kaptchuk, 2002; Moerman, 2002). I n these accounts rituals are 
at the heart of all human activity and may have a rich array of meanings for those 
performing them; the term placebo effect denotes the beneficial consequences that are 
solely attributable to the performance of a particular ritual. Thus placebo effects are in 
fact meaning responses (Moerman and Jonas, 2002), and the placebo itself is merely an 
object or procedure included i n the r i tual—in theatrical terms, a prop. Defining placebos 
as props w i t h i n meaningful rituals avoids the logical inconsistency inherent in 'inert' 
definitions. Additionally, this new definition places placebos in a longer and richer 
historical tradit ion of patient-practitioner interactions, and encourages researchers to 
consider the fu l l gamut of placebo phenomena, and not simply the improvements noted 
i n the control groups of RCTs. 
1.3 Psychological mechanisms of placebo responding 
A variety of potential psychological mechansisms have been proposed to explain placebo 
responding, for example attribution effects (Heatherton et al., 1989; Storms and Nisbett, 
1970) or responsiveness to internal states (Liberman, 1962; Beecher et al., 1953). How-
ever only two theories have developed systematic or programmatic research, and yielded 
reliable, replicated results; they are conditioning, and response-expectancy theory. 
1.3.1 Conditioning 
I n a series of early studies investigating habituation effects, Glaser and Whit tow (1953; 
1954) found that when subjects were given a drug w i t h unpleasant side effects, subse-
quent administration of an indistinguishable placebo also produced a large number of 
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side-effects. The authors offered little discussion and no explanation of this finding, but 
this may have been the first demonstration of a conditioned placebo response. Building 
on a model and predictions outlined by Wickramasekera (1980), Voudouris et al (1989; 
1985) demonstrated that both analgesic and algesic (pain-increasing) responses could be 
generated using placebo creams. These studies used a highly controllable pain stimulus^ 
and stimulus intensity was manipulated in concert w i t h the administration of the placebo 
to give the impression of pain reduction or increase in a series of learning trials. In later 
trials, at fu l l stimulus intensity, conditioned participants experienced increased response, 
either positive or negative, to the placebo. I n the early 1990s, this type of evidence 
was used to argue that classical conditioning might be responsible for phenomena, 
including placebo effects, which had previously been considered the domain of cognitive 
psychology (Turkkan, 1991). 
A number of other examples of conditioned placebos can be found in the literature, 
although as noted elsewhere they are relatively rare i n humans (Kirsch, 2004). Examples 
include Flaten et al. (1997) in which a muscle relaxant was used to attenuate eyeblink 
startle responses to a loud tone. After 3 learning trials, participants did experience 
a conditioned placebo response in a fourth tr ial , although the direction of the drug 
effect was reversed, a result more commonly observed in animal studies. CoUoca and 
Benedetti (2006) reviews evidence that patients exhibit a conditioned response to the 
hidden administration of opiates, f inding that respiratory suppression in response to 
placebo is exhibited, outside of conscious awareness, after sufficient doses of morphine 
have been administered. Along w i t h a small number of other studies, this evidence led 
'Unusually, these studies used an lontophoretic pain stimulus. Iontophoresis, involves the repulsion 
of positive potassium ions from the positive pole of an electric ( D C ) current, and drives these ions into 
the skin. This causes a prickling sensation at lower levels of stimulation, and a cramping sensation at 
higher levels. The degree of noxious stimulation is dependent on the amount of current and the duration 
of administration and is independent of skin resistance (Voudouris, 1989). 
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The literature suggests that classical conditioning procedures are one shap-
ing factor but that verbal information can also shape placebo effects. The 
literature also suggests that conditioning procedures and other sources 
of information sometimes shape conscious expectancies and that these 
expectancies mediate some placebo effects; however, i n other cases condi-
tioning procedures appear to shape placebo effects that are not mediated by 
conscious cognition. (Stewart-Williams and Podd, 2004) 
In a short response, Kirsch (2004) argued that, although broadly correct, the authors 
may have overstated the role of purely-conditioned placebos i n humans, i.e. those found 
in the absence of expectancies. Although a purely-conditioned response may exist, for 
Kirsch 'the adaptive advantage of cognition is increased response flexibility' and 'for it to 
convey that benefit... it must be capable of overriding the influence of simpler automatic 
processes'. 
Furthermore, conditioning and cognitive accounts of placebo responses need not 
be conceived as mutually-exclusive—conditioning may be thought of as one, perhaps 
powerful, way in which expectancies can be generated (Kirsch, 2004). Although Mont-
gomery and Kirsch (1997) found that verbal expectancies could reverse conditioning 
effects, a recent paper (Klinger et al., 2007) found that neutral verbal instructions did 
not override a previous conditioning procedure, and that the combination produced 
longer-lasting effects than expectancy alone. Whalley et al. (2008, also reported here 
in Chapter 2) found that experiencing a placebo effect strongly influenced subsequent 
response-expectancies, suggesting that, where it is eff^ective, administering a placebo 
might itself constitute a conditioning procedure. Establishing when and how automatic 
and conscious processes interact is a topic of interest to many researchers, and theories 
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developed elsewhere may be an aid to placebo researchers (for a review of current theory 
in this area see Toates, 1997; Smith and Decoster, 2000). 
1.3.2 Response expectancy 
Response expectancy places placebos wi th in the broader explanatory framework of 
social and cognitive psychology. Kirsch (1985b; 1997) defines a response expectancy 
as the "anticipation of automatic, subjective, and behavioural responses to particular 
situational cues" (Kirsch, 1997, p. 69). Response expectancies are distinguished from 
stimulus expectancies—the expected occurrence of external events. Unlike stimulus 
expectancies, response expectancies are held to be "directly self confirming" (p. 69), and 
are not, for instance, mediated by other psychological processes such as a reduction i n 
anxiety. The response expectancy takes, therefore, the form of a self-fulfilling prophecy. 
Al though the concept of response expectancies is applied in a number of fields (for 
example hypnosis and suggestion) response expectancy theory has become the dominant 
explanatory framework for placebo effects (c.f. Kirsch, 1999). Importantly, response 
expectancies are conceived as immediate and unmediated causes of placebo effects (or 
other changes i n experience). So, although the psycho-physiological details of the effect 
of expectancies is unspecified, no further psychological variables are required to explain 
behaviour. 
As noted above, Kirsch (2004) and colleagues (Kirsch and Lynn, 1999) note that 
conditioned responses may occur outside of consciousness and therefore independently 
of expectancies, although they point to the relatively scarce evidence for this phenomena 
in humans. Importantly, they argue that conditioning should, in most cases, be 
conceived w i t h i n a response-expectancy framework, and that conditioning may prove 
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an important source of information for individuals in generating expectancies. Although 
evidence from other researchers is equivocal regarding the hnks and interactions of 
automatic and conscious processes, it seems hkely that the two systems are linked in 
some form in human placebo responding. Theoretical niceties aside, extensive evidence 
has demonstrated that consciously accessible response-expectancies (i.e. self-reports 
of expectancy) are predictive of a wide range of placebo and related phenomena, for 
example hypnosis or therapeutic benefits obtained via psychotherapy (for a review see 
Kirsch 1997 and Kirsch 1999). 
1.4 What remains unexplained? 
Despite l imited success i n identifying contextual manipulations that modulate the size 
of placebo effects, placebo researchers are still unable to answer many basic questions 
regarding the phenomenon. For psychologists, two issues are particularly pressing. 
First, despite extensive efforts, researchers are still unable to make reliable predictions 
of individual differences i n placebo responding. Second, although extensive evidence 
suggests that expectancies for therapeutic benefit are associated w i t h greater placebo 
effects, it does not necessarily follow that expectancies cause placebo responses in all 
cases. Although the data provide a good fit w i t h response-expectancy theory, in many 
cases it is possible for two theories to explain the same results. Furthermore, there 
remain instances when expectancies do not appear to predict placebo responses, and 
researchers should remain open to the possibility that other psychological mechanisms 
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may be responsible for placebo effects, at least under some circumstances. 
1.4.1 Identifying a placebo responder: 'slippery results' 
There are two questions here: do placebo responders exist, and i f so what characteristics 
do they have? Neither has been satisfactorily answered. 
Liberman (1962) noted that several studies (i.e. Wolf's) had investigated consistency 
of responses to the same placebo, but that no study had investigated cross-situational 
consistency, and goes on to make an important distinction between 'bound' and 'un-
bound' characteristics of individuals that might contribute to placebo responding. By 
'bound' and 'unbound' Liberman refers to characteristics which are either context-
specific, and relate to features of a particular placebo, or are context-independent, and 
apply to responses to all possible placebos. He notes: 
A true consistent placebo reactor would be expected to be affected by 
placebos as an experimental subject and as a patient. He should respond 
to a placebo regardless of where he was or who was administering it. This 
extreme type is unlikely to be numerous, i f existent at a l l . . . No study has 
tested the placebo reactivity of a group of patients or subjects over a wide 
variety of clinical and laboratory situations. Hence, the distinction between 
bound and unbound predispositions is wholly obscured in the literature. 
(Liberman, 1962, p. 772) 
A wide variety of traits have been identified by researchers over the past 50 years as 
potentially related to placebo responding. However, despite positive results in individual 
studies, the overall pattern of findings i n this area has been inconclusive. Inconsistent 
1.4. W H A T REMAINS? 17 
findings have led several reviewers to conclude that there may be 'no such thing as a 
placebo responder' (Trouton, 1957; Brody, 2000; Kaptchuk et al., 2008). 
The problems of conducting research in this area are typified by an early study by 
Knowles and Lucas (1960), who reported a mixed pattern of correlations between symp-
tom reporting following the administration of a placebo and the personality variables of 
neuroticism and extraversion. I n a series of studies, participants were introduced to the 
placebo either individually or in groups of 3, w i t h the following instructions: 
The drug to be administered is a substance which is being tested exper-
imentally in the Research Department. Many effects have been reported 
following its administration and it w i l l help us greatly to have the benefit 
of your personal experience. 
Interestingly, when participants responded alone, positive symptoms predominated, 
whereas in group situations the majority of symptoms were negative. In group situations 
there was a strong correlation between symptoms and neuroticism, r(12) = .74, but 
no significant correlation wi th extraversion, r(12) = .20. However, under individual 
conditions, neuroticism did not correlate: r(46) = .17. The correlation w i t h extraversion 
was again non-significant, and this time i n the opposite direction, r(46) = —.39. These 
results are typical of the field—the authors conclude that " i t is possible... that personality 
factors operate against a background of knowledge and experience, and that where this 
is different, responses that are apparently contradictory in their relation to personality 
dimensions may occur.". However their explanations for the inconsistencies in their own 
results are post-hoc and not replicated in further studies. 
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Although inconsistencies such as these might be attributed to small sample sizes^, 
other more recent findings suggest that an interaction is taking place between charac-
teristics of the person and characteristics of the situation (the placebo). Geers et al. 
(2005a) found that optimists showed greater placebo, as opposed to nocebo responses, 
and that the relationship was reversed for pessimists. Optimism, as indexed by the 
Life Orientation Test, is closely related to negative affectivity and symptom reporting 
(Andersson, 1996). Because symptoms reported i n Knowles group condition were 
mostly negative, but were mostly positive in the individual condition, the correlation 
observed for neuroticism may have been mediated by what Geers has termed valence-
enhancement'—in essence, a form of attentional bias. Thus, even high level traits such as 
neuroticism may, in Liberman's terms, be bound or contextually dependent predictors of 
placebo responding. 
I f predictors of response must be bound to the context in which the placebo is de-
livered, the challenge for researchers is to identify suitable pairings of traits and context-
attributes. Only traits which had broad relevance to a wide variety of placebo situations 
could be expected to correlate w i t h responses w i t h any degree of consistency. In their 
extensive survey of the placebo-personality literature, Fisher and Greenberg (1997) note 
Acquiescence as the only trait w i t h empirical credibility in this regard. A series of studies, 
most dating f r o m the 1960s and 1970s, are cited w i t h positive correlations found for 
placebo responses to various placebos including: a pi l l to induce unspecified symp-
toms among undergraduate psychologists, medical students, and clinicians; placebo 
diazepam prescribed to patients w i t h 'functional psycho-neurotic complaints'; placebo 
chlordiazepoxide for female psychiatric patients; placebo anxiolytics and antidepressants 
•^Assuming a sample of 12 and an effect of r = .4, a study would only have a power of .25, way below 
conventionally-accepted levels today 
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for depressed patients; and finally 'energising' and 'tranquillising' placebos given to 
college students. Some null results are reported, and researchers should always be 
mindful of pubhcation bias; this is particularly the case, as here, when a nul l resuh w i l l 
result in an almost unpublishable paper—there are an almost infinite number of traits 
which could predict placebo responses, and editors may be especially unwill ing to give 
space to this type of null finding. However, this sequence of studies represents the clearest 
evidence for a trait that might predict a broad-spectrum of placebo responses. 
1.4.2 Non-expectancy mediated placebo effects 
The concept of response-expectancies (and of expectancies in general) has been hugely 
influential in the study of placebo effects; where authors list determinants of the placebo 
response, expectancies are at or near the top. Kirsch's original response-expectancy 
paper (1985b) has been cited over 240 times; and a recent review of the psychological 
literature describing placebo mechanisms (Stewart-Williams and Podd, 2004) noted that 
"expectancy construct has largely replaced related mentalist constructs in the placebo 
field, such as faith and hope" (p. 328). 
However, there remains an important objection to concluding that response-expectancy 
theory provides a satisfactory psychological account of placebo responding. Response 
expectancy theory posits that expectancies are (mostly) unmediated causes of changes i n 
subjective experience. However, as noted above, the data supporting this claim is sourced 
mostly from short-term laboratory based studies. Where effects are longer in duration 
or more complex—for instance multidimensional therapeutic responses to psychological 
interventions—it is less clear whether response-expectancies are unmediated predictors 
of outcome (Stewart-Williams and Podd, 2004) and other mechanisms, for example 
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anxiety reduction, may need to be invoked. 
I n practice it is relatively common for expectancy to fail to predict effects in real-
v^orld, relatively long-duration studies. The examples given below do not all fall, strictly, 
w i t h i n a conventional 'placebo paradigms', but do represent a challenge to the complete-
ness of response-expectancy theory. Meta-analyses of double-blind placebo-controlled 
trials of homeopathy show large placebo effects, which add a methodological challenge 
to the demonstration of any additional specific effect (Shang et al., 2005). Because 
of size of this placebo component, response-expectancy should predict outcomes for 
homeopathy, but a large ( N = 202) double bhnd, randomised, controlled trial of a 
homeopathic preparation for asthma (Lewith et al., 2002) failed to find any correlation 
between a surrogate measure of expectancy—attitude to complementary and alternative 
medicine ( C A M ) — a n d the improvements in physiological or psychological outcome. 
Similarly, meta-analyses of sham versus real acupuncture suggest a large placebo effect 
when participants are treated for back pain, (Ernst and White, 1998; Ernst et al., 2002; 
van Tulder et al., 2005), but a large {N = 239) open study found that there was a non-
significantly better outcome amongst those who did not believe in acupuncture (Thomas 
et al., 2005). I n these examples, expectancies were not the primary focus of investigation, 
but more direct evidence is provided by studies systematically reviewed in Delsignore 
and Schnyder (2007). The authors identified studies ( N = 35) that had focussed on 
the relationship between patient expectancies and psychotherapy outcome; only modest 
relationships were found between global outcome expectancies and actual outcomes, 
although relationships for specific-expectancies were stronger. 
In sum, it appears that response-expectancy theory is successful in explaining short-
term effects, and for outcomes where the effect of expectancies can be unmediated (e.g. 
for changes in perception). Although the data are l imited, in more complex situations 
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additional mediating variables may be needed to explain the relationship of expectancies 
to outcomes, and it is possible that other non-expectancy mediated mechanisms are also 
in effect. 
1.5 How and where should we conduct placebo research? 
Early work on placebo effects was conducted i n a wide range of experimental settings, 
including many studies in chnical populations (e.g. Lasagna et al., 1954; Dimond, 1960; 
Liberman, 1964). Wolf (1950) recorded acid secretion and other physiological variables 
i n response to both active and placebo agents, and i n a later paper reported the frequency 
of vomiting after participants received first an emetic and then a placebo to reduce 
the ensuing nausea (Wolf et al., 1957). Other experimenters required participants to 
swallow magnets, enabhng them to demonstrate the effects of placebo instructions on 
stomach motil i ty (Bternbach, 1964), or recorded symptoms reported after participants 
took placebo LSD (Abramson et al., 1955). 
More recently, ethical concerns over invasive intervention and measurement, the 
(lack of) reliability of earlier experimental stimuli and measurements, and increased 
interest in the statistical power of studies, has lead researchers to conduct basic placebo 
research i n more controlled settings (Shapiro, 1979). Often this has involved using 
healthy participants i n research laboratories. Some basic research has continued w i t h 
particular patient populations, for instance using placebo bronchoconstrictors w i t h 
asthmatics (Luparello et al., 1968; Mcfadden et al., 1969; Spector et al., 1976; Isenberg 
et al., 1992; Leigh et al., 2003). However the majority of data relating to psychological—as 
opposed to physiological—mechanisms of placebo responding comes from laboratory 
studies of placebo analgesia, and these tend to use ischemic, heat, or pressure-pain stimuh 
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(see Stewart-Williams and Podd, 2004). 
This focus on placebo analgesia is driven in part by convenience—pain stimuli and 
participant reports are easy to administer and collect—but also by the larger-than-
average placebo effects observed for trials of analgesics. Placebo analgesic effects are 
robust, are corroborated by physiological measurements, and researchers have been 
encouraged by the identification of some of the relevant opiate-mediated mechanisms 
(Levine et al., 1978; Benedetti et al., 1999). There may also have been an aesthetic 
consideration i n the choice of methodology (Feyerabend, 1981)—In the face of strong 
scepticism regarding the importance of placebo effects, using pain stimuli and placebo 
analgesics may have helped to bolster placebo research as 'real science', especially where 
studies required expensive equipment to deliver heat-pain or laser pinpricks (e.g. Watson 
et al., 2006). Additionally, doctors often use placebo analgesia in the face of repeated 
and 'inappropriate' requests for drugs from patients (Nitzan and Lichtenberg, 2004; 
Lichtenberg et al., 2004) and this may have spurred interest in this particular type of 
placebo^. 
Whatever the reason for the focus on analgesia, the effects of placebos are both 
substantial and reliable when administered for many other conditions, both i n and 
outside of the laboratory. Furthermore, responses appear to be quite sensitive to 
differences i n the context of administration. For example, i t is known that responses 
differ w i t h double bl ind vs. deceptive instructions (Kirsch and Weixel, 1988), w i t h larger 
responses observed when no mention of the possibility of receiving a placebo is made. 
This may have important consequences for generahsations made from experimental 
^It is worth noting the often negative attitudes of conventional physicians towards both placebos and 
placebo responders. Goodwin et al. (1979) found that doctors underestimated the effect of placebos and 
used them on disliked or mistrusted patients, often with the intention of identifying malingering or over-
reporting of symptoms. 
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understanding to clinical practice. I f placebos are conceptualised as 'meaning effects' 
(Moerman, 2002) then it is important to study the ful l range of meanings placebo 
substances have for individuals, and demonstrate that the generalisations from current 
theoretical explanations (both psychological and physiological) are warranted. In short, 
researchers should pay attention to placebos which are i n widespread use, effective, and 
which are meaningful for patients. 
1.5.1 Complementary medicine and placebo effects 
Complementary and Alternative Medicine (CAM) is a term ascribed to a wide variety of 
therapeutic approaches which, either for historical or theoretical reasons, fall outside 
the scope of conventional medical practice. C A M therapies are hugely popular, and 
in western countries represent a significant proportion of non-governmental spending 
on healthcare—in the USA expenditure has been estimated in excess of $30 bilhon 
per annum, and this surpasses all non-insured expenditure on conventional physicians, 
including non-insured hospital admissions (Eisenberg et al., 1998; Maclennan, 1996). 
C A M therapies are used by a wide cross section of the population, including military 
personnel (Smith et al., 2007), 
However, despite its increasing prevalence, the evidence base for the majority of 
C A M therapies is surprisingly weak. In a few instances, traditional herbal remedies 
have been found to be as effective as more modern pharmaceuticals (Kirsch, 2003, 
e.g.), however in many other cases this has not proved to be the case (for a broad 
survey of the evidence base for C A M see Singh and Ernst, 2008). Some authors have 
even suggested that the resurgence in traditional or C A M therapies may be the result 
of the difficulty of administering placebos wi th in conventional medicine, and that 
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for conditions w i t h relatively large psychological components and low pharmaceutical 
efficacy they may have much to recommend them (Vozeh, 2003). In practice, use of 
C A M seem immune to both academic debates and the ethical niceties of the medical 
profession. Reporting a qualitative study, Cartwright and Torr (2005) argues: "patient-
practitioner relationship and explanatory frameworks provided by C A M [are] perceived 
as important components of the therapeutic process, irrespective of treatment efficacy" 
(p. 559). 
As such, C A M therapies w i t h no demonstrated advantage over placebo provide a 
useful context in which to conduct placebo research. Even i f 'specific' effects of these 
therapies are found in future studies (which in many cases appears unlikely), existing 
evidence strongly suggests that these remedies induce large psychologically-mediated 
effects, and these are of interest to placebo researchers. Bach flower remedies or essences 
are a good example of this type of C A M treatment. The remedies are manufactured by 
placing a small quantity of flowers in a crystal bowl in ful l sunlight, a process which 
is said to capture the 'essence' of the flower (Bach, 1987). This source essence is then 
diluted many times (perhaps hundreds), and is preserved in bottles w i t h a quantity 
of brandy (approximately 60%). Commercially-available Bach essences are extremely 
popular, but are indistinguishable from a brandy/water solution. Proponents believe 
that the therapeutic effects of flower essences are spiritual in nature, but controlled trials 
indicate no advantage over placebo (Ernst, 2002). 
Bach essences are used i n a number of the studies reported below (Chapters 3, 5, and 
6) because they represent an ecologically-valid placebo which may be given over longer 
periods (e.g. weeks) without the ethical concerns raised by deceiving participants: flower 
essences are effective even when participants are told their use is controversial, and that 
scientists have no evidence for their efficacy (Hyland et al., 2006). 
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1.6 Summary 
Placebo effects are complex and, because of the historical connection between placebos 
and RCTs, many working definitions of placebos have been overly simplistic despite 
the fact that a more sophisticated understanding was developing amongst the placebo 
research community. Two main theories—conditioning and response expectancy—have 
been proposed to explain placebo effects. Response expectancy theorists have been 
particularly active, and have developed an extensive and programmatic range of findings. 
Conditioning effects appear less common i n humans, and it is possible to explain 
conditioned placebo responses wi th in a response expectancy framework. These suc-
cesses notwithstanding, the question of whether placebo responders can be identified 
by personality traits remains, and some real-world placebo effects don't appear to fit the 
response-expectancy model. Furthermore, theoretical placebo research has become too 
focussed on placebo analgesics administered i n laboratory settings to relieve experimen-
tal pain stimuli—other paradigms are available and may have greater ecological validity, 
generahsability, and may help to reveal additional psychological mechanisms of placebo 
responding. It is to these questions that the following work is addressed. 
Chapter 2 
Is placebo responding stable over time and 
between contexts? 
Despite extensive research efforts from the 1950s to the 1980s, reliable trait 
predictors of the placebo response have not been found. This study examines 
whether the failure to find correlates of placebo responding is due to an 
inherent lack of reliability^ in placebo responding, and whether contextual 
variation in the presentation of a placebo decreases reliability of responses. 
Results are discussed with reference to the probability of finding either cross-
situational or context-specific trait predictors of placebo responding^ 
This data has previously been reported in Whalley et al. 2008 
27 
28 
2.1 Introduction 
CHAPTER 2. PLACEBO STABILITY 
Attempts to identify 'placebo responders' make two important assumptions w i t h little 
or no supporting data. The first assumption is that placebo responding is a temporally-
consistent trait of individuals. This is to say, i f a person responds to a placebo on one 
occasion then they w i l l also respond on subsequent occasions. The second assumption 
is that responses to placebos are not context-specific. That is, i f a person responds to one 
placebo, they w i l l also be more likely to respond to other placebos, even when those 
placebos are presented differently. Where previous research (described in L4.1) has 
attempted to identify generic trait predictors of placebo responding, both assumptions 
are made. Pragmatic attempts to identify 'responders' by observation (for example in 
the 'washout'^ phase of clinical trials), and interactionist perspectives, which consider 
context-specific predictors of response, require only the assumption of temporal stability. 
I n this study, both assumptions—that there wi l l be temporal consistency in response 
to a single placebo, and that placebo responding w i l l be a generic characteristic of 
the person—are tested. To facilitate this task, the study was designed to optimise the 
l ikel ihood of f inding consistency. Specifically, responses to identical placebo treatments 
were assessed on two separate occasions because i f consistency cannot be found w i t h all 
other factors held constant it is unlikely to be found at all. Second, the study tested the 
additional assumption of the generic hypothesis: that an individual's response to placebo 
should show consistency between contexts. To this end responses to two placebos 
were measured, which differed only i n name. I f consistency can be disrupted by a 
^Washout phases are used in dinical trials in an attempt to exclude individuals who respond to placebos, 
and thus to increase the observed drug/placebo difference. Typically, a washout phase will involve all 
patients receiving placebos for the first 10-14 days of a trial, after which those patient whose symptoms 
improve will be excluded. 
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simple change in name then the discovery of a generic 'placebo responder' would seem 
unlikely. Finally, the study assessed the extent to which contextual variables (response 
expectancy), and generic traits that had previously been implicated as potential person-
ality correlates of placebo responding (acquiescence and absorption), were predictive of 
actual placebo responses. 
2.2 Methods 
Generating placebo responses Determining the consistency of placebo responses over 
time requires a repeatable and reliable experimental or clinical setting. The only previous 
investigation of temporal stability of response, in addition to being limited by a small 
sample ( N = 21), used a relatively insensitive measure of placebo outcome: Participants 
were taking part in a trial of various agents (an unspecified number) intended to reduce 
nausea following the administration of an emetic. Analysis was made of a further series of 
7 responses wi th placebo versions of these agents. Placebo response was operationalised 
as the absence of nausea and/or vomiting i f this had been experienced after an earlier 
administration of the emetic. Ih i s outcome variable was dichotomous and partial 
alleviation of symptoms was not recorded. The size of placebo efi^ ects is also known to be 
dependent on the size of the effect of the active drug the placebo replaces (Evans, 1974), 
and if participants beheved they were receiving different drugs on each occasion this 
may explain some variability in placebo responses recorded, making reliability harder to 
establish. 
In contrast, recent work on placebo analgesia has successfully employed a combina-
tion of placebo creams with a painful stimulus to the fingers (Montgomery and Kirsch, 
1996), and this was the approach adopted here. 
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Figure 2.1: The original Forgione-Barber pain stimulator 
Pain s t i m u l i Two identical Forgione-Barber Strain Gauge Pain Stimulators were 
used (the original device is depicted in Figure 2.1 and a new version, used in this study, 
in Figure 2.2). The device consists of a weight (900g) at the end of a movable bar (23 Ig) 
that pivots vertically f rom a stand at one end. The subject's index finger is placed in a 
grooved notch on the top of a 50 m m stand, so that the bar can be lowered gently onto 
the finger. The bar tapers to the point of contact which is 2mm wide. The pain stimulator 
delivers approximately 2041 grams of force to a finger. Two sets of the apparatus were 
used simultaneously, and were adjusted for the right or left hand so that the remaining 
three fingers could rest on the platform between the stand and the bar attachment (see 
Figure 2.2). 
The placebo creams Every eff^ort was made to ensure the creams used in the study 
were plausible analgesic agents because contextual factors including packaging and drug 
colour have previously been shown to effect placebo effectiveness (Nagao et al., 1968). 
Two names were selected for the creams: The first, Tbuprofen', was intended to be 
recognisable as an over-the-counter painkiller and participants were reminded it was the 
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Figure 2.2: Pain stimulator created for this study—both hands were tested 
simultaneously 
active ingredient of remedies including 'Nurofen' and 'Advil' ; all of the participants had 
heard of Ibuprofen. The second name, 'Trivaricaine', was invented by Irving Kirsch and 
had been used to describe placebos in previous studies. Trivaricaine was described as a 
'well-used and effective drug, most often given in hospitals'. Both drugs were described 
as 'safe, well tested, and effective'. It was indicated that any effects of the creams would 
wear off wi th in an hour or two. The creams were constituted from Aqueous cream bought 
from a local chemist. Labels were provided by the chemist; these listed the drug name, 
a fictitious potency (.05% BP^), and the caption 'FOR RESEARCH PURPOSES ONLY', 
and are shown in Figure 2.3. 
Pain intensity and response expectancy ratings Measurements of pain and pain 
expectancy were taken on 11-point scales, w i t h separate ratings taken for each hand. 
Endpoints were marked 0: no pain at all and 10: the worst pain you can imagine. For 
pain ratings participants were asked: 'How intensely did the lever hurt [with/without] 
the cream?' and for expectancy measurements participants were asked: 'How intensely 
'The photograph in Figure 2.3 shows a repUca of the packaging used and a mistake is visible: The labels 
for both creams in fact read: "30g D R U G N A M E .05% C R E A M " 
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Figure 2.3: The placebo packaging 
do you th ink the lever w i l l hurt [with/without] the cream?' 
Trait measures As discussed in the introduction (see 1.4.1, page 16), many researchers 
have attempted to identify stable personality correlates of placebo responding. How-
ever this literature contains many conflicting or unreplicated reports, and only two 
trait measures been associated w i t h placebo responding with any degree of reliability: 
acquiescence (Fisher and Greenberg, 1997) and absorption. 
Acquiescence was measured with the Bass Acquiescence scale (Bass, 1956, see A.2 
on page 212 for individual items), in its original 56-item form. Valid responses to each 
item are yes, no, and uncertain. Bass scale scores are calculated by summing yes responses. 
However, for a reliability analysis we assigned the following scores: yes = 2, uncertain = 
1, no = 0,{a = .80). Ahhough many of the items now appear rather dated or parochial, 
for instance " W h o does not love the opposite sex remains a fool the whole life long" and 
"Success against the odds is the greatest of American ideals", it was felt that creating new 
items, or updating those which appear dated, would not be of significant benefit. The 
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scale measures the tendency to agree w i t h statements posed, and the content of such 
statements is presumed irrelevant. Consequently, amending items that appear strange 
to contemporary readers should not affect the ability of the instrument to measure the 
concept of acquiescence. 
Absorption was measured wi th the 34-item Tellegen absorption scale (Tellegen and 
Atkinson, 1974, see A.3 on page 215 for individual items). Valid responses are 1: yes or 0: 
no. Absorption scores in this sample ( M = 19.1, cr = 5.9) were near-identical to previous 
college-based samples (Glisky et al., 1991). Internal reliability was good (a = .87). 
Procedure Students and staff at the University of Plymouth volunteered for the study^ 
and some of the students received partial course credit in return for participation. During 
the consent procedure participants were told that the experiment was to compare the 
reUability of the two analgesic creams, as described above. To administer the creams 
the experimenter donned surgical gloves. Expectancy ratings were taken after the cream 
was applied, but before the pain stimulus. The study was conducted over two identical 
experimental sessions, between one and eight days apart ( M = 2.5 days, a = 2.0). Each 
session consisted of two trials: on each trial, participants simultaneously received two 
pain stimuli, each to a finger of a different hand. One finger was treated wi th a placebo 
analgesic cream; the other finger was left untreated. For one trial , the placebo was labelled 
"Trivaricaine"; for the other, it was labelled "Ibuprofen", and order of presentation was 
balanced across the sample. Different fingers were used for each trial wi th in a session 
(see Figure 2.4). For half the trials, placebo was administered to a finger on the right 
''A portion of this dataset (30 participants) was previously reported in a dissertation for partial 
fulfilment of an M.Sc. (Psychological Research Methods) at the University of Plymouth. The complete 
dataset has been reported in Whalley et al. (2008). 
34 CHAPTER 2. PLACEBO STABILITY 
Table 2.1: Balancing of drug and finger order 
Drug (trials) Trial 1/3 Finger (treated) Trial 2/4 Finger (treated) 
Ibuprofen (1/3); Trivaricaine (2/4) Left Index Right Middle 
Right Index Left Middle 
Left Middle Right Ring 
Right Middle Left Ring 
Trivaricaine (1/3); Ibuprofen (2/4) Left Index Right Middle 
Right Index Left Middle 
Left Middle Right Ring 
Right Middle Left Ring 
hand and for half to a finger on the left hand. Table 2.1 illustrates the groups created 
by crossing finger and drug order in this way. After the pain stimulus was applied pain 
intensity was recorded. A t the end of their final session participants completed the two 
personality measures and were thanked and debriefed. 
Research ethics The study, as described above, was approved by the University of 
Plymouth H u m a n Sciences Research Ethics panel; specific permission was required 
for the deceptive instructions necessary to generate placebo effects. Participants were 
provided w i t h written briefing materials (see A. 1, on page 209, and once they had read the 
brief were asked i f they had any further questions. I f participants asked questions about 
the creams the experimenter restated information provided in the briefing sheet, and did 
not volunteer any further information. Only one participant asked directly whether the 
creams were placebos, and was told that they were not. However, this participant did not 
return for the second test session and is not included in the analyses below. 
Because deceptive instructions had been used additional time was allowed at the end 
of the final test session for debriefing. Participants were given the debriefing sheet (see 
A . l on page 210) and asked to read it before leaving the laboratory. No participants 
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appeared upset and many requested to be sent details of the research findings. Although 
a funnel debriefing procedure was not used the experimenter made informal inquiries 
to determine participants' perceptions of the study: the majority expressed surprise that 
the creams were not genuine. 
2.3 Results 
Seventy-eight participants were recruited for the study. O f these, 75 completed both test 
sessions and are included in the analysis which follows. The sample was predominantly 
female (66%) and young (mean age = 21 years, a = 4.9). Multiple one-way analyses of 
variance showed no significant effects for gender on any of the raw or difference-score 
variables (i.e. placebo or expectancy scores, see below), and male and female responses 
are combined i n the analysis below. 
C o m p u t i n g placebo scores In order to obtain estimates of the placebo effect observed 
(a) on each tr ial in order and (b) for each drug label in a given session (day), two types 
of placebo score were calculated. This was necessary because the analysis below seeks 
to identify both consistency of response over time (i.e. between sessions) and wi th in a 
given context (i.e. for one or the other of the drug labels). I n both cases this was achieved 
by subtracting reported pain scores for the treated hand from scores for the untreated 
hand^; high scores indicate greater placebo response on a given trial , or for a given drug 
in session 1 or 2. This approach was repeated for expectancy scores, again indexing either 
label or order, by subtracting the expected pain score f rom the treated hand from the 
expected pain score f rom the untreated hand. 
^ A more sophisticated analysis using multiple regression and residualized change produced an identical 
pattern of responses, and for clarity the analysis based on difference scores is presented here. 
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Consequently, the variables Trivaricaine^ Trivaricaine^, Ibuprofen^ and Ibuprofen-^ 
denote placebo responses in session 1 or 2. The variables Trivaricaine^^P '^^ '''"'^ '^^ /^ and Ibu-
profen^^''^'^'""'^^^/^ indicate scores for expectancies for response in session 1 or 2. 
To index order rather than label, difference scores were created for each of the trials, 
in the order the participant experienced them. This ignores the drug label applied in each 
trial. For the variables Placebo^ and Expectancy^superscr ipts indicate the order of 
participants' placebo responses and expectancies for response. Thus, Placebo^ is the first 
response in the first session, and Placebo^ is the second response in the second session, 
although for individual participants the drug labels used in these trials w i l l have varied. 
D i d the creams generate a placebo effect? Mean pain ratings, w i t h and without the 
placebo cream, are presented in Table 2.2 for each trial . To test for effects of the creams, 
a repeated-measures A N O V A (drug label, session, and treatment) was performed. A 
significant main effect was found for placebo treatment, F ( l , 70) = 43.61, p < .001 , 
rf- = .38, S.M.D.= .60, indicating that the placebo creams had a moderate beneficial 
effect when compared with no cream. However, no effect was found for drug label 
indicating that effects of Trivaricaine and Ibuprofen were equivalent. No other significant 
main effects or interactions were found. This analysis was repeated w i t h inter-session 
interval as a covariate and this indicated that the length of the delay between test sessions 
did not affect the rehability of placebo responses. 
Were responses temporally consistent? First, a test was performed to determine 
whether a person who responded to a placebo in Session 1 was more likely to re-
spond to the same placebo in Session 2. Large correlations between Trivaricaine^ and 
Trivaricaine^, r(69) = .60, p < .001 , and also between Ibuprofen^ and Ibuprofen^, 
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Table 2.2; Means (and a) for pain intensity scores (N=71) 
Placebo Name Time 1 Time 2 
Untreated Treated Untreated Treated 
Trivaricaine 
Ibuprofen 
6.56 (L80) 
6.61 (1.75) 
5.32(1.89) 
5.69(1.86) 
6.83 (1.78) 
6.68 (1.73) 
5.46 (1.95) 
5.78 (2.03) 
r(69) = .77, p < .001 , indicate a strong relationship between responses to the same 
placebo on different occasions. 
Were responses consistent across contexts? Correlations were used to test whether 
a person who responded to one placebo would be more likely to respond to a second, 
differently-labelled placebo. Because correlations between TrivaricaineV Trivaricaine^ 
and IbuprofenV Ibuprofen^ were large, scores were combined for each cream creating 
a mean Trivaricaine placebo score and a mean Ibuprofen placebo score. There was no 
significant relationship between mean scores for the two placebos: r(73) = .05, p = .64 
. A n analysis using individual scores f rom each trial produced near-identical results. 
D i d personality measures correlate w i t h the placebo effect? Correlations between 
the personality variables, placebo responses and expectancy responses are shown in 
Table 2.3. No significant correlations were found w i t h placebo responses, although 
one significant correlation was found between Trivaricaine^^P '^^ '""'^ ^^ and Absorption. 
No further correlations were found w i t h placebo or expectancy scores when collapsing 
across drug (i.e. mean of Trivaricaine^ and Trivaricaine^); session (i.e. mean of Placebo^ 
and Placebo^); w i t h any of the placebo scores for occasions of administration (i.e. 
Placebo^"^); or finally, w i t h the maximum placebo response exhibited i n any of the trials 
(i.e. the largest value of Placebo^"^). 
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Table 2.3: Correlations of personality, placebo, and expectancy scores 
Absorption Acquiescence °-
Placebo responses 
Trivaricaine Session 1 .06 . -.05 
Trivaricaine Session 2 .02 .02 
Ibuprofen Session 1 -.06 -.02 
Ibuprofen Session 2 -.06 -.04 
Expectancy scores 
Trivaricaine Session 1 .28* .13 
Trivaricaine Session 2 .10 .10 
Ibuprofen Session 1 .03 .07 
Ibuprofen Session 2 .01 .01 
*p < .05 
Inter-correlation between the scales was .44*** 
Previous work on reliabiUty of placebo responses had suggested that groups of 
patients who respond either positively or negatively to a placebo may have more i n 
common w i t h each other than w i t h those who do not respond at all (Shapiro, 1979). To 
examine this possibility, a follow-up analysis was performed including only participants 
who exhibited a placebo or a nocebo response (i.e. those participants who did not have 
a placebo difference score of zero). For participants who scored > 0 on Trivaricaine^ 
the correlation of Trivaricaine^ w i t h Acquiescence was r(40) = .41, p < .01 ; and for 
absorption r(41) = .30, p = .06 . For participants scoring < 0 on Trivaricaine^ the 
correlations were: Acquiescence r(9) = —.59, p = . 10 ; absorption r(9) = .20, p— .61 
. This analysis was repeated for Ibuprofen scores, but none of the correlations approached 
significance (all r's = 0, ±.05). This suggests that, for those people who d id show a 
placebo response to Trivaricaine, then the strength of the placebo effect was greater i f 
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Table 2.4: Correlations of placebo and expectancy scores on each trial 
Expectancy^ Expectancy'^ Expectancy^ Expectancy'^ 
Placebo^ .33** .43*** .57*** .24* 
Placebo^ .25* .19 .30* .60*** 
Placebo^ .10 .28* .42*** .65*** 
Placebo^ .18 .21 .45*** .59*** 
*p < .05;**p < M\***p < .001; Placebo^ = placebo scores on successive occa-
sions; Expectancy'"^ = expectancy scores on successive occasions. 
they were high i n Acquiescence and Absorption. 
Did response-expectancy predict the placebo effect? Correlations between expectancy 
and the placebo effect on each tr ia l are reported i n Table 2.4. Init ial response expectancies 
prior to any experience w i t h either placebo cream (Expectancy^, were significantly 
correlated w i t h Placebo^, and they were also significantly correlated w i t h Placebo^ (in 
which the placebo had a different name). Trial one expectancies (Expectancy^) d id not 
significantly predict Placebo^ or Placebo^. In all cases, expectancies were significantly 
associated w i t h the size of earher placebo effects, suggesting that participants' response 
expectancies were altered by experience. However, mean expectancies did not change 
between session 1 and 2 for either Trivaricaine, ^(70) = 1.10, ns , or Ibuprofen, 
t{70) = - . 0 7 , n s . 
Did response-expectancies mediate the consistency of placebo responses? To test the 
mediating effect of expectancy when the drug label remained the same, expectancy scores 
(e.g. Expectancy^ or Expectancy^) were regressed on placebo scores (e.g. Placebo^ or 
Placebo^) w i t h the previously-experienced placebo response for the same drug label 
controlled (e.g. Placebo^ or Placebo^). Because there were substantial correlations 
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between the expectancy ratings and prior (same name) placebo effects included in these 
analyses (ranging from r = .30 to r = .65), these regressions should be interpreted as 
conservative tests, although assessments of multicollinearity did not reveal excessive 
cause for concern (maximum VIF in any regression = 1.57). Then the analysis was 
repeated, this time controlling for earlier placebo responses to the differently-labelled 
drug (e.g. regressing Expectancy^ and Placebo^ on Placebo^). The results of all the 
analyses are displayed in Table 2.5. For same-placebo prediction, response expectancy 
was a significant partial mediator of the consistency between Placebo^ and Placebo^, 
but not between Placebo^ and Placebo^. For all three different-placebo models, prior 
placebo responses to different drugs predicted negatively or not at all, and expectancy 
was a significant predictor of the placebo response. Thus, expectancy was a significant 
predictor of responses, but where data for previous responses to the same cream were 
available expectancy did not completely mediate the consistency of responses. 
Mult icol l ineari ty Because there were substantial correlations between the expectancy 
ratings and prior (same name) placebo effects included in these analyses (ranging f rom 
r = .30 to r = .65), these regressions should be interpreted as conservative tests (Kirsch, 
personal communication). However, as David Kenny has observed, 'multicollinearity 
is to be expected in a mediational analysis and it cannot be avoided' (2003). Kenny 
estimates that the effective sample size for highly coUinear regressions is N ( l — r^) 
where r is the correlation between the distal independent variable and the mediating 
independent variable. A n effective sample size for these analyses is therefore between 45 
and 48, and the study is sufficiently powered for this analysis. 
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Table 2.5: Regression Analyses of Placebo Effects Predicted by Expectancy and Prior 
Experience 
DV Same-placebo predicting Different-placebo predicting 
IV's IVs 
Placebo T - - Placebo^ -.27* 
- - Expectancy^ .31* 
Placebo i' Placebo^ .50*** Placebo^ .13 
Expectancy^ .14 Expectancyr^ .39** 
Placebo 4^  Placebo^ .61*** Placebo^ -.12 
Expectancy^ .22* Expectancy^ .67*** 
° adj. = .069 
''7^2 adj. = .330 and.169 
" adj. = .570 and .333 
*p < .05;**p < m\***p < .001 
Placebo 1 = first response, irrespective of label 
Expectancy 1 = expectancy for first response, irrespective of label 
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2.4 Discussion 
Placebo responding appears to be temporally consistent but contextually dependent 
W i t h contextual factors held constant responses to a single placebo were highly reliable; 
under these circumstances there is temporal stability in placebo responding. However, 
participants' responses to the different placebos used i n this study were not consistent, 
indicating that even very small changes in the context of presentation can affect i n -
dividual differences in the placebo response. These data suggest that the search for a 
generic placebo responder—one who responds consistently to placebo across different 
situations—may never be successful. For that reason the failure to f ind an association 
between placebo responses and generic personality measures (i.e. measures that are not 
paired wi th the context in which the placebo is presented) is unsurprising. I f reliable 
prediction of a placebo response by a trait-like characteristic is possible, i t w i l l only be by 
selecting predictors that are consistent w i t h the context in which the placebo is presented 
(Geers et al., 2005b,a; Hyland et a l , 2006). 
Response expectancies were only modest predictors of placebo response Because 
response expectancies are context-specific, they are better predictors of placebo response 
than the generic trait measures included in this study. The cleanest measure of this effect 
is the correlation between init ial expectancies and the initial response to placebo (see 
Table 2.4). However, this reveals only a modest association, suggesting that, at best, 
expectancy only partially explains the placebo responses observed in this study. This 
finding is consistent wi th recent work on placebo, hypnotic, and suggestive analgesia 
(Price et al., 1999), in which expectancy only partially mediated the effect of the type of 
treatment on outcome (pain intensity). 
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Placebo effects were strongly associated w i t h subsequent expectancies, suggesting 
that the experience of placebo effects altered participants' expectations for future re-
sponding. This may account for larger correlations observed between expectancies and 
placebo responses in later trials. When controlling for prior response to the same-named 
placebo, analysis revealed that expectancy weakly and inconsistently mediated the effect 
of a response to one placebo on later responses to that same placebo. There are a number 
of possible explanations for the unexpectedly modest results obtained for expectancy in 
the mediation analysis above. One possibility is that there is little change to account for. 
The high correlations between trials of the same placebo could be interpreted as the test-
retest reliability of this measure of the placebo effect. I f this were the case, differences 
i n response f r o m one trial to the next would be error variance, which could not be 
predicted rehably by any variable. However, the problem remains that, even using the 
cleanest measure of expectancy (the correlation of Expectancy^ and Placebo^, around 
90% of the variance is unexplained. It may be that other context-specific characteristics 
of the person determine the response to a placebo, a possibility explored in more detail 
i n later chapters. It may also be that the measurement of expectancy was at fault-either 
because it is unreliable ( in future, multiple items could be used to reduce measurement 
error), or because they do not capture the ful l range of expectancies for benefit which 
participants may have. For example, i f response to placebo were due to imphcit as well 
as explicit response expectancies, the fact that only measurements of exphcit expectancies 
were taken might have attenuated the level of mediation observed. Work i n other fields 
has alerted researchers to the extent to which non-conscious processing can influence 
behaviour without provoking verbal reports (Bargh and Chartrand, 1999; Cleeremans 
et al., 1998). It follows that verbal reports of expectancies may not exhaustively measure 
the extent to which a people are processing and responding to features of a given placebo 
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setting. 
It is worthy of note that no significant gender differences were found in this study; 
neither placebo and expectancy scores nor raw pain scores differed for males and females. 
Laboratory studies generally show greater pain sensitivity and lower pain thresholds for 
women than for men (Keogh, 2006) and, although variations exist between different 
methodologies, pressure pain normally produces medium to large effect sizes for gender 
on pain threshold and tolerance (Riley 3rd et al., 1998). It may be that visual analogue 
scale ratings of pain are less sensitive to gender differences, or that taking simultaneous 
ratings of treated and untreated fingers caused participants to use the scales in an atypical 
manner. 
Practical implications for clinical trials A practical implication of these data is that 
initial response to a placebo, as might be obtained during the r u n - i n phase of a chnical 
trial , may be the best way of identifying placebo responders. However, some caveats are 
in order. First, designers of clinical trials should pay close attention to the transition 
between the 'washout' phase and the main part of the triaL Data f rom this study have 
demonstrated sensitivity to even relatively minor contextual cues. I f the experience 
of patients differs between these two phases then patients who did not respond to the 
'washout placebo' may still exhibit placebo responses when taking the (presumed) active 
agent. Relevant cues might include hints f rom physicians, a change in drug packaging, 
or even side effects experienced by patients-an 'active placebo effect' (Thomson, 1982). 
I f such cues do alter the subset of patients who exhibit placebo responses then this may 
account for the relatively l imited success of placebo washout phases when used in clinical 
trials (Posternak et al., 2002; Trivedi and Rush, 1994). 
Second, unhke the present study, placebo controlled chnical trials contain double 
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b l ind instructions such that participants are aware that they might receive a placebo. 
I n contrast, the instructions in this study were deceptive—participants were told that 
they would receive an active substance, and in this respect was similar to a comparative 
drug study without a placebo. Double-blind instructions have been shown to produce 
smaller placebo effects than do deceptive instructions, where no mention is made of 
the possibihty that participants may receive a placebo, in previous laboratory studies 
(Kirsch and Weixel, 1988; Geers et al., 2006). Third, the experiment itself was not 
double b l ind ; although the experimenter took care to record pain scores without sight 
of previous scores, it is possible that participants were responding to implicit demands 
of the situation (i.e. to be consistent). Fourth, a funnel debriefing procedure was not 
employed, and the data collected do not speak to participants impressions of or beliefs 
about the study. One explanation for the weak correlations between responses to the 
different drugs is that participants beheved that only one of the creams was genuine, and 
that the other was a placebo control. Anecdotally, none of the participants expressed this 
view, but i t is possible that participants' background knowledge of placebo-controlled 
trials (which often compare verum w i t h a placebo) informed responses in this study. 
Fourth, this study employed an experimental pain stimulus in the lab, and it is impossible 
to know whether these results w i l l generalize to clinical contexts. Finally, data on placebo 
analgesics might not generalize to other types of placebos. For this reason, tests of 
consistency of placebo responding should also be conducted w i t h other types of placebos. 
Conclusion 
The search for predictors of placebo responses is reahstic, but close attention must be 
paid to the meanings ascribed by participants to the specific placebos used. The search 
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for a generic placebo-prone personality is unlikely to be successful. However, these data 
suggest that a context-specific approach may bear frui t . 
Chapter 3 
Contextual identification of responders for a 
placebo complementary therapy 
Most placebo research is conducted within a response-expectancy frame-
work, and studies often employ experimental pain stimuli and placebo anal-
gesics. However, real-world placebos are taken in a wide range of contexts, 
and results are sometimes hard to explain without reference to other mech-
anisms of placebo action. Hyland et al. (2006) reported that dispositional 
spirituality predicted response to a popular but biologically inert comple-
mentary therapy, and this study is replicated and extended. Additional 
measures of outcome and proxy measures of expectancy are included; this 
provides a more conservative test of the hypothesis that the relationship 
between disposition (spirituality) and placebo responding is unmediated 
by expectancy. A working hypothesis—that motivational factors may be 
involved in longer-term therapeutic response—is examined by including a 
motivational priming task^. 
This data has previously been reported in Hyland et al. 2007 
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3.1 Introduction 
The results of study 1 suggest that generic trait predictors of placebo responding are 
unlikely to be found. Nonetheless, responding was consistent when the name of the 
placebo—the context—was held constant. This confirms that it may be possible to 
identify predictors of placebo responses where the predictor is related to the context of 
treatment. 
Disposit ional predictions of placebo responses. I n a previous study, Hyland et al. 
(2006) identified that a dispositional variable, the motive for spirituality, predicted the 
degree of therapeutic benefit experienced when participants took a a very distinctive 
type of placebo: a Bach flower remedy. The authors performed a mediation analysis and 
found that this prediction was not due to increased expectancies for benefit held by those 
participants who scored highly on the spirituality scale. This finding is novel because, 
although expectancy has failed to predict outcome in other studies, the identification of 
a dispositional predictor of outcome that is not mediated by expectancy indicates that 
there may be additional psychological mechanisms at work. 
Hyland et al. (2006) avoided premature explanation of the spirituality—outcome 
correlation. However they noted that the effect might be explained by greater optimism 
i n spiritual participants. Opt imism (Scheier et al., 1994) and spirituality (Saroglou, 2002) 
both correlate negatively w i t h neuroticism, and optimism correlates w i t h a number of 
spirituality scales (Salsman et al., 2005); this shared variance might explain the benefits 
observed for spiritual participants. 
Replicating Hyland et al. (2006) I n order to both replicate and extend the resuhs of 
Hyland et al. (2006), this study employs a similar methodology, but includes additional 
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measures of outcome and dispositions, and allows for a more conservative test of the 
hypotheses that the relationship between disposition and response is independent f rom 
expectancy. Finally, a goal-priming task was included w i t h the intention of exploring the 
role of goal activation in therapeutic response to flower essences. 
Addi t ional outcome measures Both practitioners and users of complementary thera-
pies report benefits of treatment that extend beyond the symptoms for which assistance 
was originally sought. A qualitative analysis of patient reports lead Cartwright and Torr 
(2005) to conclude that ' C A M serves a variety of functions beyond the explicit relief 
of symptoms'. Users describe these benefits as both physical enhancing relaxation, 
increasing energy etc. and emotional facilitating coping, enhancing self-other 
awareness. 
Homeopathic practitioners expUcitly recognize and value the 'multidimensional' 
nature of patient responses to treatment (Oberbaum et al., 2005). Oberbaum et al. 
claim that a homeopath's patients are hindered by lack of appropriate language when 
describing therapeutic changes, concluding that, in this regard, it is an 'imperfect conduit 
for expressing the ful l gamut of human experience'. 
However, they note that practitioners often report benefits for patients that are 
additional to the reduction of the symptoms for which they were treated. Such benefits 
include amnesia of secondary complaints; holistic improvements in functioning, beyond 
those which could be expected by 'mere physical amelioration of the primary complaint; 
and altered perceptions of environmental factors—for example that significant others 
may appear calmer, kinder, or more appreciative. In an attempt to capture this broader 
sense of benefit, this study includes additional outcome measures, which are not directly 
related to the intended treatment: a rating of general wellbeing, and a short measure 
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of Antonovsky's Sense of Coherence scale (SOC; Antonovsky, 1993; Schumann et al., 
2003). 
A d d i t i o n a l dispositional predictors Although Hyland et al. (2006) used a validated 
measure of spirituality, the Spiritual Involvement and BeUefs Scale-Revised (SIBS-R, 
Hatch et al., 1998), includes some items relating to organised religion or spirituality of a 
particular denomination (e.g. T have experienced healing after prayer'). I n this study, a 
new measure of spirituality was included to eliminate this potential bias. 
Because shared variance between spirituality, optimism and neuroticism had been 
suggested as an explanation for the relationship between spirituality and outcome, a 
measure of optimism was also included in the questionnaire battery. Geers et al. 
(2003, 2005b) had found that optimism predicted placebo responding where positive 
expectancies for change were induced, and that where negative expectations were induced 
then opt imism protected against nocebo effects. Although flower essence therapy 
is longer i n duration and used to create more varied therapeutic effects than the 
therapy used i n Geers' studies, the materials used to advertise and explain the study 
included phrases such as: 'Many people find flower essences to be helpful', and are 
therefore likely to have induced positive expectancies for change among participants. 
Including a measure of optimism enables the identification of any mediation of the 
spirituality—outcome correlation. 
Context manipulat ion/motivat ional pr iming task Complex social behaviours can 
be triggered non-consciously, and even very subtle manipulations appear to activate 
behavioural concepts sufficiently to alter subsequent behaviour (Bargh, 2004). Primes, i n 
the f o r m of words, pictures or social situations, may engage stereotypes of social groups 
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or categories, or may facilitate focus on social or interpersonal goals. For example, when 
words related to the goals of achievement or co-operation are embedded along with other 
goal-irrelevant words in a puzzle, these words serve to activate goals and guide behaviour, 
sometimes over extended periods of time. Participants primed w i t h achievement-related 
words perform better than controls; whereas those primed w i t h cooperation-related 
words cooperate more on a commons dilemma type game (Chartrand and Bargh, 2002). 
Such a priming technique might have an eifect on therapeutic response to flower essences 
in one of two ways: 
First, it may be that spirituality-or the desire to be a spiritual person-is an inter-
personal goal in the sense described above. Because dispositional spirituality predicts 
response to a flower-essence placebo, activating the concept of spirituality through a 
spiritual prime might increase placebo responses by making this aspect of a participants 
value system more sahent as they begin the therapy. I n this instance, the expectation 
would be that the average outcome would improve, as the construct of spirituality would 
have greater sahence for all participants. 
Second, an alternative explanation is that pr iming w i t h words such as 'spirituality', 
'love' and 'compassion' might strengthen associations between the concept of spirituality 
and the therapy presented, 'contextualizing' it as a more or less spiritual therapy, and thus 
making it more motivationally appeahng to participants who are high i n dispositional 
spirituality. I f this were the case, a spiritual prime should increase the correlation between 
spirituality and outcome, but without creating an improvement in mean responses to the 
treatment. 
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3.1.1 Hypotheses 
Five hypotheses were proposed (see Figure 3.1). First, that the original prediction 
of placebo responses f rom dispositional spirituality would be replicated (A) , and that 
the new measure of spirituality would be more sensitive than the previously used 
measure. Because adherence is associated w i t h improvements to both true pharma-
cological treatments and placebos (Horwitz et al., 1990; Horwitz and Horwitz, 1993), 
adherence was also expected to predict outcome in this study. Second, that mediation 
analysis would indicate that the dispositional variable predicted variance in outcome 
independently of both expectancy measures (B). Third, that the goal-priming task would 
serve to either (C) increase response rates amongst spiritually-primed participants, or 
(D) increase dispositional correlations (with spirituality) amongst those exposed to the 
spiritual prime. Fourth, i f evidence for optimism—outcome correlations is found, then 
expectancy should mediate this relationship (E). A n d finally, it was also i f interest 
to identify evidence of broader therapeutic benefits in response to flower essences, 
indicating changes that were not restricted to the symptoms for which the essence was 
originally prescribed. 
3.2 Methods 
Overview Participants were recruited for an open tr ial of a Bach flower remedy for m i -
nor psychological symptoms. O n entry, participants chose the essence they judged best-
suited their symptoms, and completed a questionnaire battery that included measures of 
dispositions, baseUne measures of symptoms and weU-being, and expectancy for benefit. 
Participants were also randomised to one of two motivational pr iming conditions before 
receiving their chosen essence and initiating treatment. Follow-up measures were made 
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Figure 3.1: Study hypotheses 
A 
SpirituaHty ' • Placebo outcome 
Placebo outcome 
Placebo outcome 
Placebo outcome 
Placebo outcome 
Expectancy 
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after three weeks via email. 
Recruitment Undergraduate students and members of staff" at the University of Ply-
mouth w i t h m i n o r psychological complaints (e.g. anxiety, depressed mood) were invited 
to take part in an open trial of Bach flower remedies. Posters were displayed, and flyers 
were widely distributed around the University campus by the experimenter and several 
research assistants (third-year undergraduate students). Participants were not paid and 
did not receive course credit. Exclusion criteria were: use of flower essences i n the 
previous six months; age of less than 18 years; currently receiving psychiatric treatment; 
history of alcohol abuse^; participants were required to confirm that they did not meet 
these criteria when providing consent. 
Predictor Questionnaire Assessments 
The Spiri tual Involvement and Beliefs Scale-Revised (SIBS-R) The 22-item 
SIBS-R was the first of two spirituality scales used (Hatch, personal communication, 
2001)^ The SIBS-R is a revised version of an earlier 39-item scale (Hatch et al., 1998) 
that purports to measure spirituality i n contrast to religiosity, although some items do 
refer to activities of organised rehgion (e.g. T have experienced heahng after prayer') or 
to values emphasised w i t h i n particular religious traditions (e.g. 'When I help others, I 
expect nothing i n return'). Participants respond to each item on a 7-point scale, and high 
scores indicate greater spirituality. Although there are more positive than negative items, 
the authors report that the scale is uncorrelated w i t h social desirability (Hatch, personal 
^Because the essences are primarily composed of Brandy this was considered a sensible precaution 
'Scale items Usted in Table A.6 on page 222 
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communication, 2006). We included this scale because it had been used in the earlier 
study, before the development of the Spiritual Connection Questionnaire (see below). 
The Spiritual Connection Questionnaire The second spirituality measure, the 48-
item Spiritual Connection Questionnaire (SCQ-48''), was designed especially for this 
study, and was intended to (a) provide a scale which contained only items relating to 
spirituality and not, for instance, religiosity, (b) to contain equal numbers of positively 
and negatively worded items, mitigating against a response bias, and (c) to be culture 
fair, in the sense that items do not presuppose a particular conception of spirituality (i.e. 
Christian, Buddist, Secular etc). The scale was based on Hunglemanns (Hunglemann 
et al., 1985) definition of spirituality as a "sense of interconnectedness between self, 
others, nature and Ultimate which exists throughout and beyond time and space" (p. 
152). Scale items cover the experience of a "sense of connection" in the following 
domains: with the universe, e.g., " I do not feel connected to the universe in any spiritual 
way"; wi th people, "There is something of the cosmos that binds all people together"; 
wi th nature, " I never feel any special connection w i t h a part of nature such as a flower"; 
and w i t h places, " I sometimes experience joy just from being in a beautiful place". Thus, 
the SCQ-48 is a scale measuring the experience of spirituality as it relates to a sense of 
connection. 
Participants respond to each item on a 7-point scale indicating agreement with the 
item. After correction (reversing scores), scores are summed and high scores indicate 
greater spirituality. The scale is uni-dimensional, w i t h the first factor accounting for 48% 
of the total variance Wheeler and Hyland (2008). Additionally, the scale fails to correlate 
(r = .03) wi th the Marlow-Crowne scale of social desirability (Crowne and Marlowe, 
^ scale items are listed in A.4 
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1960). 
The SCQ-14, which is used in later chapters, was developed as a short form-version 
of the Spiritual Connection Questionnaire, suitable for use in online studies, and in 
situations where there is a large questionnaire burden. Scale items were selected by 
factor analysis, w i t h 7 positive and 7 negatively-worded items chosen. A l l scale items 
loaded > .6 on the first factor of the SCQ-48 in a large public sample (Hyland, personal 
communication). 
Optimism Opt imism was measured using the 10-item Life Orientation Test-
Revised (LOT-R^; Scheier et al., 1994), which contains 6 scored items (3 positively 
worded, 3 negatively worded) and 4 filler items. Participants respond to each item on 
a 5-point scale and higher scores indicate greater optimism. The LOT-R has been found 
to correlate w i t h neuroticism (e.g. Smith et al., 1989). 
Holistic Health Beliefs I n order to provide a more conservative test of the hy-
pothesis that the relationship between spirituality and outcome is not mediated by 
expectancy, we included an additional surrogate expectancy measure: the 11-item 
Hohstic Complementary and Alternative Medicine Questionnaire ( H C A M Q ; Hyland 
et al., 2003). The H C A M Q includes separate, validated sub-scales for 'holistic health 
beliefs' ( H H B ) and 'attitude to complementary medicine' ( A C M ) . Although H C A M Q 
questions do not ask directly about expectancies for response to a flower remedy, they 
do indicate a general positive regard for alternative and complementary therapies; in 
the previous study both sub-scales were strongly correlated w i t h expectancy for a flower 
essence therapy (Hyland et al., 2006). Therefore, the H C A M Q may capture additional 
^ Items are listed in A.5 on 221. 
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variance related to positive expectancies for flower essences that was not accounted for by 
a standard, single-item measure of expectancy. Participants respond to H C A M Q items 
on a 7-point scale, and high scores on the sub-scales indicates greater positivity towards 
complementary medicine, or more 'holistic' health-beliefs. 
Outcome and expectancy measures Whereas Hyland et al (2006) used only perceived 
change as an outcome measure, in this study we measured symptoms before and 
after treatment, and also took self report measures of general well-being. For all 
measures of outcome, measurements of expectancy were made at baseline using adapted 
versions of the outcome assessment question (as recommended by Kirsch, 2006 personal 
communication). 
Perceived change Perceived change following treatment (Change''^ '''^ ^"'^ '') was as-
sessed by e-mail at the end of the study. The e-mail stated: "Thank you for taking part 
in our experiment. You chose: [name of essence] for [symptoms reported]. Below, you 
wi l l see a perceived change scale. Please make a note of the number on the scale that you 
think best illustrates how you perceive you have changed after taking the flower essences". 
Responses were made on a 7-point Likert-type scale ranging from -3: Feel worse to +3: 
Feel better. 
To measure expectancy for perceived change (Expectancy''^'''^^'^^'^), participants were 
asked "At this point in time, do you expect the flower essence wi l l help you?" before 
commencing the therapy. Responses were given on an eight-point scale ranging from 8: 
Yes, I definitely think it will help, to 1: i think it very unlikely it will help me. 
Symptom change At basehne participants rated up to two symptoms for which 
they had selected the flower essence using two, seven-point scales. The end-points were 
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labelled 0: no problem, and 6: as bad as it could be. Participants also provided ratings for 
how they expected symptoms to be after three weeks of treatment w i t h flower essences 
(wi th the first rating in sight). After three weeks, they were asked, via e-mail, to rate their 
symptoms again, but without sight of the original ratings. Basehne (Symptoms*""^^''"^) 
and final symptom scores (Symptoms^""') were obtained by taking a mean value for the 
symptom scores at basehne and final assessment respectively. 
Sense o f coherence Sense of Coherence (SOC) was developed in the late 1970s 
to measure the general tendency to perceive the wor ld as comprehensible, manageable 
and meaningful (Antonovsky, 1979), w i t h the behef that such an outlook was health 
promoting or salutogenic. Sense of coherence correlates w i t h measures of general 
health, symptom reporting, and pain, for example the General Health Questionnaire, 
the Hopkins Symptom Checklist, and the Oswestry Low Back Pain Questionnaire; and 
is negatively correlated w i t h measures of anxiety and depression—for example, the 
Hospital Anxiety and Depression Scale, and the Beck Anxiety Inventory (Eriksson and 
Lindstrom, 2005). Although initially conceived as a relatively stable measure, SOC has 
been found to change in response to both negative life events (Schnydera et al., 2000) and 
homeopathic treatments (Hyland, personal communication, 2001). On this basis it was 
selected as a measure of the broader benefits a C A M therapy such as a flower essences 
might offer. Sense of coherence was assessed using the Brief Assessment of Sense of 
Coherence (BASOC, abbreviated to SOC below), in which each item is rated on a five-
point (0-4) scale (Schumann et al., 2003). The questions included in the BASOC are as 
follows: 
1. Do you have the feeling you are in an unfamiliar situation and don't know what to 
do? 4: very often, 0: very seldomly 
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2. When you think about your life you very often: 4: feel how good it is to be alive, 0: 
ask yourself why you exist at all 
3. Do you have very mixed up feelings and ideas? 4: very often, 0: very seldomly 
Basehne (SOC^"'"''"") and final (SOC^""') scores were the sum of the three items 
at baseline and final assessment respectively; higher scores indicate greater sense of 
coherence. To allow a measurement of expectancy for SOC at baseline (SOC"''^ '^ ^""'^ ^), 
the 3 SOC questions were repeated, and participants asked to answer indicating 'how 
they expected to feel at the end of the study'. 
Well-being In addition to SOC, general well-being was included as a measure of 
broader improvements in psychological function. At baseline participants were asked to 
"Rate your general feeling of well-being during the last week". Responses were taken on a 
scale which ranged from: 6: as good as it could be, to 0: as bad as it could be. Participants 
rated where they expected to be after three weeks of treatment using the same scale. Final 
well-being was measured (via email) using the same scale at three weeks. 
Adherence Adherence is associated wi th improvements to both true pharmacological 
treatments and placebos (Horwitz et al., 1990; Horwitz and Horwitz, 1993), and in this 
study adherence w i t h the therapy was measured with a single item. Participants were 
asked to indicate which statement best applied to them: 4: / took the flower essence 
regularly, 3: / missed doses one or two days per week, 2: / missed doses three or four days 
per week, 1: I missed most of the doses, or 0: I did not take the flower essence. 
Email fol low up Outcome assessment emails were sent 21 days after the test session 
for all participants. Participants who did not reply to the follow-up were sent reminder 
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e-mails one week later. Dur ing the test session a small minority of participants had 
asked to give their repHes via the telephone, and the principal investigator made these 
calls-instead of sending emails-on the appropriate days. The follow-up and reminder 
e-mails requested ratings of perceived change, the two symptoms, well-being, the three 
sense of coherence items, and a response to the adherence question. 
P r i m i n g task I n a task ostensibly unrelated to the main study participants were asked to 
circle every instance of the letter e' in one of two texts, designated as spiritual or neutral 
No time l i m i t was set and participants were requested to be thorough. The spiritual text 
was an excerpt f r o m the Dalai Lamas essay 'Love, compassion and tolerance' (1997); the 
material text was an excerpt f r o m George Orwell's 'The Moon Under Water' (1946)^ 
Scale reliabilities Internal reliability scores (Cronbach's alpha) were computed for each 
scale: L O T - R a = .8S, SCQ-48 a = .96, SIBS-R a = .92, A C M a = .69, H H B a = .52, 
SOC a = .60. In all cases, except for holistic health behefs, reliability was good. 
Procedure 
Recruitment Participants were recruited iising advertisements posted throughout 
the university and at a neighbouring art college. The advertisements offered a free 
bottle of flower essence in return for questionnaire completion. To provide additional 
background information, i f required, the advertisements informed participants of a 
commercial website on flower essences. Participants were told that the flower essences 
were purported to have a therapeutic effect, that this claim was controversial, and that the 
*both texts are included in the Appendix on pages 224 and 227. 
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researchers were investigating flower essences, 
course credit for taking part. 
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Participants were not paid nor received 
The test session O n arrival at the advertised drop-in session participants gave 
written informed consent, and were presented w i t h the list of 38 Bach flower essences and 
descriptions of the conditions for which each essence is indicated for use. Participants 
were told they could chose up to two essences. In addition to indicating their choice of 
essence, they completed the questionnaire pack (SCQ-48, SIBS-R, LOT-R, H C A M Q ) . 
Participants were then asked to provide baseUne outcome ratings (symptoms, well-
being, and sense of coherence), and also to provide ratings on the same scales for how 
they expected to feel after the flower essence treatment (these were used to calculate 
expectancy scores). During the period in which each participant's essence was being 
bottled (the solution was diluted from stock essences provided by the manufacturer) 
participants completed the priming task, randomized to either the spiritual or the 
material condition. Following the prime, participants were given their chosen essences, 
made by placing two drops of stock essence in a 10ml bottle of brandy (60%) and spring 
water (40%) solution. This is the standard procedure for administering flower essences, 
and no deception was involved. Participants were thanked and reminded to expect the 
e-mail follow-up in approximately three weeks time. 
Research ethics The study, as described above, was approved by the University of 
Plymouth Human Sciences Research Ethics panel. No special permissions were required, 
as the study did not involve deceptive instructions (participants were informed of the 
essences' ingredients, and that their efficacy was controversial). 
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Statistical analysis of causation Relationships between variables of interest and a 
dependent variable may not be hnear or orthogonal, and researchers often need to test 
the alternative models of causation in their data. In their influential paper. Baron and 
Kenny (1986) clarify two models of causation-mediation and moderation-commonly 
employed by social psychologists and others, and describe statistical methods to identify 
them. 
Media t ion When two independent variables predict variance in a dependent vari-
able, a mediation analysis may be able to determine which of the independents is the 
proximal cause of changes in the dependent variable. I f one independent variable A is 
seen to be ful ly or partially mediated by another mediator variable B, then it may be 
interpreted as a distal cause of the dependent C. In this case B is the active mechanism by 
which the dependent C is influenced by A. For example, i f lateness in waking and throttle 
position i n a car are correlated, and both correlate w i t h fuel consumption, then the 
relationships between lateness and fuel consumption may be fully mediated by throttle 
position, but lateness remains a distal cause of fuel consumption. In other scenarios, A 
may be found to be epiphenomenal to the relationship between B and C, and considered 
to fall outside of the causal chain: For example, i f height and weight are correlated, 
both may also correlate w i t h incidence of minor head injury from low doorways. I f 
the relationship between weight and injury were fully mediated by height, only height 
(and not weight) would be considered a cause of injury. Unfortunately these distinctions 
cannot be made statistically and must arise from a theoretical understanding of the 
variables i n play. 
Operationally, mediation is identified using three regression equations (see Figure 
3.2). First, to avoid problems of multicolinearity, the independent variable must be found 
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to predict the dependent variable (see a); second, the mediator must be found to predict 
the dependent variable (see b); and third , the mediator must predict the dependent in 
a regression in which the dependent variable is regressed on both the independent and 
mediator variables (see c). Mediation is assessed as the extent to which the previously 
significant relationship between independent and dependent (a) is attenuated when the 
mediator is held constant (c). Where both the independent and the variable labelled as 
a mediator are significant predictors in this th i rd regression they may be said to predict 
the dependent independently, and that the effect of A is partially mediated by B. Two 
important assumptions of this method of estimating mediation are that (a) the mediator 
is measured without error and (b) that the dependent variable not cause the mediator. 
More formally, the Sobel-Goodman tests may be used to establish, statistically, the degree 
to which mediation occurs (Preacher and Hayes, 2004). Bootstrapping (running the 
analysis many thousands of times using resampling w i t h replacement) is typically used 
to quantify potential bias i n both estimates and standard errors. 
Moderation/interaction Where the direction and strength of the relationship be-
tween two variables is affected by the level of a th i rd variable, this th i rd variable may be 
termed a moderator, and the independent and the moderator may be said to interact 
(see Figure 3.3a). Operationally, where the moderator is continuous, moderation 
may be estabhshed by regressing the dependent variable on the independent and the 
moderator, along wi th a th i rd variable comprising the product of the independent and 
the moderator: y = Pq-\- PiXi + P2X2 + P3{xiX2). Moderation is said to occur where 
the product (or interaction) term, Pj, is a significant predictor (also see Figure 3.3). 
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Figure 3.2: Three steps required for a mediation analysis 
Independent Dependent 
Mediator 
Independent Dependent 
Independent Dependent 
Mediator 
METHODS 
Figure 3.3; Conceptual (a) and operational (b) models of moderation 
Independent Dependent 
Moderator 
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3.3 Results 
Sample characteristics and baseline scores Two hundred and forty three participants 
f r o m the university and art college took part i n the first part of the study, of whom 
167 completed follow-up assessments. One person completed the follow-up assessment 
but indicated that they d id not take the essence (because they spilt the bottle) and was 
excluded f r o m the analysis. There were no significance differences between completers 
and non-completers on any of the questionnaire assessments, nor the expectancy mea-
sures, nor gender or age. The fol lowing analysis is based on those 166 people who 
completed assessments, of w h o m two d id not complete the ratings of expectancy^ '^"''^ "'^ '^  
and expectancies one did not complete an expectancy"'^""''""^ rating, and one did not 
complete a rating of change^ '^"'^ "^'^ '^  (details of the calculation of change scores is below, 
see page 68). There were 34 males and 132 females and mean age was 26.4 (range: 19 
to 58). A series of one-way ANOVA's were performed to test for gender differences 
on baseline variables (all the expectancy measures, the two spirituality scales, and 
optimism). Women rated themselves as significantly more spiritual on both measures, 
SCQ-48: F ( l , 165) = 7.06, p = .01 ,77^ = .029; and also tended to be more optimistic 
F ( l , 165) = 3.63, p = .06 , r}^ = .015. No other significant gender differences were 
found. To check that there were no basehne differences between the prime groups 
(spiritual/material), an additional one-way A N O V A was performed for each of the 
baseline measures by group. No significant differences were found between the two 
prime groups for any baseline variable (allp's > .19). 
Calculation o f change scores To facilitate the analyses below, change scores were 
computed for all expectancy and outcome variables except for perceived change, which 
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was measured with single items at baseline and foUowup as described above. Expectancy 
scores were calculated by subtracting final outcome scores from the relevant expectancy 
score taken at baseline, and these variables are denoted expectancy'^"™*''^!. Change scores 
were calculated by subtracting final scores from the relevant baseline scores, and these 
variables are denoted change'*""'"''''^!. Raw baseline and follow-up scores are denoted 
Baselinel^"""'''^! and Finalf™""'''^! respectively 
The therapy 
D i d participants expect flower essence therapy to work? Participants had volunteered 
for a study for which there was a suggestion that flower essences would be beneficial, and 
for which they received neither money nor course credit; it was therefore reasonable to 
expect that participants would have positive expectancies for flower essence treatment. 
Table 3.1 presents descriptive statistics for all expectancy measures, outcome measures 
at baseline, outcome change scores, and dispositional predictors of outcome. 
Figure 3.5 shows the frequency of participants expecting improvement, no change, 
or deterioration, for each of the expectancy measures at baseline. For all outcomes, 
most participants expected the essences would be effective, although there was sufficient 
variation wi th in the population to test the effect of expectancy on outcome. 
Was flower essence therapy effective? Consistent w i t h other studies of flower essences 
without placebo control groups, the remedy was effective for the majority of participants 
on each of the four outcome measures (see Figure 3.6). More than 50% of participants 
had improved scores for changeP"''"'"'^ and c h a n g e " ' " " " 6 3 % had improved SOC 
scores, and over 80% experienced a reduction in symptoms. Although there was no 
control group for comparison-and change may therefore be due to natural history-it 
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Table 3.1: Descriptive statistics for Baseline, change and personality measurements 
n mean a mm. max 
ExpectancyP"'""'""'^ 236 48 1.8 1.0 8.0 
Expectanc/^'"^""" 240 1.5 1.1 -2.0 5.0 
Expectanc/"'^ 235 1.9 1.8 -1.0 8.0 
Expectancy"'^'"'^'"^ 235 1.0 1.3 -2.0 5.0 
Baseline'>""''''""' 240 41 0.97 0.5 6.0 
Baseline'"'^  240 2.9 0.77 1.0 4.7 
Baseline"'""-''"'"^ 240 3.9 1.4 1.0 7.0 
FinaF>""^^°'"^ 168 2.8 1.1 0.0 5.5 
168 3.3 0.76 1.3 5.0 
Finar""-''"'"^ 168 45 1.4 1.0 7.0 
167 47 0.94 1.0 7.0 
Change^>""^f'"" 166 2.7 2.4 -3.0 11.0 
Change^"^ 167 0.4 0.77 -1.7 3.0 
Change"'""- 167 0.6 1.7 -4.0 5.0 
SCQ-48" 233 225.0 49.0 87.0 328.0 
ACM^ 239 0.3 0.76 -1.8 2.3 
HHB'^ 238 1.8 0.48 0.1 2.5 
LOT-R'^ 239 15.0 5.0 6.0 30.0 
Adherence 167 2.9 0.93 1.0 40 
Note: some participants did not complete all of the baseline or 
follow up measures and N s vary accordingly. 
" Spirituality; Attitude to C A M and ' HoUstic Health Beliefs 
sub-scales of H C A M Q ; Optimism. 
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Figure 3.4: Adherence scores (percent) 
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Figure 3.5: Categorized scores for expectancy (percent) 
86.14 
Worse Same Better Worse Same Better 
Expectancy for SOC change Expectancy for wellbeing change 
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is clear from these results why participants may experience flower essences and other 
complementary therapies as effective. 
Hypothesis 1: D i d spirituality predict improved response to flower essence therapy? 
Correlations were computed between baseline measures of expectancy, values and 
attitudes, and w i t h the four outcome measures (Change^"'''^ "'""'^ , change'^""^""", change""^, 
and change"'""^''"'"^). These correlations are displayed in Table 3.3. Spirituality (both 
the SCQ-48 and the SIBS-R) correlated with perceived change, although not w i t h 
change in symptoms, SOC or well-being. As predicted, the SCQ-48 was slightly more 
sensitive when predicting change than the SIBS-R (r = .25 vs. .19). Expectancy mea-
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Table 3.2; Correlations between baseline scores and follow up scores and 
dispositional variables 
Baseline scores Final scores 
symptomi SOC well — being symptoms SOC well—being 
S C Q - 4 8 ' ' 0.07 0.06 -0.01 -0.08 0.04 0.07 
S I B S - R " -0.02 0.15 0.04 -0.11 0.16* 0.12 
A C M ' ' -0.24** 0.01 0.02 0.06 -0.07 -0.03 
-0.09 -0.02 0.03 -0.08 0.09 0.05 
L O T - R ' ^ 0.20* -0.53** -0.37** 0.12 -0.33** -0.22** 
*p < .05; **p < .01; Spirituality;Attitude to C A M and ' Holistic Health Beliefs 
sub-scales of H C A M Q ; Optimism. 
sures predicted change on both matched outcome measures (e.g. expectancy^"'''^"*'"'^— 
change^"''""'"''), and also predicted change on other outcome measures (e.g. expectancy^"'''^' 
change^>""^"""). 
m 
G 
Table 3.3; Correlations between outcome measures and predictors 
1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 
1. ChangeP^'-'^"''^^'^ 1.00 
2. Change^^'^P*""' 0.33** 1.00 
3. Change*"'^ 0.14 0.33** 1.00 
4. Change^""—^"='"9 0.21** 0.45** 0.33** 1.00 
5. ExpectancyP'^'-'^"^"'^ 0.22** 0.23** 0.06 0.05 1.00 
6. Expectancy^2/mptom 0.15 0.36** 0.17* 0.13 0.31** 1.00 
7. Expectancy*"'^ 0.30** 0.27** 0.35** 0.20* 0.31** 0.39** 1.00 
8. Expectancy^""—''" '"9 0.16* 0.17* 0.22** 0.45** 0.18** 0.44** 0.34** 1.00 
9. SCQ-48 ' ' • 0.25** 0.12 -0.03 0.06 0.34** 0.19** 0.17* 0.08 1.00 
10. SIBS-R'^ 0.19* 0.07 0.00 0.07 0.21** 0.03 0.07 0.00 0.78** 1.00 
11. A C M ' ' -0.20** -0.24** -0.08 -0.04 -0.30** -0.23** -0.20** -0.06 -0.37** -0.25** 1.00 
12. HHB<= 0.00 -0.02 0.11 0.02 -0.14* -0.12 -0.03 0.04 -0.28** -0.26** 0.14* 1.00 
13. L O T - R ' ' 0.01 0.05 0.20** 0.11 -0.21** 0.05 0.15* 0.08 -0.28** -0.35** 0.14* 0.15* 
*p < .05; **p < .01 
" Spirituality;Attitude to C A M and Holistic Health Beliefs sub-scales of H C A M Q ; ' ' Optimism. 
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Was the relationship due to correlations w i t h baseline scores? One possible 
explanations for the correlations between change and the dispositional and expectancy 
variables is that these variables are correlated wi th baseline scores. I f this were the 
case, then the relationship w i t h change scores might be due to correlations between 
dispositions and symptom reporting, rather than w i t h real changes. 
Table 3.2 shows the correlations between personality measures and raw baseline and 
fol low-up scores. Optimism correlated with all baseline outcome measures and many 
final outcome measures, and this is consistent w i t h a reporting bias mediated via negative 
afi^ect ( L O T - R is known to correlate wi th neuroticism. Smith et al., 1989). However, of the 
other variables, only attitudes to complementary medicine predicted any of the baseline 
scores (symptoms), indicating that the correlations between dispositional measures and 
change were not simply due to symptom reporting. 
Was adherence associated w i t h better outcomes? Descriptive statistics for adher-
ence are presented i n Table 3.1 and Figure 3.4. Adherence was not associated w i t h 
better outcomes for the single-item measure of perceived change, r(165) = .11, ns 
. For variables wi th baseline and follow-up scores (Symptoms, SOC and Wellbeing), 
regression analysis was performed predicting the follow-up score f rom adherence, while 
controll ing for baseline score. Adherence d id predict changes in sense of coherence, 
13= .19, p < .001 ; but was not associated with changes i n symptoms, (5= —.09, ns , or 
wellbeing (3= .03, ns . 
Hypothesis 2: Was the predict ion of outcome ( from spirituality) independent f r o m 
expectancy? To establish that spirituality predicts variance in outcome independently 
f r o m expectancy three steps are required. First, spirituahty must be correlated w i t h 
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Table 3.4: Standardised regression weights from multiple regression models testing 
mediation hypothesis: dependent variable is Change''''^"'"'^'' 
Model 1 2 3 4 5 
Spirituality 0.21* 0.18* 0.16 0.18* 0.23* 
ExpectancyP^'''^^^''"'' 0.12 
Expectancy^""''^"^'^ 0.22** 0.22** 0.23** 
Attitudes to C A M -0.09 
Holistic Healdi Beliefs 0.09 
SpiriUiality x Ex.'=°'"'''""'* -0.05 
SpiritualPrime -0.10 
Spirituality x SpiritualPrime 0.04 
Model 0.08 0.11 0.13 0.11 0.08 
*p < .05; **p < .01; Variables in each model were entered as a single block. 
outcome; as shown in Table 3.3, both measures of spirituality (the SCQ-48 and the 
SIBS-R) were correlated wi th change "^'^ '^ "'""'^ , although not w i t h change on other outcome 
variables. Because the correlation wi th outcome was higher for the SCQ-48 than for the 
SIBS-R this measure was used i n the analyses which follow. Second, expectancy must be 
correlated wi th outcome; again. Table 3.3 indicates that is the case. Finally, spirituality 
must remain a significant predictor of outcome while expectancy is held constant. To this 
end change^"''''""'"'' was regressed on expectancy '^"''^ "'^ "'^  and SCQ-48; results are presented 
as Model 1 of Table 3.4. Controlling for expectancy, spirituality was still a significant 
predictor of variance in outcome. 
Two additional multiple regressions were performed to provide a more conservative 
test of the independence of spirituality by including additional measures of expectancy. 
First, all four expectancy measures were combined (expectancy^"'''^"'""'^, expectancy'^'"^''"", 
expectancy""", expectancy"'"""''"'"^) to form a composite measure: expectanc/'""'"""''. 
Reliability for the four items was good: a = .65. A second regression model was 
computed replacing the expectancy^"'''"""'"'' w i t h expectancy'""'"'"""'', and results are shown 
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i n Table 3.4, Model 2. Because the models were not nested, a J-test (Davidson and 
MacKinnon, 1981) was used in place of the normal F-test for change in R^. This 
confirmed that Model 2 was a significant improvement on Model 1, f( 155) = 2.23, 
p = .03 . Even when this combined and thus more reliable measure of expectancy was 
included, spirituality remained a significant independent predictor of outcome. A Sobel 
test was performed for Model 2 (Preacher and Hayes, 2004). Mediation was significant 
{p = .02) but partial, w i t h only 30% of the total effect of spirituality on outcome mediated 
via expectancy. 
Next, the A C M and H H B sub-scales of the H C A M Q were added to Model 2. The 
results of this combined model is shown in Table 3.4, Model 3. However, Model 3 was 
not a significant improvement on Model 2, AR^ = .015, F(2,153) = 1.159, p = .32 
, indicating that these measures did not explain significant additional variance in 
outcomes. W h e n these additional measures were included, spirituality narrowly missed 
significance as a predictor of outcome {p = .06). 
A n additional multiple regression (see Table 3.4, Model 4) was computed to test for 
an interaction between spirituality and expectancy when predicting perceived change. 
Scores on the SCQ-48 and for expectancy^"""''"""'' were centred, and the product term 
calculated. The two. centred scores and the interaction term were entered in a model 
predicting perceived change but no evidence for an interaction was found. 
I n sum, the effect of spirituality on perceived change is independent of expectancy 
and related variables, and spirituality does not interact w i t h expectancy. 
Hypothesis 3: D i d goal p r i m i n g have an effect? In assessing the impact of the prime, 
two related questions were asked: first, did the prime create differences in mean outcome 
scores, and second, d id the pattern of correlations between dispositional variables and 
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Table 3.5: Mean differences (and F test) between outcome measures by priming 
condition 
N Mean a F P 
Neutral prime 84 4.67 0.88 0.01 .93 
Spiritual prime 81 4.68 1.01 
Change^^'"'"" 
Neutral prime 84 2.83 2.33 0.61 .44 
Spiritual prime 81 2.54 2.45 
Change^"' 
Neutral prime 84 0.47 0.76 0.61 .44 
Spiritual prime 82 0.38 0.79 
Change"'^"-''"'"« 
Neutral prime 84 0.74 1.76 1.65 .20 
Spiritual prime 82 0.39 1.73 
outcome measures differ between the two prime groups? 
D i d p r i m i n g affect mean outcomes? To test whether the pr iming task affected 
mean outcome scores we computed 4 one-way analyses of variance (see Table 3.5). Prime 
condition was not associated w i t h mean differences for any of the outcome measures, 
indicating that-at a group level-the primes did not differ in effectiveness. 
D i d the prime moderate relationships w i t h dispositional variables? Although 
the primes were not found to be different in terms of their effect on outcome, the 
possibility remained that spiritual participants may have gained additional benefit f rom 
the spiritual prime, or that non-spiritual participants benefited from the material prime. 
To test for this moderation effect, a multiple regression analysis was performed. In this 
analysis change^"'''"""'"'' was regressed onto scores for spirituality, and a dummy variable 
for membership of the spiritual group, SpiritualPrime (coded 0/1). Results are shown 
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i n Table 3.4, Model 5: there was no evidence of an interaction between group and 
spirituality. 
Hypothesis 4: D i d opt imism predict outcomes? Correlations between optimism 
(LOT-R) and the Change, expectancy and dispositional variables are shown in Table 
3.3. Opt imism d id not correlate w i t h any of the change measures, apart f rom change""". 
However, when examined further, this relationship appears to be due to a strong corre-
lation between optimism and sense of coherence at baseline, r(166) = —.53, p < .001 
. To test whether this was the case, SOC^""' was regressed on SOC*"""''"" and optimism. 
^QQbaseiine ^ significant predictor or SOC^""', /?= .44, p < .001; however optimism 
d i d not predict when controlling for baseline scores, P= —.09, ns . 
D i d flower essences provide broader therapeutic benefits? Although a definitive 
answer to this question would require a natural history control group, results suggest 
that, participants experience benefit on all outcome measures and not just for perceived 
changes i n symptoms, or change scores based on symptom reports. Figure 3.6 shows 
frequencies of participants reporting change on each outcome measure; changes on SOC 
and well-being are comparable w i t h the changes in symptoms, and fit the same pattern 
as thatofchange^"^^"''^"''. 
3.4 Discussion 
These data rephcate an earher finding (Hyland et al., 2006) that spirituality predicts 
perceived change in symptoms following flower essence treatment. Using a new spiri-
tuality scale w i t h equal number of positive and negative items (the SCQ-48) makes it 
less likely that this correlation is is due to an acquiescence bias, or to social desirability 
L 
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(the SCQ-48 is unrelated to social desirability; Wheeler and Hyland, 2008). Although 
positive expectancies for change were induced, there was no evidence for the relationship 
between optimism and improved outcomes reported by Geers et al. (2003). Optimism 
failed to predict change-though it d id predict baseline symptoms and other variables. 
These baseline correlations are to be expected as the LOT-R is highly correlated w i t h 
trait neuroticism (Deci and Ryan, 1985), and trait affectivity affects symptom reporting 
(Davis et al., 1995). 
Consistent w i t h practitioner reports, sense of coherence and reports of well-being 
increased during the flower essence treatment, and symptoms were reduced. However 
these changes—unlike retrospective perceptions of Change—were unrelated to spiritual-
ity. There are several possible reasons for the failure to f ind a correlation w i t h spirituahty. 
One important factor is that the use of 'pre-post' measures (as opposed to retrospective 
measurements of perceived change) doubles the error variance associated w i t h outcome 
scores. Because the correlations involved are relatively small such a reduction in signal-
to-noise ratio may attenuate them beyond detection. In a study designed to compare 
repeated and retrospective measurements of clinical outcome Fischer et al (1999) found 
that where effects were large then retrospective and serial (repeated) measurements 
correlate satisfactorily wi th change scores, but that when effects are smaller the two 
measures correlate poorly. The authors draw no f i r m conclusions as to the independence 
of the two measurements, but it appears Ukely that multipUcation of error in repeated 
measurements explains the pattern of results. In both cases (large and small effects), 
retrospective measures were more sensitive to change, and correlated more strongly w i t h 
both patient satisfaction and physical and biological indicators than did serial (change 
score) measures; the authors recommend the inclusion of perceived change measures 
whenever the results are to be applied in cUnical practice. In this study, perceived change 
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scores d i d correlate w i t h change scores f rom repeated measurements for symptoms and 
well-being, although the correlation w i t h SOC change scores was weaker (see Table 3.3). 
The mediation analysis above (see page 76) included multiple measures of ex-
pectancy, as well as measures likely to be correlated w i t h higher expectancies (e.g. more 
holistic health beliefs), and so provided a relatively conservative test of the relationship 
between dispositional spirituality and outcome. This is important because, as Baron 
and Kenny (1986) note, error i n the measurement of mediating variables w i l l lead to 
underestimates of mediation. Expectancy was only a partial mediator of the effect of 
spirituality and, even when a more rehable measure of expectancy was included (see 
Table 3.4 Model 2) spirituality remained a significant predictor. When the measurements 
of attitudes to complementary medicine and holistic health behefs were included, spiri-
tuality marginally missed significance (p = .06), but the inclusion of these variables d id 
not improve the overall model ( A = .02), and should therefore be interpreted w i t h 
caution. 
Shortcomings First, the study did not include an untreated control group. However, i t 
is unlikely that the correlations w i t h ritual-congruent dimensions would have occurred as 
part of regression to the mean or natural history because the prediction f rom disposition 
to outcome was specific to the type of therapy (i.e. spirituality, or gratitude in Study 2 
of Hyland et al. 2007). Natural variation and regression must occur, but this variation 
w i l l reduce the size of correlations between outcome and predictors and does not pose a 
threat to the validity of this study. 
Second, correlations w i t h dispositions were only found for perceived change, and 
not for before/after measures. As noted, this may be due to additional error variance 
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in before-after measures. However, although they are correlated, perceived change and 
symptom change measures may index different components of variation in outcomes; it 
may be that perceived change is more sensitive to motivational effects (i.e. benefits of 
performing a congruent ritual) because it is more dependent on state-affect. 
Third, it is not clear how the disposition of spirituality improves outcomes for flower 
essence therapy. A motivational explanation for this l ink is proposed in the following 
chapter, but alternative possibilities include a greater focusing on positive symptoms; 
a tendency to ignore a failure to benefit; or greater positivity, which translates into 
therapeutic benefit. Because correlations were only found between spirituality and 
change^"''""*'"'', and not for other outcome measures, the possibflity remains that the effect 
is only on symptom perception rather than a genuine reduction in symptoms (although 
see discussion later, on page 196). 
A n additional weakness was the homogeneity of the sample, and the heterogeneity 
of psychological and physical problems for which they took flower essences. Recruits 
were primarily female students and staff from the University of Plymouth who self-
selected for a complementary therapy. Although this was not a clinical sample in the 
sense that participants met the criteria for a particular physical or psychological disorder, 
and a great variety of symptoms were reported, qualitative feedback from participants 
indicated that these symptoms caused significant distress in a large number of cases. 
Conclusion 
This study rephcates earUer work (Hyland et al., 2006, 2007) demonstrating dispositional 
predictions of particular types of placebo—namely, that dispositional spirituality predicts 
response to Bach remedies, a spiritually-contextualised complementary therapy. 
Chapter 4 
The motivational concordance hypothesis 
Evidence from Chapters 2 and 3, and from Hyland et al. 2006 and Hyland 
et al. 2007, suggests that placebo responding appears to be a good exemplar 
of the person-situation paradox: Responses of individuals are temporally re-
liable but vary according to situational features. A psychological explanation 
of placebo effects must account for this variation, and for the correlations 
found between enduring characteristics of people (e.g. trait spirituality) 
and responses to particular types of placebo (e.g. Bach remedies). The 
motivational concordance hypothesis, presented below, derives from estab-
lished theories of personality and motivation. It is proposed that placebo 
rituals that encourage people to perform self-actualising behaviours wi l l yield 
therapeutic benefits. The basis of the theory is described, along with several 
predictions to be tested. 
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4.1 Variance and invariance in people 
The goal of the personality psychologist is to identify and understand the 'structure' of 
the person - the regularities that shape behaviours in consistent, predictable ways across 
disparate situations (and also to know when consistency w i l l not be observed). 
Comparative structures: Traits i n personality psychology A dominant heuristic 
w i t h i n personality psychology has been to use factor analytic methods to f ind reliable 
inter- individual differences in response to scale items, and to label the factors which 
emerge as abstract traits of people. This approach has been remarkably successful and 
there exists noteworthy agreement between many researchers over many years, who have 
often tackled the same questions f rom different perspectives, that there are approximately 
5 such abstract traits to be recovered from this type of data (Digman, 1990). 
However, the statistical consensus around 'big five' factor models has obscured a 
terminological and theoretical confusion. Early in the history of personality psychology 
calls were made to go beyond simply to describing traits, and instead to explain the 
causes of behaviour—for example, to understand why an individual is conscientious 
as well as noting that they are t idy (Allport and Allport , 1921). However big-five style 
personality psychology fails to ful f i l the requirements of a 'dynamic psychology' of this 
k i n d (Al lport , 1937). Factor analysis identifies statistically reliable patterns of response 
but does not explain how either regularities, nor exceptions to regularity, come to be. 
Reliably identifying variables which describe the structure of inter-individual differences 
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does not logically support the conclusion that we are identifying structures within the 
individual. Cervone writes: 
A Linnaean taxonomy differentiates plants from animals; vertebrate animals 
from invertebrates; mammals from reptiles, etc. But when one gets down to 
individual cases, one w i l l not f ind that the classificatory variables exist as 
unitary entities within the individual, such that they may combine intra-
individually. There won't be any synergistic admixture of vertebrateness, 
mammalness, and primateness in Harre's chimp. (Cervone, 2005, p. 427) 
This critique is not new, and has been made repeatedly over the past 70 years (e.g. 
Allport , 1937; Epstein, 1994; Cervone, 2005). I n essence, a distinction is made between 
abstract traits which describe the data, and hypothetical constructs which both explain 
existing data and make new predictions (MacCorquodale and Meehl, 1948), what Lewin 
termed an Aristotelian as opposed to a Galilean explanatory strategy. Behaviour is 
explained with reference to the essential nature of the object, rather than via dynamic 
interactions of object and environment (Lewin, 1935). I n a charming analogy, Epstein 
describes the process by which a researcher might use factor analysis to develop this k i n d 
of top down theory: 
Once upon a time, there was a psychologist, Sam, who decided to study 
cars rather than people ...because they are more controllable and easier 
to understand than people. . . . Sam set about establishing the fundamental 
attributes of cars. W i t h the aid of factor analysis, he uncovered five or-
thogonal attributes-color, type, size, maximum speed, and robustness (as 
operationally determined by service record) . . . One day his car broke down. 
Unfortunately, he hadn't the foggiest idea of what to do about it. He knew 
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nothing about how the car functioned . . . What he had . . . was all kinds of 
research findings about how the basic attributes of his car correlated w i t h 
breakdown . . . Robustness was obviously a relevant variable, and, to be sure, 
it predicted future breakdowns better than chance. So now he understood 
why his car had broken down—it was low on robustness. However, his car, 
not sharing his enthusiasm over this insight, budged not an inch. (Epstein, 
1994, p. 120-1) 
Thus the failure to adequately l ink structural variables (Openness, Neuroticism etc.) 
to psychological processes is regarded as a failure of the overall theoretical approach. 
This absence of explanatory (as opposed to descriptive) power is presumed to explain 
the oft-reported lack of cross-situational stability i n the prediction of behaviour from 
trait (Mischel, 1968), and i f big five type traits do not map onto fundamental processes 
involved i n placebo responses, then no reliable trait predictor for placebo responding 
may ever be found. 
Explanatory structures: Values and goals Like traits, the overlapping motivational 
constructs of goals and values (and antecedent concepts such as learned needs, Murray, 
1938), are conceived as enduring psychological structures that can organise perception 
and guide behaviour over long periods. Crucially however, goals are defined as internal 
representations of desired states and the relation of goals to behaviour is therefore less 
problematic. Many theories specify how goals may be arranged hierarchically, perhaps as 
a f o r m of control system i n which error (the disparity between actual and desired states) is 
minimised (e.g. Hyland, 1988). A t the highest level of such a hierarchy goals may appear 
to share many characteristics of traits: high level goals may endure over long periods and 
coordinate information processing and behaviour across many domains (Rohan, 2000). 
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Although attempts to create taxonomies of goals are relatively tentative (Austin and 
Vancouver, 1996; Chulef et al., 2001), the relationships between motivation, affect and 
behaviour have been extensively researched, and motivational theories of goal striving 
and affect may help to Hnk these structural concepts to behavioural outcomes—in the 
case of the present paper, to l ink motivational dispositions of individuals, such as 
spirituality, w i t h placebo responses in specified contexts. 
Relation of values to goals As Rohan notes, definitions of values vary (2000). 
However authors tend to conceptualise values as either goals in themselves (Schwartz, 
1994; Rokeach, 1973), or as constructs required for the evaluation of other goals (Eeather, 
1996; Lewin, 1952). Some authors have attempted to distinguish values from goals by 
noting that they are trans-situational (Roccas et al., 2002), but it is not difficult to th ink 
of goals which may apply in many situations (e.g. the goal to save money). For the 
purposes of the discussion which follows this distinction appears relatively unimportant. 
I f a person values spirituality, and as a consequence positively evaluates spiritually-
oriented goals (and sub-goals corresponding to 'spiritual behaviours'), this is functionally 
equivalent to describing spirituality as a goal in itself As Rokeach argues: "terminal 
values [desired end states] are motivating because they represent the supergoals beyond 
immediate, biologically urgent goals" (Rokeach, 1973, p. 14). Such supergoals are 
distinguished from everyday goals, at least in part, by their stability: 'supergoals do not 
seem to be periodic in nature; neither do they seem to satiate-we seem to be forever 
doomed to strive for these ultimate goals without ever quite reaching them'. Where goals 
are temporally stable in this way, it may be useful to say that a person has a disposition 
toward that motive. 
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Spir i tual i ty as a high level goal (or disposition) W i t h reference to the preceding 
discussion it is clear that spirituality may be considered from the perspective of both 
traditional personality psychology (as a trait, in the five-factor sense of stable inter-
individual differences in behaviour), or from the perspective of motivation theory (as a 
goal, a hypothetical construct used to explain the intra-individual structures which give 
rise to consistent behaviours over time). The perspective one adopts w i l l be indicated by 
the instrument used to measure the construct. Personality psychologists concerned w i t h 
traits would use measures of spirituality which primarily index behaviours assumed to 
be spiritual i n nature. I n contrast, psychologists concerned w i t h motivation w i l l adopt 
measures which largely ignore behaviour, and instead focus on the value respondents 
attach to spiritual events and spiritual meaning. In practice, little or no evidence has 
been found for spirituality as a trait, but spirituality is included in many reliable and 
cross-culturally validated models of values (e.g. Schwartz, 1992). 
Existing spirituality scales, such as the SIBS-R, have tended to mix these two types 
of items. I n contrast, when developing the SCQ, Hyland and Wheeler (2008) explicitly 
excluded items related to spiritual behaviour or practice. As such, the measure is 
intended to index the value respondents place on spirituality, and thus the extent to which 
spirituality may be considered a goal for that person. 
4.2 A motivational explanation of real world placebos 
H o w do placebos work i n real life contexts? The data presented i n Chapter 3 and 
other similar studies (Hyland et al. 2006 and Hyland et al. 2007, study 2), suggest that 
there may be more than one mechanism involved: The first is the well-established 
mechanism of response-expectancy (Kirsch, 1985b, 1997). Expectancy is regarded as 
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the primary psychological mechanism responsible for placebo effects (Stewart-Williams 
and Podd, 2004) and there is considerable empirical support for the role of response-
expectancies in generating placebo responses. Indeed, in the two flower essence studies 
described above and the gratitude therapy study in Hyland et al. 2007, there is evidence 
that participants who expect to get better do, in fact, experience an improvement 
in symptoms. However, expectancies explained less of the variation in outcome in 
these studies than is typical in laboratory studies of placebo analgesia: correlations for 
expectancy were all lower than .25, compared w i t h correlations in excess of .5 in a recent 
laboratory study (Whalley et al., 2008). In all three studies, dispositional predictors of 
outcome (i.e. motivational measures) remained significant even when more stringent 
tests of statistical independence were apphed. In short, although spirituality and 
expectancy are correlated, expectancy does not appear to mediate the effect of spirituality 
on outcomes, and does not explain as much variance in outcomes as researchers might 
anticipate or desire. 
It is proposed here that, in addition to response-expectancy, a second mechanism of 
placebo action is responsible for a proportion of the variance in outcomes for real-world 
placebos: that of motivational concordance. The motivational concordance hypothesis 
draws on established theories of motivation, and makes some specific predictions 
regarding the circumstances in which therapeutic benefits that are not attributable to 
response expectancy w i l l be observed. 
4.2.1 Motivation and placebo effects 
Motivation is an extremely broad psychological concept and in a straightforward sense—that 
of the 'desire for benefit'—has previously been invoked to explain some placebo effects. 
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However motivational concordance is based on a broader conception of the motivational 
dynamics of placebo therapies, and the links between goal striving and affect. 
Health s tr iv ing I n a simple sense, some theories relate the magnitude of placebo effects 
to the desire on the part of the patient to experience benefit. This may be characterised as 
a health striving hypothesis: patients who are motivated to get better are likely to improve, 
whereas unmotivated patients may not improve. Examples include situations where 
patients receive secondary benefits f rom an illness and are thus motivated to experience 
symptoms and delay recovery (Parsons, 1964). There is some experimental evidence that 
motivat ion, i n this straightforward sense does influence placebo responding. Totman 
(1975) found that participants paid to participate in an experiment in which they received 
a placebo analgesic were less likely to experience placebo analgesia than participants who 
were not paid. Totman interpreted this finding as consistent w i t h cognitive dissonance 
theory (Festinger, 1957): Unpaid participants had a greater motivation to experience 
analgesia to justify the discomfort of participating in the study, and in turn experienced 
greater pain relief. However no direct check was made that this manipulation (payment) 
d i d in fact increase motivation to experience analgesia. Jensen and Karoly (1991) directly 
manipulated both motivation and expectancy. They found that motivation did enhance 
responses to a placebo sedative and that this was independent of the manipulation of 
expectancy. It is possible that participants in flower-essence studies, who are given 
a choice regarding the remedy they use, have an investment in their choice and thus 
experience a form of cognitive dissonance favouring larger placebo effects. 
I n a separate series of studies Geers et al. (2005b) found that participants who 
were pr imed w i t h the goal for 'co-operation' experienced larger placebo effects (e.g. 
improved sleep in response to a positive psychology-type manipulation). This state-like 
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concept—of the current level of desire to experience benefit—is also predominant in the 
psychotherapeutic literature. Termed treatment motivation, it is often operationaUsed as 
the degree of wiUingness to initiate or engage fully w i t h treatment activities (Drieschner, 
2004). 
Goal achievement and affect However, from the perspective of social-cognitive the-
ories of motivation, motivation-related benefits of treatments need not be limited to 
goals corresponding to engagement w i t h and and maintenance of therapy. Frijda (1988) 
notes, in defining his emotional 'law of concern', that "Emotions arise in response to 
events that are important the the individual's goals, motives, or concerns" (p 351). 
This idea—that emotions are necessarily l inked to the appraisal of goals—is widely 
shared (e.g. Stein et al., 1993; Kuhl, 2000; Carver and Scheier, 1990). Completing 
(SruU and Wyer, 1986), progressing towards (Carver and Scheier, 1990), or anticipating 
the completion of (Bandura, 1989) goal-directed tasks, may generate emotionally-
positive experiences. Performing goal directed activities may, in itself, be experienced 
as pleasurable (Csikszentmihalyi, 1990), and cross-sectional studies that estimate the 
congruence between (i) a person's self-reported motives and (ii) implicit measures of 
motivation or values, find that congruence is related to subjective well-being and positive 
emotional experiences (Sheldon and Kasser, 1995; Hofer and Chasiotis, 2003; Hofer et al., 
2006). Activities that are consistent w i t h important or self-defining goals are both more 
likely to motivate behaviour and more likely to result in subjective well-being or positive 
affect (Emmons, 1991; Sheldon and Elliot, 1999; Sheldon and Kasser, 1995; Oishi et al., 
1999). Additionally, motive-congruence has been found to mediate the development of 
psychosomatic complaints in a chnical population (Baumann et al., 2005). 
In sum, where engaging in a therapy may be construed as a meaningful activity that 
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is consistent w i t h higher level goals, then both theory and evidence suggest that positive 
emotions and subjective well-being w i l l result. This, in turn , might be responsible 
for the non-expectancy-mediated benefits of 'real world ' placebos, if these placebos are 
meaningful for participants. 
Treatments may include self-actualising behaviour As noted above, the majority of 
basic placebo research is performed in a laboratory setting and uses placebos which 
purport to be conventional medical interventions (e.g. analgesic creams), but this 
paradigm lacks ecological validity in a number of important ways: studies may use 
double b l ind rather than 'deceptive' or unambiguous instructions, as would be the case 
i n chnical settings (Kirsch and Weixel, 1988); trials are often of very short duration; and 
sample populations are commonly drawn from undergraduate psychology courses and, 
as a result, are relatively homogenous. 
I n addition, the placebos used in experimental research may lack context, and may 
not be particularly meaningful for participants. Names of therapeutic agents are often 
invented (e.g. Montgomery and Kirsch, 1997), and even in clinical trials, where the name 
of the active agent is known, participants may need to rely on the information provided 
by researchers to set their expectations for benefit and for side effects. Thus, participants 
may have some (often l imited) information about the placebo they receive, but placebos 
are not meaningful i n the sense that they refer to important attributes of the self or culture. 
This forms a sharp contrast w i t h placebos as they are commonly used. Placebo effects 
have a r ich and vibrant hfe outside of the laboratory—both the forms in which placebos 
are administered and the meaning they hold for patients can vary widely. Motivational 
characteristics of real-world placebos are also very different f rom those used in the lab. 
When placebos are used in real hfe settings, patients are likely to have a genuine and 
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strong desire for treatment to be effective. Use of placebos (in the form of C A M therapies) 
also implies a concern w i t h health and well-being—placebos are exphcitly disallowed 
within conventional medical settings and so patients must have made additional efforts 
to acquire them. 
Complementary therapies are meaningful for patients As discussed in Chapter 1, 
many complementary and alternative medicines ( C A M ) are regarded by conventional 
medical researchers as 'no better than a placebo' (Singh and Ernst, 2008, ' ) . The 
controversy over particular techniques such as homeopathy and acupuncture can be 
fierce (e.g. Shang et al. 2005, and their reply to strong criticism from practitioners: Shang 
et al. 2006), but it appears likely that, even i f so-called specific effects are found for most 
C A M therapies, they w i l l be small in comparison to the non-specific or psychologically 
mediated components of treatment effects. The prospects for demonstrating efficacy for 
the Bach remedies used in Chapters 3, 5 and 6 appear particularly poor (Armstrong and 
Ernst, 2001; Ernst, 2002). 
Despite a lack of clearly-demonstrated efficacy C A M therapies are extremely popular 
(see 1.5.1, page 23). This growth is, in part, attributed to the richness of the context 
associated w i t h these remedies. In the sociological jargon, C A M treatments are situ-
ated wi th in a broader discourse that encompasses an assertion of alternative politics, 
environmental activism, and a 'post-Fordist' rejection of scientific materiahsm (Bakx, 
1991). More prosaically, studies of attitudes among C A M users have indicated that the 
"patient-practitioner relationship and explanatory frameworks provided by C A M [are] 
perceived as important components of the therapeutic process, irrespective of treatment 
efficacy" (Cartwright and Torr, 2005, p. 559). Therapies must 'feel right' as well as 
'Although note that a psychologist may regard them as every bit as good as a placebo' 
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working effectively, and normal evidential standards are often dismissed by proponents 
of C A M therapies as irrelevant or unhelpful i n the evaluation of C A M therapies (e.g. 
Walach 2005; Walach et al. 2006^). In this context treatments, both conventional and 
unorthodox, may be seen as constituting rituals which have the potential to facilitate 
self-actualisation-at least amongst patients for w h o m the motivational press of the ritual 
is concordant w i t h high-level and self-defining goals or values. 
Matching patients to rituals I n order for researchers and clinicians to capitalise on the 
motivational-concordance effects described above (i.e. improvements in affect and well-
being caused by progress towards valued intrinsic goals), two pre-conditions must be 
met. First, researchers must measure the values of patients and second, the motivational 
context of therapies must be known i n order to create a match. 
4.2.2 Measuring human goals and values 
Over many years, various taxonomies and models have been proposed to describe the 
range of human values, or analogous concepts (e.g. Murray, 1938; Rokeach, 1973). More 
recently, studies employing confirmatory factor analytic methods, analogous to the work 
which resulted i n the development of the 'big five' model (Digman, 1990), has taken place 
^Note that many of Walach's arguments relate to the process of evaluating complex complementary 
therapies using a model developed for pharmacological agents or surgical procedures. In large measure 
his critique is correct: effectiveness is often overlooked because of a narrow focus on efficacy, and this 
is true also of evaluations of psychological interventions (ignoring, for the moment, the fact that many 
complementary therapies may be psychological interventions). However, Walach overlooks the ethical 
problems inherent in a policy which would, by design, result in governments and medical practitioners 
endorsing and administering remedies that, to the best of their knowledge, are psychologically active 
but biologically inert. Remedies which have a large psychological component may be effective in many 
situations, but a wide variety of non-deceptive alternatives are available-for example, counselling, a wide 
variety of practitioner-delivered or self-help psychotherapies, and exercise and lifestyle modification. If 
there is a genuine need to replace 'tonics', 'cures', 'bitters', 'balsam' (or snake oil Holbrook, 1959), a policy 
to provide humanistic 'common-factors' psychotherapy and gym membership would be this author's 
preferred option. 
4.2. M O T I V A T I O N A L EXPLANATION 97 
in this field. Although details may vary between approaches, consensus has been found 
that (i) human values are a relatively consistent, stable and cross cultural phenomenon, 
(ii) there are relatively few (either 10 or 12) basic values, and (iii) that values form a 
circumplex structure (Schwartz, 1994; Schwartz and Boehnke, 2004; Kasser and Ryan, 
1996; Grouzet et al., 2005). The circumplex model depicts values as being organised 
in two dimensions. Individual values have an ordered position on the circumference 
of a circle such that values on opposing sides of the circle w i l l tend not to be joint ly 
valued by the same individual. For example, the goal of 'security' would rarely be valued 
alongside 'self direction, and 'achievement' would not be valued alongside 'benevolence'. 
Ahhough labels for individual values vary between models, the basic dimensions identi-
fied are conceptually similar: For the Aspiration Index, (originally developed by Kasser 
and Ryan 1996), Grouzet et al. (2005) labelled dimension 1 as 'Extrinsic—Intrinsic', 
and dimension 2 as 'Self-transcendence—Physical self. Schwartz (1994) labels the 
dimensions of the Schwartz Values Scale (SVS) as 'Openness to change—Conservation' 
and 'Self-enhancement—Self transcendence', although other authors have suggested 
the relabelling these dimensions as: 'Focus on opportunity—Focus on organisation 
and 'Focus on individual outcomes—Focus on social context outcomes' (Rohan, 2000). 
Schwartz's original model is shown in Figure 4.1. In summary, both the Aspiration Index 
(Grouzet et al., 2005) and the SVS appear to be suitable instruments to quantify wi th in-
subject variation in attachment to high-level goals or values. 
Spirituality as a human value Although more recent editions of the SVS have ex-
cluded the variable Spirituality because of concerns over it's cross-cultural universality, 
spirituality was included in the original circumplex model and was hypothesised to 
fall between Benevolence and Tradition (Schwartz, 1992). Spirituality and religiosity 
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Figure 4.1: Circumplex model, Schwartz, S. H. & Boehner, K. (2004) 
* hedonism 
conformity o / 
/ ° tradit ion 
security 
Conservation 
have regularly formed part of models of human values (e.g. Salvation Rokeach, 1973), 
but many instruments designed to measure these concepts conflate spirituality w^ith 
religiosity, even when efforts are made to encompass many types of religiosity wi th in 
a single instrument (Hatch et al., 1998). As discussed above (page 3.2) the Spiritual 
Connection Questionnaire (SCQ) was designed to measure 'non-religious spirituality', 
and was included in a previous study (Chapter 3) because it appeared to accord well 
w i t h the type of new-age or non-religious spiritual values characteristic of explanations 
of Bach flower remedy practitioners. 
Mot ivat ional context o f therapies The task of identifying the motivational charac-
teristics of therapies themselves is more problematic, and although some preliminary 
achievement 
Self-enhancement 
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work is described in Chapter 7, a general solution is not provided here. However, 
motivational concordance theory has developed f rom the need to explain a number 
of studies using C A M or positive-psychology type interventions which appear to have 
relatively well defined motivational characteristics: e.g. Bach flower remedies, and 
gratitude therapy (see study 2, Hyland et al., 2007). Following the theoretical principles 
of the inventor of Bach flower remedies, flower essence manufacturers and practitioners 
typically describe the remedies as spiritual in nature, and it is assumed that any prediction 
from measurements of trait spirituality (e.g. w i t h the SCQ) are due to a concordance 
of motives. As an illustration, the following text is taken f rom the Green Man Essence 
Company website: 
Green Man Essences can be used for healing, personal growth and l inking 
w i t h Nature. Each essence holds a particular vibration of the plant species 
or named energy signature so that, when used, the energy key wi th in the 
essence becomes available to you to enhance your life. (Green Man Essence Com-
pany, 2008). 
On subsequent pages, the functions of various Bach remedies are described. A selection 
of these descriptions are included below: 
Bilberry (Vaccinium myrtillus) Integration of the Self Calms and brings 
peace to thought processes. Communication clarified. Increases equanimity 
and balance in all situations, especially where there are extremes of emotion 
that may bring conflict. Clarity, discrimination and wisdom brought to 
spiritual states. 
Columbine (Aquilegia vulgaris) Activates higher chakras located above the 
crown chakra. This greatly enhances the healing and integration of higher 
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faculties and functions. Aids in the rebirth and complete healing of the Self 
Inspirational. 
Daisy (Bellis perennis) Spiritualises intellect. Scattered information brought 
into clear focus. Understanding from an intuitive level. Stabilises those who 
are constantly seeking but not finding. Clarity and understanding, especially 
i n spiritual areas. (Green Man Essence Company, 2008) 
4.3 Complementary models of placebo responding 
Response expectancy Kirsch (1997) defines a response expectancy as the "anticipation 
of automatic, subjective, and behavioral responses to particular situational cues" (p. 
69). Response expectancies are distinguished from stimulus expectancies—the expected 
occurrence of external events. To give an example, one might have a stimulus expectancy 
that a analgesic cream would provide rehef against a pain stimulus applied to someone 
else, or to oneself in the abstract; the concept of stimulus value refers to the importance 
attached to the expected outcome by the person—for example, in a a gambling context, 
expectancy value might vary as a function of the stakes involved. In contrast, a response 
expectancy would only arise i f a person had an expectancy that an analgesic cream 
applied to their own hand would reduce the experience of pain caused by an imminent 
pain stimulus. Furthermore, the concept of expectancy value is not applied to response 
expectancies—the presumed value of the response is independent of the effects of the 
expectancy on experience. 
Unhke stimulus expectancies, response expectancies are held to be "directly self 
conf i rming" (p. 69). Although the concept of response expectancies are applied in 
a number of fields (for example hypnosis and suggestion) response expectancy theory 
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has become the dominant explanatory framework for placebo effects (c.f. Kirsch, 1999). 
Importantly, response expectancies are conceived as immediate and unmediated causes of 
placebo effects (or other changes in experience). So, although the psycho-physiological 
details of the effect of expectancies is unspecified, no further psychological variables 
are required to explain behaviour. Figure 4.2^ illustrates this model. Consistent w i t h 
Kirsch (1997), stimulus expectancies and stimulus values are l inked, in a multiplicative 
relationship, to motivation and behaviour—in this case the taking of a placebo''. 
Motivational concordance As described above, the motivational concordance hypoth-
esis posits that, in addition to effects that may or may not be generated by response 
expectancies, placebo effects w i l l also result f rom performing behaviours that are self-
concordant and thus generate positive affect and subjective well-being. The model is 
illustrated in Figure 4.2. 
Dispositional motives of the person and the motivational context of the situation 
(placebo context) are presumed to interact and generate motivation to take the placebo 
(perform the therapeutic ritual). I f the placebo ritual is concordant w i t h the person's 
values, then this performance w i l l result i n intrinsic motivation for the task, facilitate 
self-concordant behaviour, and generate positive emotional experiences and positive 
affect. The result of this change in affect is an observed placebo response; the theory does 
not specify the nature of the connection between positive affect and placebo responses, 
and in fact the nature of this connection may vary depending on the context. I n some 
cases observed placebo responses may be purely the result of a shift in readiness to 
^In each model, the key pathways are indicated by soUd lines, and the variables used to predict placebo 
outcomes are in bold face. 
''Note that this part of the model (the link between stimulus expectancy, motivation, and behaviour) 
is not necessary to explain placebo responses in a laboratory setting, where demand characteristics of the 
situation will generate the required behaviour: taking the placebo. 
102 CHAPTER 4. M O T I V A T I O N A L CONCORDANCE 
report symptoms (Pennebaker, 1982; Rief and Isaac, 2007). In others, positive affect 
may generate therapeutic benefits which are biologically-mediated, for instance via a 
modulation of inflammatory or immune processes (Benedetti et al., 2006; Koh et al., 
2008), and this is discussed further in Chapter 8. 
Motivational concordance differs from response expectancy theory in a number of 
respects. Most crucially, motivational concordance suggests that exphcit, conscious 
expectancies for a specific response are not necessary antecedents of placebo responses. 
I n contrast, motivational concordance proposes that placebo effects maybe non-specific, 
generalised, and result f rom a high-level compatibility between individual values and 
the perceived motivational characteristics of a ritual. As a consequence, a number of 
predictions can be made f r o m the model: 
w 
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Figure 4.2: IVIodels of placebo responding: response expectancy and motivational concordance ^ 
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4.4 Predictions from motivational concordance 
As outlined above, the motivational concordance hypothesis generates several predic-
tions: 
1. It w i l l be difficult/impossible to find traits which consistently predict responses to 
all placebo effects. 
2. Therapies which are meaningful for participants w i l l generate benefits which are 
not mediated by expectancy. 
3. Benefit w i l l only occur where the values/goals of the person and the context of the 
therapy are congruent. 
4. Benefit w i l l only occur where the person perceives themselves to have satisfactorily 
performed or engaged w i t h the ritual. This engagement is subjective and not 
synonymous w i t h compliance or adherence i n the conventional medical sense, 
although compliance may correlate with subjective engagement. 
The studies reported below attempt to explore and provide evidence for these 
predictions, and the discussion which follows addresses a number of weaknesses and 
limitations of both the theory and the evidence available to date. 
Chapter 5 
Manipulating the meaning of rituals: using 
instruction sets to determine dispositiona 
correlations with placebo outcomes 
To date, studies identifying dispositional predictors of placebo response 
make an assumption that participants interpret the context in which a ther-
apy is delivered as having particular value characteristics, and that it is the 
concordance of these values with the participants values which predicts the 
therapeutic benefit. In this chapter, context is manipulated experimentally 
with instruction sets that either emphasise or de-emphasise the spiritual 
nature of the therapy. Prediction from dispositional spirituality is hypoth-
esised to occur only where the therapy can be presented as spiritual in 
nature. Results are discussed with reference to response-expectancy and 
motivational concordance theories ^ 
This data has previously been reported in (Hyland and Whalley, in press a) 
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5.1 Introduction 
I n Chapter 3, and in similar previous studies (Hyland et al., 2006), the disposition 
of spirituality was found to predict outcomes for a placebo complementary therapy: 
Bach flower remedies. These data were interpreted as indicating that, independently of 
expectancy, a concordance between the motivational dispositions of participants, and 
the motivational context or 'press' of the therapy, produced therapeutic benefits. 
A weakness of these earlier studies was that the spiritual nature of the therapy was 
inferred rather than manipulated. Although the second study in Hyland et al. (2007) 
found that dispositional predictors appeared to be specific to the therapeutic intervention 
administered (i.e. that dispositional gratitude predicted response to a gratitude therapy, 
but dispositional spirituality did not), a more stringent test of the concordance hypothesis 
requires that the concordance of the participant and the therapy is manipulated. 
Approach Dispositions are not, by definition, readily manipulated. In this study 
the motivational context of the intervention is ahered and dispositional correlations 
compared under these different conditions. Participants are recruited for an open trial of 
Bach flower remedies for minor psychological and physical complaints, and randomised 
to three groups in which flower essences are contextualised as either a spiritual or 
'positive' therapy, or are given no additional instructions. Because optimism has been 
found to correlate w i t h placebo responding when participants hold positive expectancies 
for outcome (Geers et al., 2003), a measure of optimism was again included as a predictor 
of outcome. Repeated measurements of outcome were made, and independent variables 
used to predict rates of therapeutic change over time using multilevel growth-curve 
modelling. 
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Hypotheses 
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1. That spirituaUty wi l l predict variance in outcome, but only where the motivational 
press of the therapy is manipulated to be concordant w i t h a spiritual motive. 
2. That where spirituality predicts variance in outcome it w i l l do so independently 
from expectancy. 
3. That optimism may predict outcome, particularly when the flower essences are 
characterised as a 'positive' therapy. 
Theories of motivation suggest that therapies which are concordant w i t h self-defining 
goals may be easier to perform than non-concordant rituals, in addition to creating 
positive affect 4.2.1. For this reason two additional hypotheses are made: 
4. That adherence (with instructions to take the essence regularly) w i l l predict 
outcome. 
5. That the degree to which participants are able to engage w i t h the ritual w i l l predict 
outcomes. 
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Finally, i f the benefits observed among participants high in dispositional spirituahty 
are due to motivational concordance (rather than, for example, response expectancy), 
then only those participants who actually complete the spiritual ritual should obtain these 
benefits. This leads to the hypothesis that: 
6. Adherence w i l l moderate the relationship between spirituality and outcome — 
benefit due to motivational concordance w i l l only be observed for participants who 
adhere to the therapy. 
5.2 Methods 
Overview Participants were recruited and completed baseline assessments online, and 
chose a flower essence remedy to suit their symptoms. Their chosen essence was posted to 
them, along w i t h a unique study I D which they used to register on an online telephone 
system. A n automated system made outcome assessments by telephone over the next 
21 days. The overaU progression of participants through the study is shown in Figure 
5.1. This figure (and figures 5.3 and 5.2 below) follow the conventions described i n Jesse 
James Garrett's Elements of User Experience (2003); these conventions are widely used in 
industry for specifying this type of system. 
Recruitment Members of the general pubhc w i t h minor psychological complaints were 
invited to take part in an open tr ial of Bach flower remedies. Advertisements, alongside 
press, radio and television coverage orchestrated by the University of Plymouth press 
office, offered a free sample of flower essence in return for questionnaire completion and 
response to outcome assessments via a mobile telephone. Participants were not paid 
and d id not receive course credit. Exclusion criteria were: use of flower essences in the 
METHODS 
Figure 5.1: Participant flow through the study 
Register via 
website (baseline 
assessment) 
Posted Essence 
plus unique I D 
Call automated 
telephone system 
to register I D 
System schedules 7 
calls over 21 days 
> 
Outcome Calls 
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previous six months; age of less than 18 years; currently receiving psychiatric treatment; 
history of alcohol abuse^. 
Procedure Participants were instructed to log-on to a web page where they (a) were 
provided w i t h information about flower essences and the study, (b) gave consent, 
(c) confirmed that they did not meet the exclusion criteria, (d) completed basehne 
questionnaire assessments (SCQ-14 and Expectancy), (e) selected any one of the 38 
Bach flower essences, w i t h essence descriptions and picture of the flower taken from 
a commercial website, and (f) gave a telephone number and time of day for follow-up 
contact. The flower essences (genuine commercially-produced essences w i t h a standard 
label) were then posted to the participants. 
Participants were randomised to one of three treatment groups (spiritual, positive 
and neutral) using a random number list as they consented to the web study. A l l 
participants received a brief introduction to flower essences on the website, and were 
told that, although they are biologically inert, practitioners and users make controversial 
claims that they work through a spiritual mechanism not yet understood by science. 
However, no reference was made to mechanisms of action proposed by practitioners (for 
example, spiritual or vibrational healing). Participants were sent their flower essence with 
an instruction to take three drops twice per day, and at this point in time the ritual was 
extended for the spiritual and positive groups. The spiritual group received the written 
information: 
'Flower essences work best if, whfle you are taking them, you imagine the essence 
connecting you to a universal pool of heahng and love'. In the positive group participants 
received the writ ten information: 'Flower essences work best if, while you are taking 
^Because the essences are primarily composed of Brandy this was considered a sensible precaution 
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them, you imagine them helping you to solve your problem'. Neutral group participants 
were not provided w i t h additional information. These extensions to the ritual are 
consistent w i t h instructions sometimes found in complementary medicine (where auto-
suggestion is called 'affirmation'). 
When participants received their essence they were instructed to call an automated 
telephone line, and register their entry into the study w i t h a unique identification code 
provided. This telephone registration initiated a series of calls by an automatic telephone 
system; calls were made on days 1, 2, 3, 4, 7, 14 and 21 after registration, at the time of 
day preferred by the participant (unanswered calls were foUowed-up 30 minutes later, 
wi th up to 5 attempts made with in the time period specified by the participant). During 
each call, participants were asked to provide an assessment of outcome and adherence by 
entering numbers on the telephone keypad. At the end of the call, the written instructions 
for the spiritual and positive groups were repeated as part of the ritual extension. A l l 
participants were reminded to take the essence twice daily, but those in the spiritual and 
positive groups heard additionally: "Remember, flower essences work best if, while you 
are taking them, you imagine. . . " Finally, on day 21, the spiritual and positive groups 
received a question about how easy the ritual was to practice. 
Automated telephone system The automated telephone system used to collect out-
come data was programmed by the author using the Envox 6 package and Microsoft 
Access. The system works by playing pre-recorded messages to the participant, and Us-
tening for user-input made via the telephone keypad. The system is fully programmable, 
and was able to respond to incoming data from participants. Cafls were scheduled 
when participants registered their unique study I D code, and a call list generated in the 
database. The system polled this call list at regular intervals to determine when calls to 
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participants should be made. 
Flow diagrams indicating participants' progression through the system (both incom-
ing and outgoing calls) are shown i n Figures 5.2 and 5.3. The ful l text of the recorded 
speech used for the telephone calls is given in A. 10 on page 235. 
Study website The study website was built using open source software (PHP and 
mySQL), and a library of functions to generate online questionnaires which were written 
by the author. These functions convert questionnaires in spreadsheet format to a series 
of H T M L pages, and securely record user inputs. This approach was preferred over 
commercially available questionnaire software for several reasons, particularly that the 
system could be easily customised to meet the needs of successive studies; that it handled 
multi-page forms, and could programatically alter the forms displayed to participants 
based on data they entered; and that data from participant questionnaire responses (e.g. 
for baseline measures) could be stored separately from identifying information (e.g. 
name and address) used for study administration. Additional description of the system 
and examples of its use are shown in A.9 on 230. 
Data security I n accordance w i t h recommendations of professional and ethical bodies 
(Kraut et al., 2004), numerous steps were taken to ensure that privacy and anonymity 
were preserved. These included: (i) Design of systems to minimise risks of data 
loss/exposure. Specifically, systems were designed not to present any user-entered data 
at any time, reducing the risk of accidental or malicious access of participant data; (ii) 
Use of up-to-date software (including all patches) on research web servers and telephone 
systems; and (i i i) Regular inspection of access logs etc. 
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Figure 5.2: Flow diagram for calls in, indicating participant progression through the 
automated telephone system for registration 
Welcome 
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Figure 5.3: Flow diagram for calls out, indicating participant progression through the 
automated telephone system for repeated data collection 
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Research ethics The study, as described above, was approved by the University of 
Plymouth Human Sciences Research Ethics panel. No special permissions were required, 
as the study did not involve deceptive instructions (participants were informed of the 
essences' ingredients, and that their efficacy was controversial). Particular attention was 
paid to ensuring that informed consent was given. Briefing information was written in 
clear and straightforward Enghsh, and care taken to omit any psychological jargon. To 
successfully register on the online system participants were required to 'tick' an h t m l 
checkbox, indicating that they understood the briefing information and agreed to take 
part in the study. 
Baseline assessments 
Spirituality Spirituahty was assessed w i t h the SCQ-14, a short-form version of the 
original SCQ-48 used in Study 2 (see page 57). The scale consists of 7 positively worded 
and 7 negatively worded items, each scored on a seven-point scale, from unlike me (-3) to 
like me (-1-3). During the development of the SCQ-14 one of the criteria for item inclusion 
was longitudinal correlation with outcome for a flower essences therapy, and data from 
Study 2 were used to select items. A more detailed description of the development of 
the SCQ-48 and SCQ-14 can be found in Wheeler and Hyland (2008). Scale items are 
included in A.4 on page 218. 
Expectancy Expectancy was measured by a single 7-point scale where participants 
were asked to rate "At this point in time do you expect the flower essence w i l l help you?"; 
the endpoints of the scale were marked unlikely it w i l l help (-3) and definitely think it 
w i l l help (-1-3). 
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O p t i m i s m Optimism was measured using the 10-item Life Orientation Test (LOT-R; 
Scheier et al., 1994, ^), which contains 6 scored items (3 positively worded, 3 negatively 
worded) and 4 filler items. Participants respond to each item on a 5-point scale and 
higher scores indicate greater optimism. 
Outcome To assess outcome, participants heard the following message 'How much 
better do you feel from taking the flower essence? Press a number from 1 to 9, where 
1 means you feel much worse, 5 means you feel the same, and 9 means you feel much 
better." I n the analysis below, outcome scores for calls on days 1, 2, 3, 4, 7, 14 and 21 are 
denoted outcome^ Responses were recoded such that zero became the midpoint (i.e. 
no change). 
Adherence Adherence was measured by the question: " D i d you take the flower essence 
this morning? Press 1 for yes, 0 for no, or 9 i f you can't remember". Don't know 
responses were re-coded as 0, and the variables adherence^ indicate mean responses 
for individual calls. Adherence'"'^"" denotes the participant's mean score for ah adherence 
assessments. 
Ease o f the r i tua l We wished to measure the extent to which participants in the spiritual 
and positive groups found it easy to foUow the additional instructions. Ease of ritual was 
assessed by a single question i n the final automated telephone call, which corresponded 
w i t h the ri tual extension in the spiritual and positive groups. I n the spiritual group, 
this question was "How easy was it to imagine the flower essence connecting you to a 
universal pool of healing and love?" I n the positive group, the question was: "How easy 
was it to imagine the flower essence helping you solve your problem?". Both groups were 
^Items are listed in A.5 on 221. 
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requested to "Give your answer on the telephone keypad, where 9 means it was very 
easy and 1 means it was very difficult". Ease of ritual was not assessed for the neutral 
group because no additional instructions to perform a ritual when taking the essence 
were given. 
Multi level (growth curve) analysis Outcome data was collected at muhiple time 
points for each participant, and analyses must take account of this nested structure or 
observations wi th in individuals. Multilevel growth-curve modelling allows researchers 
to estimate intra-individual changes which occur over time, whilst respecting inter-
individual differences (Hox, 2002, page 73). Additionally, models may contain fixed 
components, and covariates may be entered at all levels of the model (e.g. observations 
and participants). For example, in the context of this study, outcome scores at each 
time point can be adjusted to take account of adherence; and change for individual 
participants can be adjusted to take account of group or dispositional spirituality scores. 
Multilevel analyses reported here were performed w i t h the xtmixed component of Stata 
10 (see Rabe-Hesketh and Skrondal, 2008, chapter 5). For ease of interpretation, and 
to facilitate model convergence, all continuous variables were standardised before being 
entered into a model (Hox, 2002). 
Missing data i n multi level analyses One advantage of the multilevel approach is 
tolerance for missing outcome data. In this study most participants did not complete 
all of the outcome assessments, and some completed as few as 2 or 1 assessments. 
Using traditional methods (e.g. standard regression) i n which scores are aggregated 
to before/after measures, or to change scores, would mean that information from these 
participants is lost. However in the multilevel approach, even participants wi th only one 
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data point are included in the analysis—although their data cannot be used to estimate 
variance in slopes, a single data point can be used to estimate variation in intercepts 
(effectively, mean levels of response) between participants. Although the approach 
assumes data are 'missing at random', this assumption is in fact less demanding than 
that of traditional approaches which employ listwise deletion of cases w i t h missing data, 
and is less susceptible to bias. According to Rabe-Hesketh and Skrondal (2008), the 
probability of data being missed on a given occasion may be correlated w i t h covariates 
i n the model, and also w i t h prior or future data points. However 'Missing at random' 
does mean that the probability of data being missing must not correlate w i t h the value 
that would have been observed (page 207). Although this is somewhat problematic i n 
a therapy-outcome study, because participants may decline assessments on the basis of 
their condition, the multilevel approach is recommended over traditional before/after 
comparisons (Rabe-Hesketh and Skrondal, 2008), and other techniques-for example 
structural equation modelling for longitudinal data-suffer from similar shortcomings. 
5.3 Results 
Sample characteristics, drop-outs and response rates Three hundred and fifty six 
people responded to advertisements and registered on the web site, and Table 5.1 displays 
the numbers of participants retained within each group at various stages of the trial . O f 
those participants who registered on the telephone system and responded to one of the 
final 3 assessments (and are therefore included in the main analyses below), 42 were male, 
207 female and 2 did not state their gender. The mean age of participants was 37 years, 
a = 11.9, range = 18 to 66 years. 
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Table 5.1: Participants entered and retained at various stages of the trial, by group 
Entered study 
online 
Registered via 
telephone" 
> 1 response, 
days 7-21'' 
Response on 
day 21'' 
Spiritual 118 94 (79.7) 87 (92.6) 73 (77.7) 
Suggestion 117 85 (71.8) 75 (89.3) 70 (83.3) 
Neutral 121 99 (81.8) 89 (89.9) 78 (78.8) 
Total 356 277 (77.8) 251 (90.6) 221 (79.8) 
" N and (%) of original entrants online 
N and (%) of those registered via telephone 
Figure 5.4: Outcome and adherence scores at each time point, by Group 
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D i d participants find flower essences effective? Figure 5.4 presents scores for outcome^ 
. . . outcome^^ and adherence^ . . . adherence^^ Scores are standardised to aid comparison; 
raw outcome scores are shown in Table S.2, and adherence rates are shown in Table 5.3. 
Table 5.2: Mean outcome scores (standard deviations in row below) in the three 
groups 
Group Assessment day 
1 2 3 4 7 14 21 
Neutral 0.08 0.25 0.52 0.65 0.83 0.72 0.82 
1.07 0.91 0.80 1.35 1.15 1.46 1.63 
Positive -0.16 0.02 0.29 0.40 0.66 0.95 0.62 
1.04 1.10 1.04 1.07 1.25 1.49 1.47 
Spiritual 0.25 0.32 0.46 0.50 0.72 0.71 0.82 
0.98 1.15 1.18 1.28 1.15 1.42 1.48 
Table 5.3: Adherence rates (%) in the three groups 
Group Assessment day 
1 2 3 4 7 14 21 
Neutral 83 91 88 90 88 79 69 
Positive 80 86 92 92 84 75 70 
Spiritual 86 91 90 88 85 73 73 
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To determine whether participants experienced an improvement over time outcome 
scores were entered into a growth curve model i n which observations on days 1 . . . 21 were 
nested with in participants. To examine whether or not rate of change was linear over the 
days of observation, both day of observation (days: 1,2,.. . 14, 21) and the quadratic term 
for days (days^) were entered into Model 1; resuhs are shown in Table 5.4. Coefficients 
for both days and days^ were significant, indicating that participants improved over time, 
but that the rate of improvement slowed over time; this mirrors the pattern observed i n 
Figure 5.4. 
Table 5.4: Growth curve models for outcomes over days 1 to 21 
Model Variable Coef. Std.Error P 
1 days 0.116 0.017 <.001 
days^ -0.004 0.001 <.001 
[log likelihood = -2087, N = 267, observations = 1373] 
2 days 0.116 0.017 <.001 
days^ -0.004 0.001 <.001 
positive -0.205 0.118 .083 
spiritual -0.065 0.113 .569 
[log likelihood = -2086, N = 267, observations = 1373] 
3 days 0.116 0.017 <.001 
days^ -0.004 0.001 <.001 
spirituality 0.132 0.048 .006 
[log likelihood = -2086, N = 267, observations = 1373] 
continued... 
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Continued... 
Model Variable Coef. Std.Error P 
4 days 0.116 0.017 <.001 
days^ -0.004 0.001 <.001 
neutral 0.156 0.116 .179 
spiritual 0.142 0.115 .217 
spirituality'' -0.134 0.100 .182 
neutral x spirituality 0.295 0.129 .022 
spiritual x spirituality 0.374 0.123 .002 
(log likelihood = -2078, N = 267, observations = 1373] 
5 days 0.115 0.017 <.001 
days^ -0.004 0.001 <.001 
spirituality 0.118 0.048 .014 
adherence 0.129 0.032 <.001 
[log Ukelihood = -2052, N = 267, observations = 1367] 
6 days 0.124 0.022 <.001 
days-^ -0.004 0.001 <.001 
spirituality 0.069 0.066 .291 
ease .155 0.065 .026 
[log likelihood = -1276, N = 150, observations = 836] 
7 days 0.124 0.021 <.001 
days^ -0.004 0.001 <.001 
spirituaUty 0.063 0.065 0.334 
ease 0.159 0.065 .015 
adherence 0.105 0.043 .015 
continued... 
''Represents the coefficient for spirituality in the positive group, because this group is acting as the 
reference category: dummy variables for the other two groups are included in the model 
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Continued... 
Model Variable Coef. Std.Error P 
[log likelihood = -1252,N = 150, observations = 832) 
8 days 0.115 0.016 <.001 
days^ -0.004 0.001 <.001 
expectancy 0.125 0.048 .009 
[log likelihood = -2084,N = 267, observations = 1373] 
9 days 0.116 0.017 <.001 
days^ -0.004 0.001 <.001 
expectancy 0.088 0.052 .090 
spirituality 0.097 0.052 .063 
[log likelihood = -2082,N = 267, observations = 1373] 
10 days 0.070 0.020 .007 
days^ -0.002 0.001 .065 
expectancy 0.088 0.087 .315 
spirituality 0.218 0.080 .007 
[log likelihood = -700, N = : 92, observations = 475] 
* The positive group is the reference category to which this coefficient refers 
D i d benefit vary between groups? I n order to account for different levels of change i n 
different groups, dummy variables were created for group, coded 0/1 to indicate group 
membership. As for standard multiple regression, where more than 2 values (k > 2) must 
be dummy coded then dummy variables representing k - 1 values are entered into the 
model. The dummy value not represented in the model represents the baseline from 
which comparisons are made. I n Model 2, dummy variables for membership of the 
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positive and spiritual groups were added to Model 1, and neutral group membership 
therefore represents the baseline f rom which comparisons are made. Results of Model 2 
are shown in S.4. Contrasts revealed no significant differences between any of the groups, 
although there was a non-significant trend (p = .08) for positive group participants to 
fare worse than those in the neutral group. 
D i d spir i tual i ty correlate w i t h outcome, and was there a moderating effect o f context? 
I n previous studies (see Chapter 3 and Hyland et al. 2006) dispositional spirituality 
predicted outcome i n response to flower essences. However, in this study the context 
i n which flower essences were administered was experimentally manipulated, and it 
was hypothesised that the relationship between spirituality and outcome would vary as 
a funct ion of context: specifically, that spirituality should correlate w i t h outcome for 
participants i n the spiritual group, but not for participants in the positive group. To test 
this prediction two additional models were computed. First, standardised scores on the 
SCQ-14 (spiritualityz) were added to predictors from Model 1; results of Model 3 are 
displayed in Table 5.4. For the whole sample, including all three groups, spirituality d id 
predict outcome {coef= .132, p .006), but this relationship was weaker than i n previous 
studies. 
To test whether prediction varied by group. Model 4 included spiritualityz, along w i t h 
interaction terms for spirituality and the dummy coded groups. To facilitate comparison 
of the spiritual and positive groups, the positive group was selected as the reference group, 
and dummy variables for the neutral and spiritual groups were entered. As w i t h multiple 
regression, interaction terms for growth curve models are simply the product of the two 
variables: in this case, neutral x spiritualityz and spiritual x spiritualityz. Results are 
displayed in Table 5.4. The likelihood ratio test indicated that Model 4 was a significantly 
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better fit than was Model 3 (p< .001). Coefficients for the interaction terms indicate that 
outcome slopes in both the neutral and spiritual groups were significantly different f rom 
slopes in the positive group. Using the positive group as a baseline, spirituality negatively 
predicted outcome (—. 133), but there was a large interaction between membership of the 
spiritual group and spirituality (.37, p = .002), and was thus comparable w i t h previous 
findings (Hyland et al., 2006, 2007). 
D i d optimism predict outcomes? Although optimism did not predict outcomes i n 
Chapter 3, in this study flower essences were contextualised as a 'positive' therapy for 
one of the groups. To test whether optimism predicted outcomes additional growth 
curve models were computed: first, for the whole sample, and second for positive 
group only. Models included time and the quadratic term for time, and also included 
standardised scores on the LOT-R. For the entire sample optimism d id not predict 
outcomes (—.08, ns). However, for the positive group only, there was a trend for more 
optimistic participants to have worse outcomes, ( - . 156,p = .064; i n an additional model, 
the coefficient for the neutral group was very similar). 
Were adherence and ease of the r i tual associated w i t h outcome? It was predicted that 
spiritual people would become more involved w i t h spiritual instructions, as indicated 
by the variables ease of ritual (ease) and adherence. For the spiritual group, spirituality 
and ease were correlated, r(69) = .37, p < .01 , but they were not correlated for the 
positive group r(65) = .15, p = .23 . Mean adherence rates did not correlate with ease 
r( l37) = .09, p= .28 , suggesting that adherence and ease of ritual measure different 
types of involvement w i t h the ritual. There we no significant correlations between 
spirituality and adherence in any of the groups. 
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To establish whether adherence or ease predicted variance in outcome (i.e., slopes for 
participants i n the growth curve models) three additional models were buih. As before, 
outcomes on days 1 . . . 21 were nested within participants, and covariates for the day of the 
observation (days) and the quadratic term (days^) were included, along w i t h standardised 
SCQ-14 scores. Next, either standardised adherence scores, or standardised ease scores 
were entered (Models S and 6). Note that the sample for Model 6 is smaller ( N = ISO) 
because ease was not measured for the neutral group. Finally, Model 7 included both 
ease and adherence (again, excluding participants f rom the neutral group). A l l results 
are shown i n Table 5.4 on page 121. Likelihood ratio tests indicated that all three models 
fitted better than Model 3, and that Model 7 was a significantly better fit than was Model S 
( p < .001) 
Both adherence {coef= .13, p .001 ), and 'ease' {coef = .16, p .002 ), predicted 
variance i n outcomes when entered in separate models (5 and 6), and also predicted 
independently when entered together in Model 7. 
To test whether ease and adherence interacted w i t h spirituality to produce improved 
outcomes, additional models were computed i n which the product terms for ease^ x 
spiritualityz and adherence x spiritualityz were entered (Models 11 and 12; these models 
were computed separately for the spiritual group only). There was no evidence for an 
interaction between ease^ and spirituahtyz, coef= .037, p .656 , but adherence was 
a significant moderator of the effect of spirituality on outcome, coef= .239, p .032 , 
indicating that participants who were both high i n dispositional spirituality and who 
took the spiritually-contextualised essence regularly gained additional benefit. 
D i d expectancy predict outcome, and were spirituality and expectancy independent 
predictors o f outcome? Expectancy for outcomes was measured at baseline, and, as i n 
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previous samples, expectancy and spirituality scores correlated, r(355) = .43, p < .001. 
It was hypothesised that, as before, both expectancy and spirituality would independently 
predict variance in outcomes. To test this hypothesis, a further series of growth curve 
models were calculated, following the pattern of a mediation analysis described in 
Chapter 3 (page 64). For all models, observations were grouped by participants, and 
time and a quadratic term for time were included. 
First, for the whole sample, a model i n which standardised expectancy score was 
the only independent variable was built (see Model 8, Table 5.4). I n this model 
expectancy did predict variance in outcomes {coef= .13, p .009 ). Second, because it 
had already been established that spirituality predicted variance in outcomes, a model 
wi th standardised scores for both expectancy and SCQ-14 was computed (see Model 9). 
In this model neither expectancy nor spirituahty were significant predictors. However, in 
this study the presentation of the flower essence had been experimentally manipulated, 
and it was correctly hypothesised that spirituality would predict outcome i n the spiritual 
group, but not in the positive group. For this reason Model 9 was repeated, including 
only those participants who had received spiritual instructions. Results are shown in 
Model 10. I n this model, spirituality (coe/= .22, p .007), but not expectancy (coe/= .08, 
p .315 ) predicted outcome. A similar pattern was observed when both the spiritual 
and neutral group participants were included. This implies that although spirituality 
and expectancy are correlated, for participants i n the spiritual group expectancy scores 
were epiphenomenal in the sense that, controUing for dispositional spirituality, higher 
expectancies did not result in improved outcome. 
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5.4 Discussion 
This study builds on earher work, and again replicates the finding that a motivational 
disposition predicts outcome (or a placebo complementary therapy It also provides 
a more stringent test of the motivational concordance hypothesis; spirituality only 
predicted outcomes when the therapy was contextualised in a manner congruent wi th 
this motivational disposition, and only for participants who engaged with the ritual and 
complied w i t h instructions to take the essence each day. 
N o group differences There was no evidence for group-level differences i n out-
come, despite the widely varying instructions provided to participants in the neu-
tral , spiritual and positive groups. I n part this may reflect the wealth of background 
knowledge and expectation participants bring to studies of 'real-world' placebo effects. 
Unlike laboratory analogue studies, particularly those using placebo analgesics for 
artificially induced pain st imuli , participants in this study often had prior knowledge 
of Bach flower remedies. Anecdotally, it appears that this knowledge is very often 
inaccurate^, but prior knowledge and experience may have made it harder to manipulate 
participants' expectations sufficient to identify group differences. However, the fact that 
the relationship between dispositional variables and outcome was reversed for the two 
groups suggests that a true patient-treatment interaction took place. Patient treatment 
interaction research is reviewed more fully i n Chapter 7, but historically it has proved 
difficult to identify reliable methods of selecting the 'right therapy' for a given patient 
and thus maximising therapeutic benefit. This area of research has been particularly 
^in the course of 4 experiments using Bach flower remedies the author has found numerous participants 
to be surprised to discover that the only known ingredients of the remedies are water and brandy. 
Typically, people equate Bach essences with other active herbal remedies and expect them to contain 
pharmacologically active plant extracts. 
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hampered by the lack of a theoretical basis on which to select interventions (Dance and 
Neufeld, 1988), and it may be that motivational concordance provides a framework for 
future studies in this area. 
Although the lack of group-level differences in outcome was somewhat surprising ' 
in this context, this finding is consistent wi th meta-analytic work on psychotherapy 
outcomes. Although controversial, meta-analyses have consistently found that therapist-
delivered psychological interventions produce equivalent outcomes (Wampold, 2001), 
even where the theoretical orientations of treatments and researchers diverge widely 
(Benish et al., in press). 
Motivational congruence, adherence, and performance of the r i tual Consistent 
with motivational concordance theory, spirituality—outcome correlations were only 
found when the motivational context of the Bach remedy was congruent wi th that 
disposition, and negative correlations were found when the remedy was given an 
incongruent context. Although participants in the neutral group received no addi-
tional instructions contextualising the essence as a spiritual therapy, in the absence of 
exphcit instructions it is likely that these participants relied upon prior knowledge of 
the remedies, which like other complementary therapies are typically conceived-of as 
both outside of conventional medicine and compatible w i t h hohstic or new-age beliefs 
(Cartwright and Torr, 2005). This evidence provides additional support for motivational 
concordance theory, and demonstrates more clearly that it is the motivational context 
of a placebo therapy-rather than characteristics of the therapy itself-that produces the 
observed correlation. 
The pattern of correlations suggests that the enhanced rituals (positive and spiritual 
groups) may have provided greater opportunity for engagement, but also for discomfort 
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when the therapeutic ritual was discordant. Neutral instructions may ahow for greater 
flexibility i n interpretation, but reduce the maximum benefits which may be gained for 
highly spiritual individuals. 
Adherence was not correlated w i t h spirituality. However, amongst the spiritual group 
spirituality and adherence interacted: Highly spiritual people who also took the essence 
regularly gained additional benefits. This is consistent w i t h motivational concordance 
theory which posits that it is the performance of a self-actualising ritual that w i l l generate 
changes i n affect and consequent therapeutic benefits. Thus, although adherence was 
a moderate predictor for the sample as a whole, i t was particularly relevant for those 
participants w h o were assigned to congruent instructions. 
In this study, an additional measure of 'ease' of performing the ritual was made, and 
self-reported identification w i t h the ritual significantly predicted variance in outcome, 
and predicted variance independently of the conventional measure of adherence. This 
measure was retrospective, and it is possible that ease or adherence is confounded w i t h 
outcome. However, taken together w i t h the evidence that adherence moderated outcome 
for spiritual participants in the spiritual group, this provides some additional support 
for the contention f rom motivational concordance theory that is the performance of a 
meaningful, self-actualising ritual that is responsible for therapeutic outcomes. 
O p t i m i s m and expectancy In an earlier study, Geers et al. (2005a) had suggested 
that where positive expectancies were generated for a placebo response, then dispo-
sitional optimism may predict outcomes. I n this study, as for previous studies using 
Bach flower essences (see Chapter 3), positive expectancies were generated for outcomes 
but opt imism did not predict outcome. The repetition of this null finding in two large 
samples (N = 167 — 267) suggests that the relationship between optimism and outcomes 
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may be due to an unidentified component of the intervention context—perhaps contact 
w i t h a more cheerful experimenter than the author. 
A in previous studies, dispositional spirituality predicted outcome independently of 
expectancies. Furthermore, when both spirituality and expectancies were entered in the 
same model expectancies no longer predicted independent variance in outcomes. This 
is consistent w i t h previous studies in which expectancy only weakly predicted outcome 
when spirituality and expectancy were included in the same model (see Hyland et al. 
2006 and Chapter 3), and provides further evidence for the existence of motivational 
concordance as an additional mechanism of placebo change. 
Conclusion 
The finding that dispositions can predict placebo responses was replicated in a large 
sample of the general pubhc. Additionally, a manipulation of the motivational context 
of the therapy demonstrated that it is context, rather than specific characteristics of 
the therapy itself, which is responsible for this relationship between dispositions and 
outcomes. Expectancy was a weak predictor of outcomes and did not predict variance i n -
dependently from dispositional spirituality. In sum, these data support the motivational 
interpretation provided in Chapter 4. 
Chapter 6 
Placebo substances and placebo effects: 
parental dispositions predict child response 
to a placebo complementary therapy 
The hypothesis that responses to long-term therapeutic placebo maybe me-
diated by the motivational concordance of the therapy was further examined. 
Parents or caregivers of children aged between 2 and 5 were recruited for a 
trial of a complementary (placebo) therapy for temper tantrums; baseline 
data were collected via a website, and repeated measures of outcome were col-
lected using a programmable telephone system. Motivational characteristics 
of parents at baseline predicted the responsiveness of children to therapy, and 
these findings are discussed with reference to the role of adherence in placebo 
response, the role of response expectancy as an unmediated mechanism of 
placebo change, and the motivational concordance hypothesis^ 
'This data has been submitted for pubUcation in a manuscript entitled: Reduction in Temper Tantrums 
in Young Children by a Vicarious, Behaviourally Mediated Placebo Ritual, and is now under review. 
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6.1 Introduction 
When placebos are used i n experimental or clinical research, measurements of outcome 
are taken f rom the person receiving the placebo. However, as several authors note, 
placebo effects cannot logically be defined as the effects of inert substances without 
contradiction (Moerman, 2002). Inert substances are, by definition, inert, and we must 
identify the psychological context rather than the physical properties of an experimental 
situation to understand how placebo effects are generated. It follows then, that placebo 
effects need not be restricted to those who ingest placebo substances. Inert substances 
may generate vicarious placebo effects, defined as the effect that the administration of 
a placebo to one person has on a second person. Vicarious placebo effects may be 
distinguished f r o m behaviourally mediated placebo effects, in which the behaviour of a 
person is altered by the change i n behaviour of a second person to whom a placebo has 
been administered (or who is affected by a vicarious placebo effect). In this chapter, 
data are presented f rom an open tr ial of a placebo complementary remedy for temper 
tantrums i n young children. The intervention appears to generate vicarious placebo 
effects i n the caregiver, and behaviourally-mediated placebo effects in the child. 
Emotional and behavioural problems in pre-school children Diagnosis and treat-
ment of emotional and behavioural problems in pre-school children is an immature 
discipline, and one fraught w i t h cultural as well as methodological difficulties. Rapid 
physical, cognitive, emotional and behavioural changes in preschool children mean that 
identification and classification of clusters of symptoms is problematic, although not 
intractable (Potegal et al., 2003). However, the belief that problematic behaviour in 
young children is not located ' i n the child' but i n their environment-particularly the 
6.1. I N T R O D U C T I O N 135 
behaviour of their caregivers-adds to the reluctance to label children wi th a psychiatric 
disorder prematurely. It is clear that, like adolescents and adults, pre-school children 
can be vulnerable to psychiatric disorders that both predispose them to future harm and 
may be treated with psychological and pharmacological treatments; in cases where such 
treatments are successful it appears likely that the illness is ' i n the child'. However it is 
unlikely that psychiatric disorders account for the majority of'problematic' behaviour in 
pre-school children. In many cases environmental variables-particularly the behaviour 
of caregivers-are likely to remain an important determinant of outcome. 
'Temper tantrums' are a normal component of the pre-school child's behaviour, but 
are nonetheless a cause for concern among parents who experience them. Although 
temper tantrums are largely 'sub-chnical', in the sense that no conventional medical or 
psychological therapy is deemed necessary or offered for them, they are associated w i t h 
recurrent low-level illness in children, poor sleep, and w i t h maternal stress (Hart et al., 
1984). A sample of 502 English mothers of 3-year old children also highlighted links 
between tantrums, maternal stress and child health (Needlman et al., 1991). Tantrums 
were reported for approximately 7% of children, of w h o m 52% exhibited multiple 
behavioural problems. Variables independently associated w i t h tantrums were: maternal 
depression and irritability, low education, use of corporal punishment, manual social 
class, marital stress, child care provided exclusively by the mother, and poor child health. 
From a straightforward learning-theory perspective, it would seem somewhat para-
doxical to expect an intervention, like flower essence therapy, in which parents are 
encouraged to administer a sugar pillule to children would reduce problem behaviours. 
Such an intervention appears to provide positive reinforcement for problem behaviours 
through both attention and the (desirable) p i l l . However the broader attribute of 're-
sponsiveness' is associated w i t h secure maternal attachment and a reduction in problem 
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behaviour (Strand, 2000), and on this basis a placebo intervention that boosts positive 
affect among parents may also increase responsiveness and positive engagement w i t h 
children, thereby improving behaviour. Four mechanisms could explain how flower 
essences work, should they be shown to reduce reported tantrums in young children: 
Expectancy/real change: parents may expect the tantrums to reduce in response 
to therapy and communicate this expectation to their child. The child actually re-
duces tantrums i n response to this suggestion. This first mechanism fits a standard 
response-expectancy placebo paradigm, but wi th the caregiver rather than an experi-
menter providing the suggestion. 
Expectancy/perceived change: caregivers may expect a reduction in tantrums and 
consequently perceive a reduction even though there is no real reduction in tantrums; 
this would constitute a vicarious placebo effect on the perceptions of symptoms. 
Concordance/perceived change: This constitutes another example of a vicarious 
placebo affecting perceptions of symptoms. According to the motivational concordance 
hypothesis, flower essences are contextualised as a spiritual ritual and engaging in this 
therapeutic r i tual is self-actualising for spiritual people, which leads to positive affect. 
This positive affect could lead to a perceived reduction i n tantrums via a reporting bias, 
even though there is no real reduction in problem behaviour. 
Concordance/real change: This final mechanism involves both a vicarious placebo 
effect and a behaviourally mediated effect: It is proposed that the behaviour of caregivers 
is altered by performing a motivationally concordant ritual. This change in behaviour 
influences the child, and results in a real reduction in temper tantrums. In the case of 
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this fourth mechanism, the ritual of taking the flower essence does not affect the child 
directly, but does so via the unintended behaviour of another person who is taking part 
in the ritual. 
On the basis of each of these four mechanisms, it is possible to predict which baseline 
variables should- correlate wi th outcome (i.e., reduced reported tantrums). For the 
two expectancy-related mechanisms, baseline expectancy should predict outcome. For 
mechanisms involving motivational concordance, spirituality should predict outcome, 
so long as the therapy is contextuahsed as a spiritually therapy (Hyland and Whalley, i n 
press); furthermore, spirituality should predict outcome independently of expectancy. 
I f the therapeutic outcome is mediated via parental mood (i.e., change in perceived but 
not real tantrums), then change i n parental mood should correlate w i t h outcome. Tests 
of predictors of change w i l l therefore provide insight into the different mechanisms of 
tantrum reduction, should such a reduction be found. For practical reasons, and because 
objective measurement tends to be obtrusive, measures of temper tantrums normally rely 
on reports from parents, and reports from parents were used to measure outcome in this 
study. This makes it difficult to distinguish whether reported reductions in tantrums 
are real or only perceived. However, a measure of tantrum frequency was included, 
and this is less likely to be affected by a reporting bias than are evaluative judgements 
of tantrum severity. To reduce recall-based error we asked parents to report on the 
child's tantrums and their own mood in the previous 24 hours, and we took repeated 
measurements before and after treatment. Other variables relevant to the theoretical 
predictions above (i.e., expectancy and spirituality) were measured at basehne. The 
results allow us to examine whether reported tantrums reduce after placebo treatment 
compared w i t h before treatment, and identify the factors associated w i t h that reduction 
should it occur. 
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6.2 Methods 
Overview Participants were recruited, and registered, provided informed consent, and 
completed baseline measures via a specially designed study website. Assessments of 
reported tantrums began immediately and continued for ten days. Dur ing this period, 
flower essences and instructions were sent to participants. Flower essence treatment 
began, and continued w i t h assessments for a further 10 days. After assessments were 
complete a fol low-up question was sent via email. Excluding technical support there was 
no human contact w i t h participants who provided outcome data using an automated 
telephone system. The overall flow of participants through the study is shown in Figure 
6.1. This figure (and figures 6.3 and 6.2 below) foUow the conventions described in Jesse 
James Garrett's Elements of User Experience (2003). 
Study website The study website was built using open source software (PHP and 
mySQL), and a library of functions to generate onhne questionnaires which were written 
by the author for a previous study (see page 112). These functions convert questionnaires 
in spreadsheet format to a series of H T M L pages, and securely record user inputs. 
Automated telephone system The automated telephone system used to collect out-
come data was programmed by the author using the Envox 6 package and Microsoft 
Access. The system works by playing pre-recorded messages to the, and listening for user-
input made via the telephone keypad. The system is fully programmable, and was able 
to respond to incoming data f rom participants; for example, when participants indicated 
no tantrum had occured in the previous 24 hours, questions relating to tantrum severity 
were omitted. Calls were scheduled when participants registered for the study, and a 
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Figure 6.1; Participant flow through the study 
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call list generated i n the database. The system polled this call list at regular intervals to 
determine when calls to participants should be made. 
Flow diagrams indicating participants' progression through the system (both incom-
ing and outgoing calls) is shown in Figures 6.2 and 6.3. The ful l text of the recorded 
speech used for the telephone calls is given in A . l 1 on page 237. 
Data security As in Chapter 5, numerous techniques were employed to secure user data 
and ensure anonymity. Crucially, all systems were programmed such that user responses 
were not recorded w i t h identifying information such as names and addresses—this 
information was stored w i t h the participant I D number as a key, and could only be 
retrieved via manual intervention on the part of the investigator. Furthermore, both 
the web and telephone systems did not contain functions which could display user 
information; once data was entered into the system then public facing web pages or call 
scripts d i d not have access to this data, significantly reducing the possibility of a security 
breech. 
Recruitment A number of techniques were employed to recruit suitable participants 
over a 6 month period. 
Broadcast media: The study was featured, and the investigators interviewed, on 
several television and radio channels, including BBC Radio Scotland, BBC Radio Devon, 
Outlook Southwest (BBC 1 local news programme), and each appearance coincided w i t h 
increased participant recruitment i n the geographical area covered by the programme. 
Local/national press: In addition, a press release was issued and followed up w i t h 
telephone calls, securing brief coverage in the Telegraph magazine, and the Daily Express. 
A larger feature on the study in the Plymouth Herald was accompanied by photos of one 
METHODS 
Figure 6.2: Flow diagram for calls in, indicating participant progression through the 
automated telephone system for registration 
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Figure 6.3: Flow diagrann for calls out, indicating participant progression through the 
automated telephone system for repeated data collection 
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of the first volunteer parents and her child. 
Posters and information sheets: The lead author contacted the head-teacher or 
manager of over 100 schools and day-care centres, and arranged for leaflets to be sent to 
around 1500 potential parents of young chUdren (leaflets were sent home with children 
aged up to 6 in nursery, reception, and year 1 classes). A further 3000 information 
sheets and 300 posters were sent, by arrangement, to toy retailers and chfld entertainment 
venues (e.g. safari or amusement parks). 
Online: Finally, the study was advertised online in a number of places. First, the 
study was promoted via the university staff portal, and on the 'Plymouth University' net-
work on the Facebook website. Second, messages were placed on around 30 appropriate 
message boards and discussion forums—for example boards related to child behaviour, 
parenting skill, or complementary and alternative medicine. Third, a budget of £60 was 
aUocated for onhne advertising. This was used to place keyword-based, text-only adver-
tisements on the Google search network. These advertisements resulted in approximately 
3,800 'click-throughs', and around 25 'conversions' (participant's recruited. 
Volunteers were offered a free bottle of flower essence in return for questionnaire 
completion and evaluation. Volunteers were required to: be the primary caregiver of a 
child aged over 2; have a child who suffered from moderate to severe tantrums (defined 
as 1 or more tantrums lasting at least 5 minutes per day); and to own a mobile phone. 
Exclusion criteria were: non-UK residence and use of flower essences wi th in the past 6 
months. 
Flower essence remedies used Complementary practitioners have added to, and made 
'special' combinations of, the original Bach flower essence remedies, and many hundreds 
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of products are now sold purport ing to treat specific conditions. I n this study we used an 
essence combination specifically designed to help reduce tantrums in young children 
(named T U T S I ) made by the Green Man Essence Company. We used marketing 
materials f r o m the firm as the basis for information about flower essences given to 
participants. I n this study flower essences were purposefully contextualised as a spiritual 
therapy: instruction booklets emphasised the role of the Vibrational essence' of the 
flower and, at the end of the assessment cafls, parficipants were told that: "Flower 
essences work best if, while giving them to your child, you imagine the spirit of the 
flower connecting you and your chfld to a pool of universal heahng and love". These 
instructions are consistent w i t h the practice of many complementary therapists, have 
been shown to increase the effectiveness of flower essences for spiritual patients, and to 
increase prediction f rom measurements of motivational disposition (i.e. dispositional 
spirituality Hyland and Whalley, i n press). 
Baseline measurements Spirituality was measured w i t h the 14-item version of the 
Spiritual Connection Questionnaire (SCQ 14) described previously. Two measurements 
relating to expectancy were made. First, participants responded to the question " H o w 
much better or worse do you expect your child's tantrums w i l l be after taking the flower 
essence?"; val id responses ranged from much worse (-3) to much better (-1-3). Second, 
participants gave a response to the question: " I f you think the flower wiU help, how soon 
after beginning to take the flower essence do you think it wf l l help?". Valid responses 
were: 1 or 2 days (1), 3 or 4 days (2), 5 or 6 days (3), A week or longer (4). The gender 
and age of child and caregiver were recorded, as well as the relationship of parent to the 
child. 
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Outcome assessments Assessments were made via an automated telephone system 
every 2 days during the study period, wi th 10 calls made in total. Comphance was 
measured in the final 5 calls when flower essences were being taken. 
Tantrum frequency: Caregivers were asked "How many tantrums has your child 
had with in the past 24 hours?" Responses were made using the telephone keypad. 
Provided the child had experienced at least one tantrum, caregivers were asked the 
following questions about the severity and additional characteristics of the worst tantrum 
in the past 24 hours. 
Tantrum severity: Caregivers were asked: "On a scale of 1 to 9, how bad was the 
tantrum?" Responses were made using the keypad, where 1 was not bad at all, 5 was 
about average, and 9 was very bad. 
Tantrum characteristics: Six additional characteristics of the worst tantrum re-
ported were assessed. Single questions measured the incidence of screaming, whining, 
kicking and hitt ing, and crying. Ratings were given from not at all (1) to a great deal 
(9). Two further characteristics were measured w i t h 2 or 3-item scales. Caregivers were 
asked: " D i d your child hold their breath?" responding No (0), or Yes (1); and then 
" D i d your child get down on the floor?" responding No (0), Crouching down (1), or 
Lying on the floor (2). These symptom measures correspond to the key characteristics of 
problematic tantrums in young children (Potegal et al., 2003). 
M o o d ratings: Caregiver mood ratings were measured w i t h an individual item in 
each call: "How happy are you today?" Caregivers responded on a scale ranging from 
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much more unhappy than normal (-4), about normal (0), to much happier than normal 
(4). 
Compliance: Caregivers were asked: "How many times did your child take the 
essence yesterday?" and responded not at all (0), once (1), or twice (2). 
Fol low up question A follow up email asked participants to endorse one of the 
fol lowing statements: I to ld my child that the remedy would reduce his or her tantrums 
(1), I can't remember whether I told my child that the remedy would reduce his or her 
tantrums (0), or I did N O T tell my child that the remedy would reduce his or her tantrums 
(-1). 
Procedure A n outline of the study flow is shown in figure 6.1. After recruitment, 
participants provided consent via the study website, and completed basehne measures 
(demographic information, spirituahty, and expectancy). Following submission of 
baseline measures, participants were provided w i t h a unique identity code and asked 
to call an automated telephone line to complete the signup process by entering their 
unique I D code and the mobile telephone number at which the participant wished to 
receive assessment calls. After hanging up, the automated system dialled the participants' 
number to complete the first assessment call (day zero). 
Assessment calls continued for the period before treatment-in total 5 caUs on days 
0, 2, 4, 6 and 8. During this time a sample of the essence and an instruction pack was 
posted to participants, t imed to arrive no earlier than day 8, and w i t h a note that the 
essence was not to be used unt i l day 9. Assessments continued on days 10, 12, 14, 16 and 
18. For the assessment on day 10, the automated system inserted additional questions 
to check that (a) the essence had been received and (b) treatment had begun. I f either 
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of these conditions were not met, all further assessment calls were delayed by 1 day; the 
maximum delay for any participant was 3 days. 
Assessments before treatment (days 0 to 8) included measures of tantrum frequency 
and parent mood. I f a tantrum had occurred then severity and the other characteristics of 
the tantrum were also measured. Assessments after treatment began (days 10 to 18) were 
the same, but also included the measure of compliance, a reminder to take the essence 
in accordance with the instructions, and the message contextualising the essence as a 
spiritual therapy. Follow-up emails were sent following collection of all data, arriving 
between 3 and 22 weeks after the final outcome measure. 
Research ethics The study, as described above, was approved by the University of 
Plymouth Human Sciences Research Ethics panel. At the suggestion of the panel, sugar 
piUules (approx 2mm diameter) were used i n place of the brandy/water solution used in 
Chapters 3 and 5. Two independent physicians (a Emergency Medicine specialist and 
a Psychiatrist) were consulted to verify that the pillues posed no risk to the participant 
population. No special ethical permissions were required as the study did not involve 
deceptive instructions (participants were informed of the essences' ingredients, and that 
their efficacy was controversial). However, particular attention was paid to ensuring that 
informed consent was given. Briefing information was written in clear and straightfor-
ward Enghsh, and care taken to omit any psychological jargon. To successfully register 
on the online system participants were required to 'tick' an html checkbox, indicating 
that they understood the briefing information and agreed to take part in the study. 
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6.3 Results 
Sample characteristics 
Figure 6.4 shows the numbers of participants at various stages of the study; only 
participants who completed at least one outcome measure prior to taking the flower 
essence, and another measure after taking the essence were included in the final analysis. 
From the 58 parent-child dyads, 48 parents (89%) and 18 children (35%) were female; 41 
parents (71%) completed at least 2 calls before and after treatment (i.e., responded to at 
least 4 calls), and 23 (40%) completed at least 3 before and 3 after. Descriptive statistics 
for basehne variables are shown i n Table 18. Completers and non-completers were com-
pared w i t h one-way analyses of variance for baseline measures (spirituality, expectancy, 
child gender, child age, parent gender, parent age). No significant differences were found 
between completers and non-completers, except for child age: Parents of older children 
were more likely to have completed the study than younger children, F ( l , 100) = 5.6, 
p = .02; the mean difference was 6.4 months. 
Table 6.1: Descriptive statistics for baseline variables 
mean cr 
Expectanc/""'""' 5.7 0.79 
Expectancy'^""'^ 2.6 1.2 
8.3 1.2 
Spirituality 4.5 1.0 
Parent aget 34.0 8.0 
Chi ld age-1- -41.0 14.0 
S C Q - 1 4 ; t years; t months 
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Figure 6.4: Participant attrition 
Registered via website (104) 100% 
Registered on teleplione system (89) 8 6 % 
Answered one of calls 1-5 (86) 8 2 % 
Started taking the essence (70) 7 9 % 
Aswered one of calls 6-10 (60) 5 8 % 
Included in analysis (58) 5 6 % 
Note: Two part ic ipants answered one o f 
calls 6-10 bu t d id no t answer any of calls 
1-5. 
Expectancy ratings Participants were generally positive about the flower essences, 
although sufficient variability in expectancy was found to test for expectancy effiects. 
Reliability for the two expectancy items was a = .47, and for the main analysis the items 
were combined into a single measure of expectancy. The pattern of analyses below 
remained unchanged i f the single item expectancy measure was used in place of the 
combined score. 
Compliance Overall, compliance was relatively high. Tables 6.2 and 6.3 show the 
number of parents initiating treatment at each time point, along wi th the mean number 
of doses administered. Figure 6.5 shows the frequencies for participants administering 
0, 1 or 2 doses at each time point. 
150 CHAPTER 6. VICARIOUS PLACEBO EFFECTS 
Figure 6.5: Frequency of doses administered at each time point 
0 1 2 0 1 2 
Call 9 Call 10 
Table 6.2: Percentage of participants initiating treatment at each time point 
Day % 
10 66 
12 86 
14 95 
16 97 
18 100 
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Table 6.3: Mean number of doses administered at each time point 
Day Mean cr 
10 1.1 0.83 
12 1.8 0.52 
14 1.9 0.45 
16 1.6 0.59 
18 1.8 0.52 
Changes in response to treatment 
Multi level approach In this study, multiple measurements of outcome were taken, 
both before and after treatment. I f enough data were available, a growth curve modelling 
approach such as that used in Chapter 5 should be able to determine the change in 
individual trajectories that is attributable to treatment, and also the proportion of this 
change attributable to other independent variables. This would make it possible to 
determine which proportion of the change i n a childs trajectory was due to being treated, 
to their parent's dispositional spirituality, and to the interaction between treatment 
and parent's spirituality—that is, the effect of motivational concordance. However, 
the number of missing data points for outcome makes it hard to justify growth curve 
modelling in this instance; too few data points remain to rehably model curves for before 
and during treatment ( in many cases, only one 'before' and one 'during' measurement is 
available). Nonetheless, a simpler multilevel approach may still be used to model a 'main 
effect' of treatment and account for predictors of change. 
I n the analysis which follows measurements of outcome are nested wi th in partic-
ipants; no further nesting (i.e. use of a three-level model) is required because no 
separate measurements were taken from children. A dummy variable at level-1 is used 
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to indicate whether an observation was taken before or during treatment w i t h flower 
essences (treated, 1/0) and estimates for the effect of treated are aUowed to vary randomly 
between participants; thus the model aUows for children to vary i n their response to 
treatment. Addit ional independent variables such as spirituality, expectancy, parental 
mood, are then entered at level 1 or level 2 as appropriate. This approach is similar to 
a repeated measures analysis of variance, except that level-1 predictors may be included 
where available, for example using comphance or parental mood to predict outcomes on 
individual measurement occasions. 
Were reported tantrums reduced when taking flower essences? This was an open trial 
w i t h no natural history control. As such, it is impossible to be sure what proportion of 
any benefit observed should be attributed to the flower essence treatment; other factors, 
particularly a regression to the mean, may account for a proportion of benefit normally 
attributed to a placebo, as other authors have noted (Hrobjartsson and Gotzsche, 2001, 
2004). However, as was also the case for the studies reported above (see Chapters 3 and 
5), estimating the efficacy or effectiveness of a Bach flower (i.e. placebo) treatment was 
not a design goal. Nonetheless, to ensure that changes in symptoms had occurred—and 
therefore that there was an improvement in symptoms which might be predicted by dis-
positional variables—a model was developed to predict standardised combined tantrum 
scores (tantrumsz'^""''''"^'^) f rom a level 1 variable of treatment (coded 0/1 to indicate 
whether an observation had been made before or during treatment). Coefficients for 
treatment were allowed to vary randomly between participants. Results are displayed 
in Model 1 i n Table 6.4. Treatment accounted for approximately half of one standard 
deviation i n outcome scores, indicating that children's behaviour improved significantly 
during the study ( p < .001). 
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Table 6.4: Models predicting combined tantrum ratings (tantrumsz™'"'''"'^'') before and 
after treatment 
Model Variable Coef. Std.Error P 
1 treatment -0.495 .066 <.001 
[log likelihood = -406, N = 58, observations = 397] 
2 treatment -0.255 .099 .010 
parentalmood^'z -0.092 .040 <.001 
[log likelihood = -256, N = 54, observations = 257] 
3 treatment -0.261 .091 .004 
parentalmood~\ -0.082 .044 .064 
spirituality^ 0.209 .096 .029 
spirituality^, x treatment -0.218 .091 .017 
[log Ukelthood = -253, N = 54, observations = 257] 
4 treatment -0.217 .099 .029 
parentalmood~'z -0.095 .045 .034 
spirituality^ 0.251 .114 .028 
spirituality^ x treatment -0.228 .114 .046 
expectanc/"'"'''"^''^ 0.083 .099 .400 
expectancf'"'''"^''^ x treatment 0.040 .101 .691 
[log likelihood = -237, N = 52, observations = 242] 
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Was change i n reported tantrums predicted by parental mood? It was hypothesised 
that parental affect, or mood, would predict changes in reported tantrums among our 
sample of children. Although 'mood' may often be conceived as a short-term summary 
report of affective state, autocorrelations exist wi th in time series data of mood states 
spanning multiple days (Huba et al., 1976). I n this dataset, significant autocorrelation 
was found for parental mood, F ( l , 42) = 8.37, p = .006 (Drukker, 2003), and i t was, 
therefore, possible that parental mood might predict tantrums over subsequent days. To 
test whether this was the case, a lagged level-1 variable of standardised parental mood 
was created, parentalmood^^z. This variable comprised the parental response measured 
at the previous t ime point. A lagged variable was used to ensure that responses could not 
be influenced by the tantrum symptoms which were themselves to be predicted. Model 
1 was repeated w i t h parentalmood~^^ included at level-1, and results are displayed as 
Model 2 in Table 6.4. Parental mood was a significant predictor of reported tantrums at 
the subsequent point of measurement ( p < .001 ). 
D i d dispositional spirituality amongst parents predict a reduction i n reported tantrums 
w i t h treatment? Adapting the multilevel analysis used in Chapter 5 (see page 117), 
growth curve models were developed to predict whether chfldren of highly spiritual 
participants responded more positively to treatment than did children of non-spiritual 
parents. Because measurements of outcome were taken both before and during treat-
ment, to test the hypotheses it was necessary to estabhsh whether treatment interacted 
w i t h spirituality scores. For Model 3 (see Table 6.4) parameters f rom Model 2 were 
reprised, w i t h two new terms added: standardised scores on the SCQ-14, spirituality^. 
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and the product term for spirituality and treatment, spJnYufl/iYyz x treatment. Inspection 
of the coefficient for the product term indicates that spiritual participants were signifi-
cantly more responsive to treatment ( p .017 ). However the coefficient for spirituality^ 
indicates that spiritual participants were also more likely to report more tantrums before 
treatment ( p .029 ). Because of the method of analysis employed (i.e. examining 
interactions between treatment responses and dispositions wi th in the individual), it is 
unlikely that these higher baseline scores account for the greater treatment responses 
among spiritual participants. Although it is possible that a scaling effect is occurring, 
whereby spiritual participants have greater room for improvement in symptoms, i n 
previous studies (e.g. Hyland and Whalley, in press) spirituality was found to predict 
outcome without also predicting higher baseline symptoms. 
D i d expectancy predict outcomes, or mediate the effect of spirituality on outcomes? 
Scores for the two expectancy questions were averaged to create a more reliable com-
posite measure of expectancy: expectancy^"'"'""^^; a for the two items was .47^. This 
new variable was standardised, expectancy^"'"'^'"^'^^, and entered alongside the product 
term for expectanc/"'"'""^''z x treatment into Model 4; results are shown in Table 6.4. 
The interaction of expectancy and treatment was not significant {coef= .04, p .69 ), 
indicating that expectancies of parents did not account for changes in tantrum behaviour 
in response to treatment. Parental expectancies did not predict higher overall levels of 
reported tantrums (as did spirituality). 
D i d telling a child the purpose of the essence (i.e. generating expectancies) increase 
treatment effects? To test whether affirmative responses to the follow-up question 
^Repeating the analysis below with separate scores produced almost identical results 
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{toldchild), indicating that parents told their children that the essence would help their 
tantrums, would predict larger treatment effects, an additional model was computed. 
This followed the pattern established above: combined outcome scores were predicted by 
the variables: treatment, toldchild, and the product of treatment x toldchild; this product 
term was not a significant predictor {coef= —.12, p .23 ) indicating that children who 
were told the essence would help experienced no greater benefit than children who were 
not told. 
D i d compliance w i t h treatment predict a reduction i n tantrums? To test whether 
compliance predicted variance in outcome, a conventional growth-curve model was 
computed predicting tantrum scores during the treatment phase only (i.e. tantrums/"'"'""' 
but excluding assessments made before treatment began). As in Chapter 5, trajectories 
over the days of assessment were allowed to vary randomly for individual participants, 
and compliance scores were entered as a level-1 predictor. In this model, compliance 
d i d not predict tantrum scores {coef= —.009, p .921 ). However, compliance scores 
may have lacked sufficient variation to predict outcomes in this way (see above, and 
discussion). 
6.4 Discussion 
This study shows that placebo or 'meaning responses' are possible i n young children when 
caregivers deliver the therapy to the child. Carer's responses indicated that there was a 
reduction in both the frequency and severity of reported tantrums. Seventy six percent of 
those who completed the study reported a drop in tantrum frequency, and about a th i rd 
of the sample experienced a reduction in frequency of reported tantrums to less than 
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50% of their original value. Consistent wi th previous research on adult use of FEs (see 
Chapters 3 and 5, and Hyland et al. 2006), spirituality correlated w i t h positive outcome, 
but caregivers' expectancies did not predict change. 
O f four possible explanations for the reduction in tantrums, two are inconsistent 
w h h these data. It is unlikely that the reduction is due to either (i) parents expecting 
benefit, communicating this to children, and ehciting a response expectancy in the child, 
or (ii) parents expecting benefit and so perceiving an improvement in the absence of 
real change. I n both cases expectancy should predict outcome and should mediate the 
relationship between dispositions and outcome; this was not the case in this study. 
It appears more likely that either (iii) parental mood improved because of motiva-
tional concordance w i t h the flower essence therapy, and so caused parents to perceive an 
improvement in their child's behaviour, without real change having taken place, or (iv) 
that motivational concordance improved parents' mood, and subsequently altered their 
behaviour to create a real reduction in tantrums. Dispositional spirituality of parents 
predicted reported responses of chfldren, and as in previous studies this relationship was 
not mediated by expectancy. 
Because changes in parent behaviour were not measured directly and measures of 
tantrums were subjective, these data do not directly help distinguish between hypotheses 
3 and 4. However there are a number of reasons to believe that the change in tantrums 
was real rather than simply perceived, and stemmed from changes in parental behaviour. 
Reductions were observed for all measures of tantrums, including reports of tantrum 
frequency, which are less likely to be biased than subjective ratings of severity. Fur-
thermore, these measures were made on repeated occasions and required participants 
to recaU the incidence of tantrums over a relatively short period of time (24 hours); it is 
known that retrospective judgements are subject to recafl biases (Kahneman et al., 1982; 
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Redelmeier et al., 2003), and that more frequent samphng may partially alleviate these 
problems (ScoUon et al., 2003). 
Children are sensitive to parental cues of distress or dissatisfaction (McDonald et al., 
2007). I f chi ld rearing is found to be non self-actualising, then parents may emit cues that 
elicit tantrums. Spirituality is generally considered a psychologically healthy disposition; 
it is correlated w i t h better mental health (EUison and Levin, 1998; Siegel et al., 2001) and 
addressing spiritual needs may hasten physical recovery (Mueller et al., 2001). However 
i n this study high pre-treatment spirituality correlated positively w i t h tantrum frequency. 
Al though spiritual people might systematically differ f rom non-spiritual people on other 
attributes, this f inding is consistent w i t h a hypothesis that the everyday experience of 
child rearing may fail to enable self-actualisation for spiritual people. The instruction to 
"imagine the flower connecting the child to a universal pool of healing and love" provides 
spiritual people w i t h the opportunity to re-conceive child-caring as a spiritual, and thus 
self actualising, activity. This may alter the affective tone between the caregiver and 
the child, and thereby reduce tantrum-inducing cues. Many parents sent emails after 
the study to say how effective the treatment was, and that the change i n the child was 
instantaneous—consistent w i t h the hypothesis of cue elimination rather than a change 
i n reinforcement schedule; a selection of qualitative feedback recorded during the study 
is included i n A. 12 on page 239. 
A l imitat ion of this study was that no wait-list or no-treatment control was included. 
It is therefore possible that changes were due to natural history, regression to the mean 
or other artefacts confused w i t h placebo effects (McDonald et al., 1983; Kienle and 
Kiene, 1997). However dispositional spirituality, as i n previous studies, predicted the 
degree of therapeutic benefit; because of the analyses employed, it is unlikely that this 
relationship is the result of statistical artefacts; natural variation and regression must 
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occur, but this variation w i l l tend to reduce the size of correlations between outcome and 
predictors and does not pose a threat to the validity of this study. Nonetheless, to estimate 
the true size of the effects observed, future studies would benefit f rom both a control 
group and objective measures of child behaviour—perhaps via ambulatory recording of 
physiological variables associated w i t h arousal. 
Additionally, the attrition rate for this study was relatively high when compared to 
the previous studies. Although high attrition rates are normal in studies of self help 
therapy, some caution is required when interpreting coefficients when data for such a 
large number of participants is unavailable. 
Conclusion 
This study provides limited evidence for the existence of a 'vicarious placebo effect'. As 
in previous studies, concordance between the motivational context of a placebo and the 
high-level goals of participants seemed to be responsible for the therapeutic benefits 
observed, lending additional credence to motivational concordance theory. 
Chapter 7 
Choosing the right therapy: are expectancies 
for therapy outcome determined by values? 
A n attempt is made to broaden the range of pairings between motivational 
dispositions (or values) and outcome for specific therapies. Studies to date 
have found relationships between dispositional spirituality and response 
to a flower essence therapy, and between dispositional gratitude and re-
sponse to gratitude therapy. However, generalising predictions from the 
motivational concordance hypothesis requires that the value-contexts of 
therapies are identified. This would allow therapists-ft^r instance eclectic 
psychotherapists-to select therapies uniquely suited to their patients. Here, 
multidimensional scaling is used to relate validated scales of dispositional 
values to the perceived efficacy of a range of therapies for depression. Data 
are presented which should facilitate identification of contextually-specific 
dispositions for the therapies studied^ 
This data is reported in: Whalley and Hyland (in press b) 
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7.1 Introduction 
CHAPTER 7. CHOOSING A THERAPY 
Half a century ago, Lee Cronbach suggested that the important question in psychother-
apy was not whether therapy was effective, but rather which therapy and for whom 
(Cronbach, 1953). This suggestion was based on the observation that patients are not 
un i form and so may respond differently to different therapies (Kiesler, 1966). The 
continuing popularity of eclecticism i n clinical practice (Norcross et al., 2002), as com-
pared w i t h the manuahsed therapies that are subjected to randomised trials, rests on an 
assumption that treatment should be tailored to the patient. However, this commonsense 
notion—that one size w i l l not fit all—has not been matched by unambiguous evidence 
upon which researchers and clinicians could recommend individual treatment decisions. 
Patient-treatment interactions Part of the problem is that patient-matching—selecting 
the appropriate treatment for any individual patient—can be considered i n different 
ways. First, different types of therapy may be appropriate depending on the state of 
the patient i n the disease/treatment process, for example, the patient's stage of change 
(Prochaska and Norcross, 2002) or the phase of psychotherapeutic treatment (Beitman, 
1987). Second, matching based on traits of patients might be used to aid practitioners 
when selecting techniques w i t h i n a therapeutic orientation. Particular techniques might 
be considered more suited to one patient than another, irrespective of the stage of 
disease or treatment (HoUon and Beck, 1986). Third, therapists can adopt a 'technical 
eclecticism' i n which patients' trait characteristics determine the selection of effective 
techniques, irrespective of theoretical orientation (Lazarus, 1981), and both trait and 
state characteristics may be combined (Beutler et al., 2000). In this paper, we examine 
the extent to which dispositional characteristics can be used to inform choice between 
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theoretically diverse therapies. 
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Previous patient-treatment interaction research Some interactions have been found 
between stable patient characteristics^ and types of therapy. In a study of individual 
treatment for major depression, Ogrodniczuk et al. (2001) found a large sex-by-treatment 
interaction: Men experienced greater improvement in interpretative as opposed to sup-
portive therapy, and this pattern was reversed among female patients. In a second study 
of group therapies for depression (Ogrodniczuk et al., 2004), there was no interaction 
but instead a main effect of gender, w i t h women experiencing much larger gains than 
men in group therapy. Reanalysing RCT data, Blatt and Shahar (2004) found that 
pre-treatment patient characteristics differentially predicted response to psychoanalytic 
and supportive/expressive treatments. Patients were classified according to chnical case 
reports, and "dependent and affectively labile" patients showed greater improvement 
w i t h supportive treatment than w i t h psychoanalytic treatment. However, psychoanalytic 
treatment was more effective for "independent and self critical" patients, for whom 
supportive therapy induced a slight worsening in symptoms. In a comparison of 
cognitive, experiential, and supportive therapies, Beutler et al (1991) found that exter-
nahsing and non-defensive patients improved most in response to cognitive therapy, 
whereas internalising and defensive patients responded best to experiential or supportive 
therapy. MiUer (1991) claims, on the basis of chnical experience, that individuals low 
in openness may prefer directive therapies whereas those high in openness may benefit 
from more imaginative approaches, and also that extraverts may respond more positively 
to treatment i f the therapist speaks quickly and avoids long introductory sessions. 
Interventions for smoking cessation also appear sensitive to baseline characteristics of 
^Note: patient-treatment interaction research based on the severity or type of dysfunction a patient is 
suffering is not discussed here, although the picture is similarly unclear. 
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clients (Hall et al., 1998; Jacobs et al., 1971; Ogrodniczuk et al., 2003; Canuto et al., 2007). 
Empir ica l and theoretical problems w i t h patient-treatment interaction research De-
spite these interesting findings, reviewers note that research has been patchy, and 
hampered by the lack of a theoretical framework for predicting interactions (Dance and 
Neufeld, 1988). Additionally, several high profile studies have failed to match patients 
w i t h treatments. Project M A T C H , a large RCT for alcohol treatments (Project M A T C H 
Research Group, 1993), was specifically designed to facilitate the identification of patient-
treatment interactions. The failure to match patients to therapies in this study, and 
also i n similar U K studies (Heather et al., 2008), has lead some researchers to call into 
question the whole endeavour of attempting to match patients to alternative treatments 
(Allen et al., 1998). There are a number of explanations for the difficulty in identi-
fying interactions between types of patients and different therapies. First, identifying 
individual differences i n clinical settings is fraught w i t h methodological problems and 
costs (Shoham-Salomon, 1991). I n particular, large samples are required to demonstrate 
patient/treatment interactions. Secondly, recognising that different patients w i l l respond 
to different treatments has appeared philosophically at odds w i t h the recent drive to 
demonstrate the efficacy of 'specific' psychological treatments and techniques and gain 
institutional support for their dissemination. Thirdly, and perhaps most importantly, 
researchers interested i n common factors, or eclectic clinicians delivering a variety of 
techniques, have lacked a broad theoretical rationale (beyond the observation that their 
patients differ) for individual differences in response to different therapeutic approaches 
(Dance and Neufeld, 1988). Here we propose that motivation theory—in particular the 
relationship between self-actuahsing behaviours and positive affect—may explain at least 
part of the variance i n individual responses to psychological treatments. 
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A n alternative approach: common factors and human values It is possible that 
researchers have simply been testing the wrong matching hypotheses. The interactions 
that are tested have often been based on matching hypothesised 'specific' components 
of therapies studied and relevant dispositional characteristics of the patient. However, 
there is considerable evidence that specific factors play only a smaU role in psychotherapy 
outcomes compared w i t h contextual factors (Wampold, 2001). I f contextual factors play 
an important role in outcome, i t may be more productive to predict interactions f rom 
clients' perceptions of therapies rather than from researchers' theoretical understanding 
of the therapeutic process. 
Using motivational concordance to identify interactions Motivational concor-
dance, as described in Chapter 4, may be helpful i n the attempt to predict patient-
treatment interactions. In previous flower-essence studies, a dispositional measure of 
values (spirituahty) was related to both expectancies for positive outcome and outcome 
(where the therapy was concordant w i t h the disposition measured). 
These effects are explained with reference to theories of motivation: self help 
therapies constitute a ritual which enables the expression and fulfilment of self-defining 
goals, and this goal-achievement leads to subjective well-being. It follows, that the 
'non-specific' benefits of motivational concordance w i l l be experienced in addition 
to any 'specific' benefits a therapy has (e.g. the psychological benefits of taking an 
antidepressant medication wiU be experienced in addition to the pharmacological action 
of the drug). Therefore, in order to maximise contextual benefits of a therapy, researchers 
or practitioners should select therapies that are concordant w i t h their clients' motiva-
tional dispositions (or the therapies re-contextuahsed in such a way as to maximise 
congruence). 
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Unfortunately, in real-life contexts the motivational characteristics of therapies are 
u n k n o w n and without this information it is impossible to select motivationally con-
cordant therapies. The priority, therefore, is to identify the motivational characteristics 
of real-world therapies, after which new pairings of dispositions and therapies may be 
identified i n studies of real therapy outcomes. 
Structure o f human values As discussed above (see page 86), 10 (or 12) human 
values may be thought of as high-level goals towards which people may express varying 
degrees of commitment. Results f rom large-scale, cross-cultural studies suggest that 
human values form a circular two-dimensional structure, most likely a circumplex 
(Schwartz, 1994; Grouzet et al., 2005). 
This larger structure provides a useful starting point for our task of attempting to 
describe the motivational characteristics of therapies for depression. In the motivational 
concordance studies, congruent dispositions (spirituality, gratitude) were correlated 
w i t h expectancy for benefit, but values predicted variance in outcomes independently 
of expectancy. That is to say, where patients have values that are congruent w i t h a 
therapy then they w i l l have positive expectancies for it, but that the relationship between 
congruence and positive outcomes does not depend on these expectancies. 
For the purposes of this study, i t is assumed that this pattern continues for other 
dispositions. I f the assumption proves to be correct, it may be possible to identify 
pairings of relevant motives and therapies by, in the first instance, mapping the relations 
between values and the perceived efficacy of various therapies, and later directly testing 
the independence of the relationship between congruence and outcome. 
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A i m 
Do a person's values predict their perceptions of effectiveness for different therapies? 
A questionnaire was designed to answer this question, and samples collected from 
two populations: undergraduate psychologists and members of the general pubhc. 
Because of the exploratory nature of this research, it was not appropriate to conduct 
it in a therapeutic context at this stage, for instance by observing correlations between 
motivational variables and real therapy outcomes. Instead, a laboratory analogue is 
used to gain preliminary data. Perceived effectiveness, or expectancy of benefit f rom 
a therapy, was measured, rather than an outcome for a real therapeutic intervention. 
Therefore, this is not a direct test of the hypothesis that therapies that are concordant 
w i t h a patient's values w i l l improve therapeutic outcomes. Nevertheless, the data 
presented provide a starting point from which to establish such a relationship in future 
studies. The approach is to (a) describe various therapies for a common psychological 
complaint (depression), (b) elicit ratings of perceived effectiveness of those therapies, 
(c) measure dispositional values and (d) perform multidimensional scaling (MDS) to 
identify similarities between dispositional values and the perceived effectiveness of 
therapies. For comparison w i t h previous studies, a description of a therapy (Bach flower 
essences) for which dispositional values (dispositional spirituality) are known to predict 
therapeutic outcome, was included. 
7.2 Methods 
Recruitment and procedure Sample 1 comprised undergraduates at the University of 
Plymouth who volunteered in return for partial course credit. For sample 2 members of 
the public volunteered to complete questionnaires, and were entered into a prize draw 
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for £100. The study was publicised via the university intranet, internet message boards, 
and w i t h keyword and location-specific advertising. Online advertising appeared on the 
Google search network. I n both cases, inclusion criteria were U K residence and age 
18-I-. Exclusion criteria were a current diagnosis for a serious psychological condition 
or current receipt of psychological treatment for depression. Participants consented to 
the study and completed questionnaires online. Ratings of therapies were completed 
first, followed by questionnaire measures. 
Study website I n common w i t h studies presented above, the study website was built 
using open source software (PHP and mySQL), and a library of functions to generate 
online questionnaires which were written by the author (see page 112 for more details). 
These functions convert questionnaires i n spreadsheet format to a series of H T M L pages, 
and securely record user inputs. Procedures for informed consent, anonymity and data 
security were the same as those followed in Chapter 5 (see page 112). 
The therapy vignettes Participants read a series of vignettes of 6 therapies for m i l d -
moderate depression, and were asked to picture themselves in a situation in which 
they might need this type of support. The therapies were: cognitive behavioural 
therapy (CBT), antidepressant drug therapy (Drug), psychodynamic psychotherapy 
(Psychodynamic), existential psychotherapy (Existential), chent centered psychotherapy 
(Rogerian), and flower essence therapy (Flowers). Therapies were selected on the basis 
that they should be perceived as distinctly as possible; flower essence therapy was 
included pr imari ly as a point of comparison w i t h previous work. The descriptions of 
the therapies were constructed and expressed i n terms of treatment for depression. Each 
description stated the cause of depression presupposed by the therapy and the remedy 
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proposed and the type of practitioner responsible for the treatment (see Table 7.1 for 
summary details). 
o 
Table 7.1: Key information from the therapy vignettes 
Therapy Supposed cause of depression Remedy and type of practitioner 
Rogerian psychotherapy 
CBT 
Drug therapy 
Flower Essences 
Experiences that are harmful to the person, including 
lack of unconditional positive regard. 
Inaccurate or incorrect beliefs and thought patterns. 
Chemical imbalance in the brain (lack of serotonin). 
Existential psychotherapy Being overwhelmed by meaninglessness of life. 
Energy flow can be unbalanced by the pressures of 
modern life, leads to emotional and psychological 
problems. 
Psychodynamic psychotherapy Unconscious (repressed) memories, often of early 
childhood experiences, brought about by 
psychological trauma. 
The counsellor avoids judging the client in any way, 
attempts to understand their problems fully - in the 
chent's own terms - and offers unconditional positive 
regard. 
A cUnical psychologist teaches the cUent exercises 
which help control and challenge unhelpful thoughts, 
and develop positive thought patterns. 
Antidepressant drugs increase levels of serotonin in 
the brain. After being prescribed by a medical doctor 
the drug is taken each day. 
The existential psychotherapist (a psychologist) will 
focus on present problems, ways to progress in the 
future, and explore with the chent how they find 
meaning in life. 
Flower essences capture the energy signature of 
plants. This healing energy can be transmitted to the 
cUent via the essences, which are dispensed by 
complementary practitioners. 
The psychotherapist recovers repressed memories 
using dream analysis, hypnosis and word association, 
interprets dreams and other statements, bringing 
prior memories into conscious awareness and resolves 
them. 
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Perceived effectiveness of the therapies For each therapy participants were asked, " I f 
you were depressed, how likely is it that this therapy would work for you?" and "Does 
this therapy 'feel right' to you?" Responses were made on 7-point scales, and the anchors 
were Very likely to work for me/Very unlikely to work for me; and Feels right/Doesn't feel 
right. Responses to both questions were highly correlated and were combined to form a 
perceived effectiveness score for each therapy; Cronbach's a for item pairs ranged from 
.83 to .87 in sample 1, and from .85 to .92 in sample 2. 
Questionnaire measures Participants completed the Spiritual Connection Question-
naire 14 (SCQ-14; Wheeler and Hyland, 2008) and the Schwartz Values Scale (SVS; 
Schwartz, 1994). The SCQ-14 consists of seven positive and seven negative items about 
the experience of spiritual connection with the universe and other people, and the 
happiness such connection brings. The SCQ-14 correlates w i t h outcome for flower 
essence therapy. The SVS has 57 items, each of which is followed i n parentheses by a short 
explanatory phrase. For instance item 1: "Equality", is fohowed by the phrase: "Equal 
opportunity for all". Respondents rate the importance of each value item as a guiding 
principle in their life on a 9-point scale from opposed to my principles (-1), through 
not important (0), to of supreme importance (7). Responses were scored in accordance 
w i t h the author's instructions to create ten subscales: Conformity, Tradition, Benevo-
lence, Universahsm, Self-Direction, Stimulation, Hedonism, Achievement, Power and 
Security. Higher scores indicate greater importance. 
Analysis Although the comparative model fit of variants of the circumplex model is 
normally tested via confirmatory factor analytic models (Schwartz and Boehnke, 2004; 
Perrinjaquet et al., 2007), the relationships between values are best visuahzed w i t h 
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multidimensional scaling (MDS). MDS is particularly useful for revealing unknown 
structures (Shepard, 1964), and when dealing w i t h large correlation matrices (Hills, 
1969), and is therefore well suited for our exploratory purposes. MDS is a set of related 
techniques for exploring similarities or dissimilarities in data. A matrix of dissimilarity 
relationships may also be constructed from the inter-correlations between responses, and 
here this technique is used to overlay relations between (a) scales of values and (b) ratings 
of perceived effectiveness of therapies for depression. I f participants rate a particular pair 
of items i n a similar manner they w i l l be located in a multidimensional space such that 
the distance between them is smaller than the distance for other pairings. The resulting 
map indicates the relations between all items in the analysis. Correlation matrices are 
also provided for reference. M D S was performed using Stata 10. Dissimilarity matrixes 
for correlations between items were computed (Borg and Groenen, 2005), and scaled 
using iterative non-metric MDS. Because the relative positioning of axes w i t h i n MDS 
plots is essentially arbitrary, plots were rotated where this aided comparisons between 
samples. Model fit was assessed using conventional stress indices, and w i t h comparison 
to previous M D S studies of human values (Schwartz and Boehnke, 2004). I n all cases 
two-dimensional solutions were preferred on the grounds of interpretability, and for 
comparability w i t h previous data on the structure of values. 
Research ethics Permission to administer the questionnaire battery described above 
to (i) undergraduate participants and (ii) members of the general public was obtained 
f rom the University of Plymouth Human Sciences Research Ethics panel. No risk of 
harm to participants was identified, although particular attention was paid to ensuring 
participants gave informed consent. Briefing information was written i n clear and 
straightforward English, and care taken to omit any psychological jargon. To successfully 
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register on the online system participants were required to 'tick' an html checkbox, 
indicating that they understood the briefing information and agreed to take part in the 
study. 
7.3 Results and Discussion 
For sample 1,126 undergraduates, of whom 111 (85%) were female, completed question-
naires; the average age was 21, cr = 6. For sample 2, 163 members of the public, of whom 
113 (69%) were female, volunteered to complete questionnaires onhne. Nine responses 
were excluded because of missing data and the average age was 32 years, cr = 14. 
1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 12. 13. 14. 15, 
1 C B T 1 
2 Rogerian -0.19- 1 
3 Drug •0,13 -0.37" 1 
4 Existential 0.06 -0.13 -0.27" 1 
5 Flowers -0.27" -0.11 -0.37" -0.21* 1 
6 Psychodynamic -0.38" -0.24" -0.04 -0.35" 0.01 1 
7 
8 
conformity 
tradition 
•0.20* 
-0.26" 
-0.19* 
0.09 
0.16 
-0.13 
-0.08 
-0.16 
0.20-
0.20-
0.07 
0.26" 
1 
0.22* 1 
9 benevolence -0.06 0.18* 0.0 0.01 -0.08 -0.06 0.09 -0.12 1 
10 universaiism 0.17 -0.03 -0.29*» 0.06 0.12 0.04 -0.17 -0.12 0.04 1 
11 selfdirection 0.20* 0.1 -0.14 0.19* -0.16 -0.16 -0.35** -0.23* -0.09 0.02 1 
12 stimulation 0.04 0.01 -0.09 0.04 -0.02 0.05 -0.43** -0.20* -0.29** -0.05 0 .31" 1 
13 hedonism 0.09 -0.03 0.24" -0.12 -0.13 -0.08 -0.34** -0.36** -0.07 -0.36" 0.07 0 .31" 1 
14 achievement -0.05 0,1 -0.06 0.06 -0.05 0,0 -0.1 -0.05 -0.05 -0.25** 0.22* 0.03 -0.06 1 
15 power -0.14 -0.02 0.24" -0.05 -0.05 -0.03 0.0 0.0 -0.30** -0.46" -0.21* -0.01 0.26*' 0.1 1 
16 security -0.01 -0.17 0.32" -0.1 -0.06 -0.02 0.12 0.05 -0.16 -0 .33" -0.42** -0.26" 0.13 -0.20* 0.26* 
17 Spirituality •0.23- 0.18* -0.29" -0.04 0.23" 0.16 -0.01 0.1 0.13 0,18* -0.06 -0.08 -0.24** 0,05 -0.34* 
16. 
*p < .05; " p < .01 
Table 7.2: Correlation matrix of expectancy and value variables in sample 1 
1. 2, 3. 4. 5. 6. 
1 C B T 1 
2 Rogerian -0,16* 1 
3 Drug -0.09 -0.32** 1 
4 Existential 0.03 0.04 -0.25** 1 
5 Flowers -0.31** -0.24** -0.28** -0.36** 1 
6 Psychodynamic -0,39" -0.20** -0.17* -0.30** 0.04 1 
7 conformity -0.04 0.15 -0.11 0,07 -0.10 0.06 
8 tradition -0,18* 0,03 0.010 -0.17* 0.13 0.14 
9 benevolence 0.18* -0.02 -0.03 0.12 -0.20* -0.01 
10 universaiism 0,07 0.09 -0.22" 0.04 0.09 -0.05 
11 selfdirection 0.09 0.01 0.02 0.03 0.04 -0.18' 
12 stimulation 0.05 0.10 0.02 0,0 -0.06 -0.10 
13 hedonism 0.1 -0.14 0.19* -0.11 -0.14 0.08 
14 achievement -0.01 -0.05 0.10 -0,07 -0.08 0.11 
15 power -0.17* -0.08 0.17* -0.07 0.10 0.01 
16 security -0.06 0.00 0.010 0,0 -0.02 0.07 
17 Spirituality -0.19* 0.10 -0.37** 0.04 0.42*' -0.02 
'p < .05; "p < .01 
7. 8. 9, 10. 11. 12. 13. 14. 15. 16. 
1 
0.40** 1 
0.08 -0.05 1 
-0.30"* -0.22** 0,12 1 
-0.49" -0.51'* 0.01 0.34" 1 
-0.42** -0.34** -0.22** -0.01 0.38** 1 
-0.24** -0.31" -0.14 -0.38** -0.05 0.31** 1 
0.04 -0.12 -0.41** -0.44** -0.03 0.24** 0.20* 1 
0.22** 0.18* -0,44** -0.60** -0.38** 0.00 0.22** 0.38** 1 
0.41** 0,15 -0.10 -0.32** -0.47** -0.50** -0.05 -0.04 0.26** 1 
-0.11 0.14 -0,01 0.29** 0.18* -0.06 -0.42** -0.17* -0.25** -0.27' 
Table 7.3: Correlation matrix of expectancy and value variables in sample 2 
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Correlation matrices of all variables for samples 1 and 2 are shown in Table 7.2 
and Table 7.3. Results of the M D S analysis are presented in Eigure 7.1 and Eigure 7.2. 
Eigure 7.1 shows MDS solutions including only the value scales (SVS subscales and the 
SCQ-14). For both samples, the relative positions of SVS subscales are comparable 
w i t h previous w o r k on the SVS (Schwartz and Boehnke, 2004; Perrinjaquet et al., 2007), 
although i n the student sample, the position of Achievement was somewhat displaced. 
For samples 1 and 2 the position of Tradition and Conformity varied, and was found 
either on the same polar angle, or at separate locations on the circumplex. This reflects 
an existing debate regarding the independence of these constructs (Perrinjaquet et al., 
2007). 
Figure 7.2 shows MDS solutions when both the value subscales and perceived 
effectiveness ratings for therapies were included. Both plots suggest that therapies are 
perceived and evaluated i n terms of values or motives. 
Flower essences As in previous studies, positive expectancies for Flower essence 
therapy was associated w i t h Spirituality, and also w i t h Tradition, and was opposed to 
Stimulation and Hedonism. Because flower essences are exphcitly contextualised as 
a spiritual therapy they act as a form of control in this study, and provide a point 
of comparison w i t h previous work i n which dispositional spirituality predicted real 
therapeutic outcomes (Hyland et al., 2007, 2006; Hyland and Geraghty, 2008). 
CBT Positive expectancy for CBT was consistently associated w i t h the values 
of Self-Direction and Stimulation, and was opposed to Tradition, Conformity and 
Security. Therefore, participants w i t h high expectancies for CBT may be broadly 
characterised as high in values relating to 'openness to change', and low in values relating 
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Figure 7.1: Two-dimensional MDS plots for SVS values and spirituality 
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Figure 7.2: Two-dimensional MDS plots for SVS values, spirituality, and therapy 
effectiveness ratings 
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to 'conservation' (Schwartz and Boehnke, 2004) or that they focus on 'opportunity' 
rather than 'organisation (Rohan, 2000). Intuitively, the relation between CBT and self-
direction makes sense; CBT requires participants to undertake active problem solving, 
and to take a large degree of responsibility for their treatment—institutional or personal 
authority is not emphasised with in the treatment context. 
D r u g therapy Expectancies for Drug therapy were associated w i t h Power and 
Security amongst undergraduates, and w i t h Hedonism and Achievement in the Internet 
sample—values that would be classified as 'self-enhancing' or related to individual oppor-
tunity. In both samples expectancies for Drug therapy were opposed to Universahsm and 
Spirituality, and for the internet sample Drug therapy was also opposed to Benevolence. 
Again, this pattern of relationships makes intuitive sense: because drug therapy 
does not involve extensive problem solving or talking about difficulties (as does CBT) 
it may be interpreted as a quicker or more efficient means of treatment, avoiding 'fuss'. 
Additionally, the fact that drug treatment is delivered by an authority figure within 
an impressive institutional setting may reassure individuals valuing power or security. 
As Liberman (1962) noted in a discussion of context-specific predictors of placebo 
responding: 
Patients, especially when sick and totally dependent upon the doctor, could 
be expected to respond positively to physicians who are viewed as authority 
figures. Similarly, people who tend to possess uncritical respect for author-
ities in general (such as parents, employers, the church) may be susceptible 
to the induction of placebo effects by 'authority-type' doctors. (Liberman, 
1962, p. 773) 
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Einally, i t may be that the relation to hedonism is caused by a requirement for quick 
gratification (a relatively simple solution to the problem) overriding other concerns. 
Psychodynamic, Existential and Rogerian therapies Associations w i t h Psycho-
dynamic, Existential and Rogerian therapies were less reliable between samples, but 
nonetheless revealing. 
Existential psychotherapy was consistently associated w i t h Self-Direction, but also 
w i t h Benevolence in the internet sample. Psychodynamic therapy tended to be associated 
w i t h self-enhancement or conservation values (e.g. tradition, security, conformity). 
Rogerian therapy was associated w i t h Universaiism, Spirituality and Benevolence in 
the undergraduate sample, but was less clearly placed in the internet sample. These 
relationships, while less consistent than those for the Drug and CBT therapies, retain an 
intuitive sense, and appear to reflect the differences between the therapies: Self-direction 
is emphasised i n existential psychotherapy, because the therapy itself is concerned w i t h 
the participant f inding meaning in life. Universaiism and Benevolence are clearly 
compatible w i t h the general approach of Rogerian practitioners; and the direction 
provided by the therapist in the Psychodynamic therapy (as described in the vignette) 
appears to have appealed to participants who valued conservation-oriented values such 
as tradit ion and conformity. 
Agreement w i t h bivariate correlations W i t h few exceptions, this pattern of results 
was replicated i n the bi-variate correlations (see Table 1.1 and Table ?.3). Because relative 
positions w i t h i n the MDS solutions are hkely to be more stable than a correlation for 
any single pair of variable, these are used as the primary outcome of these studies. 
However, the fact that there exist moderately-sized correlations between expectancies 
7.3. RESULTS A N D DISCUSSION 181 
and values (comparable w i t h correlations between expectancy for flower essence therapy 
and dispositional spirituality found in earlier studies) provides encouragement that these 
measurements of values may be of use when predicting real therapeutic outcomes. 
Limitations A number of additional limitations of the study must be noted. First, 
the samples were drawn from healthy volunteers w i t h no current or past diagnosis of 
depression or any other mental illness. Interpretations and evaluations of different 
therapies may change as a result of the experience of iflness, although the results f rom 
both samples were comparable despite significant differences i n average age. 
Second, the associations revealed by the MDS models are between values and 
perceived effectiveness, and not real therapeutic outcomes, and perceived effectiveness 
was evaluated for only one condition: depression. Although expectancies may correlate 
wi th outcomes, further work is needed to establish whether dispositional values can 
predict real therapeutic outcomes. 
Third, both value and expectancy measurements depend on self-reports, and may be 
subject to various presentational biases. Recent methodological developments in social 
psychology, including the use of reaction time tasks in which participants categorise 
category-relevant words may be of use in developing new measures of values (Nosek 
et al., 2006; Nosek and Banaji, 2001). I n fact, this type of task was suggested as early 
as 1937; Allport noted that, during word association tasks, participants responded more 
quickly to stimulus words associated w i t h their interests. 
Fourth, the vignettes used in this study are not in any sense 'thick descriptions' of 
the therapies investigated (Geertz, 1973). Reading about a therapy is very different 
from experiencing it first hand, and the meanings attached to therapies in real life 
may differ from those elicited by the vignettes. Videotaped encounters from real 
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therapeutic sessions might represent an improvement over short vignettes, although 
suitable materials may be hard to obtain, and it is not clear how variation due to the 
therapist or the clients involved i n the taped sessions would be controlled between 
therapies. 
Finally, indices of stress in our MDS models were low in comparison to previous 
work on the SVS, but high when compared to conventional cut-off levels (e.g. stress 
< .2). There are two possible sources of stress in MDS: insufficient dimensionality and 
a lack of reliability i n measurement; both may have contributed to observed stress in 
our data. Although the SVS values are well described by a two-dimensional model, it 
seems unlikely that evaluations of therapies are constrained solely by their motivational 
characteristics, and this may account for the increased stress in the combined models. It 
may also be the case that some therapies have a greater motivational 'press' than others, 
or are interpreted more flexibly by participants creating a less reliable association with 
single value. Additionally, the SVS is a broad instrument designed to measure a wide 
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range of values. Each sub-scale is composed of between 2 and 9 items, and the sub-scales 
wi th small numbers of items are likely to be less reliable. 
Notwithstanding, this study has, for the first time, identified a correspondence be-
tween dispositional values and perceived effectiveness of therapies, drawing on a theoret-
ical rationale derived from motivation theory and the contextual model of therapy. Be-
cause perceived effectiveness is an important determinant of outcome i n psychotherapy 
(Kirsch, 2005), this alone may have clinical imphcations, providing a theoretical rafionale 
for clinicians to tailor the way in which any given therapy is presented. From a practical 
perspective, these preliminary data suggest that tailoring the presentation of standard 
therapies to the motivational characteristics of patient may be of therapeutic benefit. For 
example, i f a patient is identified as highly spiritual then cognitive behavioural therapists 
could present standard techniques in a more spiritually oriented way—for instance using 
prayer or affirmation as homework—and place less emphasis on scientific validahon of 
the treatment. Similarly, i f a patient is high in Benevolence, then emphasising values of 
kindness or caring wi th in the treatment may be particularly beneficial. This conclusion 
is in accordance w i t h early unpublished studies, reported by Rokeach (Rokeach, 1973), 
in which attrition in psychotherapy was associated w i t h concordance between the values 
of patient and therapist; it may be the case that the motivational context of the therapy, 
as perceived by the patient, is determined i n part by the values of the person delivering 
it. 
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Conclusion 
Patients w i t h mental health problems are faced w i t h a range of therapeutic options and 
must choose between them on the basis of restricted empirical evidence. Similarly, the 
expanding array of empirically supported therapies presents eclectic psychotherapists 
w i t h a di lemma—which therapy should be assigned to which patient? The results 
presented here indicate that a persons value system predicts which therapies they believe 
wiU be effective for them, and that it may be possible to use this value framework to 
predict client-treatment interactions. It is desirable therefore, i f for this reason alone, to 
preserve variety in the provision and presentation of treatments (Soffer, 2007). 
Chapter 8 
General discussion 
The preceding chapters described a new motivational mechanism responsi-
ble for real-world placebo responses—motivational concordance. This new 
mechanism is not incompatible with existing accounts of placebo respond-
ing, including response expectancy theory, although it does suggest that these 
accounts are incomplete. In contrast with previous research on dispositional 
prediction of placebo responding, motivational concordance moves beyond 
a simple description of inter-individual differences in behaviour; it provides 
an account of intra-individual structures involved in placebo responses, and 
makes several specific predictions. 
Taken together, the new theory and data suggest that high-level or self-
defining goals represent enduring dispositions, and that these dispositions 
interact with features of the situation in predictable ways to produce placebo 
responses. The mechanism has broader implications for all therapeutic 
interventions-including conventional medical therapies-where there is a 
psychological contribution to outcome and where patients must actively 
participate in treatment. 
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Religious man can live only in a sacred world, because it is only in such a 
w o r l d that he participates i n being, that he has a real existence (Eliade, 1959, 
p. 64) 
8.1 Summary of key findings 
Placebo responding is temporally consistent, but highly sensitive to small changes 
i n context. I n Chapter 2 participants responded consistently to a placebo analgesic 
cream across a period of several days, but only when the cream retained the same label. 
Responses to differently labelled responses were not significantly correlated, indicating 
that participants were highly sensitive to this change in the context of the placebo. These 
findings confirmed that dispositional predictions of placebo responding are theoretically 
possible, but only if the disposition measured is contextually-relevant for the placebo 
used. 
*Real-world' placebo effects are not ful ly explained by response-expectancy theory. 
Results presented in Chapters 3, 5 and 6 replicated other studies using a similar method-
ology (Hyland et al., 2006, 2007; Hyland and Geraghty, 2008), in which response ex-
pectancies did not mediate disposition-outcome correlations. Furthermore, predictions 
f r o m expectancy were much lower than is common in laboratory based placebo studies. 
A common feature of all of these studies is that placebos are administered over longer 
periods of t ime (days or weeks) than typically is the case w i t h laboratory studies. I n 
addition, the placebos administered held richer contextual meanings for participants. 
Tests of mediation estabhshed that, even when controUing for muhiple measures of 
expectancy, motivational characteristics of participants continued to predict outcomes. 
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Additionally, in Chapters 5 and 6, evidence was found that compliance w i t h treatment 
instructions, i.e., better 'performance' of the ritual, interacted w i t h dispositional mot i -
vations to produce better outcomes: When the ritual was congruent wi th individuals' 
values, then better performance of the ritual produced larger placebo effects. These 
findings are consistent wi th the motivational concordance hypothesis, and are more 
difficult to explain wi th in a response-expectancy framework. 
Congruence between an individual's values and the motivational context of a placebo 
r i tual predict outcome. The study reported in Chapter 5 demonstrated that the pre-
dictions of placebo responses from motivational characteristics of the person were, as 
predicted, dependent on concordance of these characteristics w i t h the motivational 
context of the therapy. 
Placebo effects were found 'by proxy' i n parents who administered a placebo to 
their young chi ld. Results from Chapter 6 suggested that parents benefited from a 
vicarious placebo response when they administered a motivationally-concordant therapy 
to their young children. In turn, children experienced behaviourally mediated placebo 
responses—tantrum severity and frequency were reduced, most likely due to changes i n 
parental affect. Responses to a follow-up question indicated that the majority of parents 
did not teU their children the purpose of the flower essence remedy, and this provides 
additional evidence that placebo effects need not be mediated via response expectancies 
in all cases. 
Stimulus expectancies for various therapies for depression were systematically related 
to dispositional values. Notably, expectancies for anti-depressant medications were 
related to the values of Power and Security, whereas expectancies for cognitive be-
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haviour therapy were related to Self-Direction and Stimulation. This suggests that value-
orientations may be a useful guide to future patient-treatment interaction researchers. 
8.2 Theoretical implications 
8.2.1 Relationship to existing theories 
M o t i v a t i o n as health str iving Linking placebo responding to motivation in a straight-
forward sense is not new. A 'health striving' hypothesis (reviewed in 4.2.1) has a relatively 
long history (Parsons, 1964), and has been invoked to explain some laboratory-based 
placebo effects (e.g. Jensen and Karoly, 1991). However, although the health striving 
hypothesis allows for participants' motivations to affect perceptions (of symptoms or 
other relevant stimuli) , or enhance other placebo mechanisms, goals are not not fully 
integrated as causal elements of the placebo response. The theory suggests that i f 
participants desire improvement then improvement w i l l happen, and is very similar in 
structure to response-expectancy theory—i.e. that what participants expect to happen 
w i l l happen. I n both cases—health striving and response expectancy—desires and 
expectancies are presumed to be responsible for therapeutic responses but distal causes 
of therapeutic response are left unspecified (except i n the very general sense that 
expectancies and desires are learned through prior experiences). 
Proximal causes of placebo effects—weaknesses i n current theories In addition to 
the distal causes of placebo responding, proximal causes of therapeutic change are also 
neglected by health-striving hypotheses and by response expectancy theory as it applies 
to complex placebo contexts. As noted above, in simple contexts expectancies can have 
unmediated effects on outcomes, but in more complex scenarios additional psychological 
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variables are required to explain generalised therapeutic effects, for example in anxiety 
reduction in psychotherapy (Delsignore and Schnyder, 2007; Stewart-Wilhams and 
Podd, 2004). Indeed, where (placebo) complementary therapies are used to promote 
general well-being, rather than to treat a particular problem, it is difficult to explain 
the wide variety of benefits experienced (Oberbaum et al., 2005) wi th in an expectancy 
framework, and outcome predictions from response expectancies are often disappointing 
(see 1.4.2). 
I n contrast, the motivational concordance hypothesis uses established theories of 
motivation to provide an explanation of both the distal, intermediate, and proximal 
causes of therapeutic benefits of placebos: Taking a placebo is conceived as a form of 
motivated behaviour directed towards certain goals, and extensive evidence links both 
progress towards goals and goal-striving w i t h changes i n affect. It this l ink between 
behaviour (performance of the ritual) and emotional experiences has both perceptual 
(Emmons, 1991) and physiological (e.g. Hoppmann and Klumb, 2006) effects, which are 
presumed to underpin the wide variety of therapeutic effects observed. In addition, a 
motivational approach allows researchers to predict individual differences in placebo 
responses, and may facilitate the identification of patient-treatment interactions in 
psychotherapy research. 
Goal congruence might facilitate expectancy effects Over the past 30 years there 
has been a general trend in psychology to include 'hot' or emotional influences on 
information processing. Many authors conceive moods and emotions as representing 
information about the context in which stimuli are to be processed, alerting individuals 
to situational requirements (Schwartz, 2002, 1990). Well-studied examples include 
the counter-intuitive findings that participants perform better on analytic or numeric 
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problem solving tasks when in a negative mood, whereas performance on creative tasks 
requiring playful or divergent th inking improves during positive moods (for a review of 
this research area see Schwartz and Clore, 1996). Other findings that message scrutiny 
may be affected by mood valence are particularly relevant here: Wegener et al. (1995) 
found that positive moods increased scruhny (or processing) of positive information, 
but reduced scrutiny of mood-threatening information. 'Hot' or emotional influences 
on placebo responding are ignored by response-expectancy and conditioning theories, 
but i t may be that, i n addition to the direct benefits of goal attainment and positive 
m o o d on psychological and physical state (see Chapter 4), the affective consequences 
of motivationally-concordant placebo rituals also facilitates expectancy or conditioning 
effects. I f performing placebo rituals generates positive mood it may also facilitate 
processing of information intended to generate expectancies or conditioned responses; 
this might account for the observed correlations between dispositions and expectancies 
i n the motivational concordance studies presented above. 
8.2.2 Relationship to developments i n personality psychology 
The motivational concordance hypothesis fits neatly w i t h a number of recent trends 
in personality psychology and provides an interesting test-case for new, interactive 
models of persons and situations. A core problem for personality psychologists, i n 
common w i t h researchers trying to identify a 'placebo responder', is to create models that 
reconcile enduring characteristics of the person w i t h cross-situational inconsistencies, 
which are so ofLen observed in practice (Mischel, 1968). Although abstract dispositions 
have produced disappointing results when predicting placebo responses (see 1.4.1), the 
concepts of goals and motivation may form the basis of a more satisfactory explanatory 
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framework. 
Weaknesses of dispositional research As previously noted (4.1 page 86) dispositional 
research, and particularly the 'five factor' model of personality, has been successful i n 
building consensus around an empirically-derived model (Digman, 1990). However, 
personality psychologists have faced greater challenges when attempting to map per-
sonality dimensions onto regularities in behaviour, and critics of big-five models point 
to two related problems w i t h predictions of behaviour from this type of dimensional 
information, one empirical the other theoretical. First, simple predictions of behaviour 
from personality dimensions ignores important attributes of the situation, and cross-
situational inconsistencies are likely to undermine the uti l i ty of this type of prediction 
(Mischel, 1968). Second, and more importantly, critics argue that factor-analytic 
dimensions are theoretically inadequate for the task to which they are put: Although 
dispositional researchers have provided a reliable account of the structural regularities 
between individuals, it is inappropriate to assume that the data on which five factor 
models are based also describes structures and processes that actually exist within 
individuals. To take Epstein's (1994) analogy, a factor analysis of the attributes of cars 
(weight, colour etc.) might provide an acceptable fit w i t h the data, but would teU us 
nothing about how cars operate or how to go about fixing one. 
Motivations provide a theory-driven alternative to trait-based constructs that are 
inductively derived from behavioural regularities. This allows a 'bottom-up' account of 
the structures and processes required to explain cross-situational consistency in placebo 
responding. Recent models of cross situational consistency in personality psychology 
emphasise the role of intentional constructs—motivations—in determination of be-
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haviour. Both Mischel and Shoda (1995) and Cervone's 2005 models of personality 
stress the importance of motivation to create an integrated account of structures and 
processes. Cervone's KARA model (Knowledge and Appraisal Personality Architecture) 
distinguishes Knowledge—any enduring representation of the self, others or information 
about the w o r l d — f r o m appraisals—relational judgements that concern the meaning of 
encounters for oneself. 
Is the Spiri tual connection questionnaire a pseudo-ideographic measurement? When 
constructing instruments to measure aspects of personality, researchers must reconcile 
themselves to making one of two assumptions and decide whether they believe the 
construct they wish to study does or does not vary in content between individuals. I n 
dispositional personality psychology researchers typically make the first assumption, 
adopting what is termed a nomothetic approach to measurement; when developing 
measurement instrument, the primary goal is to achieve construct validity, and this is 
done by eliminating scale items which fail to correlate w i t h a hypothesised latent variable 
(see Figure 8.1a). Great care is taken to be sure that scale items are clear, unambiguous 
and interpreted i n a consistent fashion by all participants. A n alternative approach is 
to take construct validity for granted, making the assumption that the construct does 
i n fact exist as a property of the individual, and allow individuals to identify which 
items correspond to that construct for them, and the importance they place on them 
(see Figure 8.1b). As can be seen from Figure 8.1, nomothetic measurement comes to 
an empirical description of the construct based on participant responses, and that the 
construct represents a statistical average of all participant interpretations; i n this example 
items 2 and 4 might be rejected because only a minori ty of participants endorse them. In 
contrast, ideographic measurement requires a theoretical assumption that the construct 
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in fact exists, but that it's content (indexed by various scale items) differs from individual 
to individual. In this example, the concept is divorced from the items (content), which 
may vary widely from individual to individual. 
A n interesting feature of the measurement of human values, for instance via the 
SVS or SCQ, is that this nomothetic/ideographic distinction becomes somewhat blurred. 
Whereas dispositional researchers tend to employ scale items that are concrete and 
require relatively little interpretation (e.g. 'Complete tasks successfully', 'Love large 
parties', 'Go on binges', 'Love to read challenging material'), measures of values use 
language which is more open and ambiguous. Examples f rom the SCQ include: ' I 
feel I have an inner spiritual strength', ' I w i l l never have a spiritual bond w i t h another 
person'. The key concept—spirituality—is left undefined. Similarly, other items such 
as ' I sometimes experience other people "shining w i t h an inner hght'" or ' I feel an 
inner strength from a spiritual connection w i t h others' could be interpreted literally, but 
are equally likely to be interpreted metaphorically and could refer to a wide variety of 
subjective experiences. Thus, the SCQ appears to presume the existence of'spirituality' 
or spiritual motivation as a within-person construct, but allows for considerable variation 
with regards the content the concept refers to. 
Abstracting the concept of spirituality f rom specific content may be an important fac-
tor in the success of the SCQ in predicting motivational concordance effects. Although 
participants may differ in what they understand by the word 'spirituality', participants 
wi th divergent interpretations of the concept may still score highly on the scale. Provided 
these 'spiritual' participants also interpret the placebo ritual as 'spiritual' in nature, the 
pseudo-ideographic approach of the SCQ makes it possible to predict concordance of 
participants' dispositions w i t h their evaluation of the ritual, and consequently explain 
variance in outcomes. In the flower essence studies presented here, the therapy was 
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presented as generically spiritual and was not tied to any particular form of spirituality 
or religious tradition, and this may explain the relatively large proportion of people for 
w h o m it was effective. I f the contextualising information provided had described the 
therapy as imbuing a person w i t h the 'wisdom of the Budhha, or the 'magical healing 
power of Eir', then the range of people for whom the essences were effective is hkely to 
have been much reduced. 
8.3 Limitations, weaknesses and questions outstanding 
Lack o f repeated measurements of response expectancies Response-expectancies 
were measured only once during each study. It is possible that, as illustrated in Figure 4.2, 
performance of the ritual served to increase response expectancies, generating a positive 
feedback loop between improved and consistent performance of the ritual, improved 
expectancies, and changes in subjective experience. I n fact, without such a feedback loop 
it is difficult to envisage how relatively short-duration conscious response expectancies 
would be able to generate the longer-term improvements in well-being demonstrated 
here. 
Potential for measurement error to underestimate mediation via response expectan-
cies A weakness of Baron & Kenny (Baron and Kenny, 1986) type mediation analyses is 
that error in the measurement of mediating variables (in this case response-expectancies) 
may result in an underestimate of the extent of mediation. Because this is a problem 
of measurement rather than design, no clear solution can be offered. However, i f 
an experiment could be designed such that participants had neutral expectancies for 
outcome—perhaps using deceptive instructions that misled participants as to the true 
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purpose of the ri tual—then this could provide additional evidence for the motivational 
concordance hypothesis. I f participants gain benefits when performing a ritual for which 
they have no expectation of benefit, at least for the primary outcome measure, then this 
would support motivational concordance rather than response-expectancy explanations. 
Other issues relating to the measurement of response expectancies The architect of 
response expectancy theory explicitly states that response expectancies are consciously 
accessible mental constructs and argues that the concept of an implicit response is unfal-
sifiable and therefore scientifically disallowed (Kirsch, 2004). However developments i n 
social and cognitive psychology have highlighted the benefits of some types of implicit 
measurement when compared w i t h explicit self-reports, and suggest possible directions 
for future research; these are discussed below (see page 205). 
Examining possible interactions between mood and expectancy As noted above, 
some theories of emotion conceive of mood as conveying important information about 
the requirements of situations; as a consequence mood may affect the processing of 
situational information, especially where new information may have consequences for 
mood-maintenance (Schwartz, 2002), including expectancies for benefit or harm from 
placebo interventions. A future study might test this hypothesis more directly by first 
inducing positive and negative moods and second observing whether differential effects 
are observed on placebo or nocebo responses—current theory imphes that a positive 
m o o d induction would boost placebo effects and protect against nocebo effects, and that 
negative m o o d would have the opposite effect. 
Were observed therapeutic changes 'real' or mediated by symptom reporting? The 
studies presented here primari ly employed measures of outcome that were based on 
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retrospective participant reports. This type of outcome measure is extremely convenient 
for researchers and is widely used in both theoretical and clinical work. Ahhough 
before/after measurements of symptoms have intuitive appeal as less likely to be subject 
to response biases, researchers have suggested that perceived change measures are 
superior to change scores i n some important respects. Fluckiger et al. (2007) found that 
although retrospective and pre-post measures were equally mood dependent, only pre-
post measures were subject to regression effects. Fischer et al. (1999) also found good 
agreement between retrospective and pre-post measures, and noted that retrospective 
symptom scores correlated better w i t h patient satisfaction ratings. 
Nonetheless, demonstrating motivational concordance effects w i t h physiological or 
observer-rated outcomes would be an important additional f inding, and would bui ld 
on the finding that congruence of daily activities and goals was predictive of decreased 
Cortisol fluctuation (Hoppmann and Klumb, 2006). 
It is unfortunate that the data reported here cannot be used to distinguish between 
real' changes i n symptoms and changes that are due solely to altered symptom reporting. 
It is plausible that observed therapeutic benefits are caused (proximally) by changes i n 
symptom reporting, and (distally) by improvements i n affect—previous work has shown 
that trait negative affectivity is related to symptom reporting (Pennebaker, 1982; Rief 
and Isaac, 2007). Such changes should not be dismissed as tr ivial however; a perceived 
reduction in symptoms may improve overall levels of psycho-social functioning. Reduc-
ing symptom reports in this way (i.e. by reducing negative affect rather than inducing 
a reporting bias via the demands of the situation) is a worthy goal. However, it is also 
possible that motivational concordance generated 'real' changes i n symptoms—that is, 
changes which might be identified more objectively via observer report or physiological 
measurement, as is the case w i t h response-expectancy placebo effects (Kirsch, 1997). 
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Estimation o f an effect size for motivational concordance The studies presented here 
d i d not use natural history (or similar) controls, and employed relatively heterogeneous 
samples—with the exception of Chapter 6, participants for motivational concordance 
studies were recruited for a variety of 'minor psychological complaints'. Although 
estimation of effect sizes across heteregeneous populations is possible (e.g. Hrobjartsson 
and Gotzsche, 2001, 2004), it is undesirable because poohng of effects may obscure 
differential efficacy of the treatment for population subgroups (Wampold et al., 2007; 
Kirsch and Scoboria, 2002). For both of these reasons, it is impossible to gauge the 
true size of the effects caused by motivational concordance, nor their potential clinical 
significance. Additionally, none of the participants involved in these studies had a serious 
illness, and the clinical significance of effects observed must therefore be treated w i t h 
caution. However, i t should be remembered that although participants did not meet 
clinical diagnostic criteria they self-selected for treatment and must have perceived their 
problem as w o r t h treating; reported compliance was relatively high i n all three flower 
essences studies. 
W h a t types o f motive does motivational concordance apply to? Like other similar 
work (Hyland et al., 2007; Hyland and Geraghty, 2008), the studies presented here 
used only therapies that were concordant wi th intrinsic motives. These interventions 
are, therefore, similar to a class of interventions grouped under the label of 'positive 
psychology' (Seligman et al., 2005). Would other types of motives produce similar 
therapeutic benefits? 
Limited data from other fields suggest that congruence w i t h extrinsic motives would 
not produce the same benefits as congruence w i t h intrinsic motives (Hofer and Chasiotis, 
2003; Hofer et al., 2006; Sheldon and Kasser, 1995), but this should be tested directly 
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by future studies. It is an intriguing prospect that actuahsing 'negative' motives—for 
example to harm others—might create well-being in individuals who value such goals. 
Researchers might be able to employ violent first-person computer games to enable self-
actualisation in this area. 
Additionally, there remains some theoretical debate about precisely what SVS-type 
values scales are measuring. It maybe the case that SVS-style responses are influenced not 
only by the (hypothesised) value system, but also by other factors related to the availabil-
ity or salience of these values in recent experiences; reported values are influenced by the 
degree to which values have been satiated by recent experiences. For example, Rokeach 
(1973) reports that the value most distinctive of prison inmates is wisdom. Although 
this finding is based on cross sectional data and cannot be used to draw strong causal 
inferences, i t is unclear whether the prisoners believed that wisdom was an attribute 
they possessed or lacked (Rokeach, 1973, p. 134). Similar effects are found in the 
motivation literature. Gollwitzer and Wicklund (1985) reported a series of experiments 
showing that the extent to which a person had fulfilled self-defining goals (e.g. to be 
a musician or to be a psychologist) negatively predicted self-presentational behaviour 
aimed at demonstrating competence in that domain. Future work on motivational 
concordance should investigate the extent to which value-fulfilment predicts therapeutic 
benefits; the self-actualising rituals of motivationally concordant therapies may offer 
diminishing returns for those whose everyday behaviour is already self-actualising. 
However, distinguishing between satiated and non-satiated values (Murray, 1938) may 
be difficult i n practice. 
Some values may be easier to use than others I f goals are hierarchical (Hyland, 1988), 
to pursue high-level values such as spirituality requires the identification of a series of 
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nested sub-goals, reducing in abstraction to the level of motor potentials. W i t h i n a given 
cultural or historical context, it may be easier to identify sub-goals of some high-level 
values than for others, at least w i t h regard to heahh and therapy. Ahhough arguing from 
a failure of imagination is a dangerous strategy, it is easier for this author to imagine a 
'spiritual' remedy than one based on the values of Power or Hedonism. This may simply 
reflect the current popularity of C A M therapies, and the waning fortunes of traditional 
psychoanalytic approaches, but it might also be the case that some values are easier to 
reconcile w i t h therapeutic activities than others. 
8.4 Practical implications 
8.4.1 Predicting placebo responding is possible and should be attempted 
W o r k to prospectively identify placebo responders, or to predict patient-treatment 
interactions i n psychotherapy research, has faced numerous chaUenges, and often results 
have been disappointing. Critics have focused on the lack of a theoretical rationale 
for identifying patient-treatment interactions (Dance and Neufeld, 1988), as well as 
high profile empirical failures (Project M A T C H Research Group, 1993) to suggest that 
matching patients to treatments might be best abandoned (Heather et al., 2008). 
Al though at an early stage, the work presented i n Chapters 2 and 5, and also Chapter 
7 suggests that (a) empirically, placebo responses vary wi th in individuals, based on 
relatively small changes i n the context of presentation, and (b) motivation theory may 
be a useful organising principle in predicting these person x situation interactions. 
Based on the resuhs f rom Chapter 7, researchers might match patients to treatments by 
measuring both the values of patients and the motivational characteristics of therapies. 
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Replication of these findings in patient samples w i t h chnical outcome measures would 
be an exciting development. 
8.4.2 Variety should be preserved i n the choice and delivery of treatments 
Preserving a variety of equivalent treatments may be of use, particularly when alternative 
treatments for a condition are of similar efficacy but differ in their delivery context—for 
example different psychological treatments of depression (Wampold, 2001; Soffer, 2007). 
However, the benefits of variety may also apply to the delivery of conventional medicine. 
A large component of the response to all therapies, even powerful analgesics, is psy-
chologically mediated (Benedetti et al., 1998). Consequently, both doctors and pohcy 
makers should strive to maximise the psychological benefits of any therapy. 
Existing therapies could be reframed in motivationally-concordant forms for i n d i -
vidual patients Many existing therapies might benefit f rom enhancing concordance 
between values of patients and the motivational context of the therapy. To take one 
example, instructions for dosing of a conventional pharmaceutical agent might be 
altered, where appropriate, to reflect the motivational characteristics of patients. This 
might be particularly applicable in circumstances where dosing is frequent and must 
respond to symptoms—for example i n asthma. Patients who place high value on Self-
Direction could be given a maximum, but told to dose 'as they feel is correct for 
them'. Patients who value Tradition or Power could be provided w i t h details of the 
doses which other people used in similar circumstances, or have strict rules set which 
must be followed when determining a dose, in the form of a letter from an authority 
figure—perhaps a respected secondary care speciahst. Such an approach might also 
improve compliance wi th medications, a factor that is often overlooked in the transition 
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from clinical trials to clinical practice (Bouchard et al., 2007). I n clinical trials, adherence 
is associated w i t h lower mortality for both verum and placebo arms, but adherence to 
medications for chronic conditions is typically poor. 
I n a similar fashion, cognitive behaviour therapists might reframe therapy activities 
in motivationally-concordant terms. Homework exercises designed to challenge negative 
thoughts might be described as as analogous to devotional practice for highly spiritual 
patients; as self-improvement activities for achievement-oriented participants; or as a 
time to remember connections w i t h other people and w i t h nature for patients who place 
value on Universaiism or Benevolence. It is possible that the extent to which therapists 
can be flexible, describing interventions in terms that are accessible and motivationally-
compelling to patients, w i l l prove to be another factor in the large variability between 
therapists i n studies of psychotherapy outcomes (Wampold and Bolt, 2007). 
M i n o r i t y groups and context of health provision Public health specialists have long 
been concerned w i t h disparities in health status between particular ethnic or minority 
groups and the population at large. Research in this area tends to be epidemiological 
i n nature, and focussed on identifying relatively gross disparities in disease risk due 
to socio-economic or genetic factors. However, in the psychotherapeutic literature 
concepts such as 'micro-aggression' have been developed to explain poor treatment 
outcomes amongst minor i ty service-users (Sue et al., 2007). I f treatment contexts tend 
to be more motivationally discordant for minority users then motivational concordance 
may be an additional mechanism by which disparities in outcome are maintained. 
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Implications for C A M research 
Is this a scientific validation of Bach flower remedies? Harald Walachs observation 
of homeopathy: "[that it] is scientifically banned, [ . . . ] for lack of a sound theoretical 
model to explain its purported effects" (Walach, 2005, p. 192) apphes in equal measure to 
many other C A M therapies, including Bach flower remedies. Motivational concordance 
appears to supply, at least in part, a theoretical rationale for how such therapies work, 
and for whom they should be prescribed. As such, this undermines a perceived barrier 
for wider adoption of C A M therapies. 
However accepting motivational concordance theory does not necessarily entail 
supporting the general prescription of biologically inert remedies. Alternative means of 
capitalising on motivational effiscts are avaUable (e.g. Hyland et al., 2007; Hyland and 
Geraghty, 2008; Seligman et al., 2005) and should be chosen in preference to C A M 
therapies which, although they may be effective and have an increasingly plausible 
theoretical rationale, would be fundamentally deceptive i f supported by governments 
that are otherwise committed to evidence-based policy making. 
Wider impact Over recent years C A M research, for example on the effects of homeopa-
thy or acupuncture, has been dominated by increasingly heated debates over estimates of 
efficacy—that is, the extent to which C A M therapies differ from various types of control 
conditions. Increasingly sophisticated meta-analyses have identified shortcomings w i t h 
the reporting of trials (for example, unclear descriptions of randomisation/allocation 
procedures and descriptive statistics omitted), and a bias towards the pubhcation of 
larger effects in smaller, underpowered studies (Shang et al., 2005). However the ensuing 
arguments over the vahdity of meta-analytic methods obscure a larger t ruth : Whatever 
the case w i t h regards the specific effects of homeopathy, these effects are dwarfed by 
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the psychological components of the interventions. Motivational concordance theory 
may provide additional impetus to the psychological study of some C A M therapies. 
Empirically it explains new variance in outcome, and may be more palatable to both 
proponents and opponents of C A M therapies. It is at least preferable to the conclusion 
that C A M therapies are 'no better than placebo', a phrase which explains nothing 
and hides much that is interesting. A motivational concordance explanation allows 
researchers to view patients as engaged in a self-actualising ritual. Patients' active 
participation in giving meaning to a therapy is a key component in the therapeutic 
benefits observed. I n short, psychological explanations of C A M no longer require a 
deceptive researcher or practitioner and a gullible patient. 
8.5 Future directions 
A number of directions for future research are suggested by the data presented here: 
Repeated or improved measurements of response expectancies As noted, a possi-
ble alternative explanation for the findings presented here is that the mediating role 
of response-expectancies is underestimated because (a) expectancy measurements are 
subject to error and (b) expectancies may change over time. 
Taking repeated measurements of expectancy throughout a study would enable the 
researcher to be sure that expectancies were not, for example, increased by early changes 
i n symptoms due to natural history; such an increases in expectancies might account for 
subsequent therapeutic improvements. These repeated measurements would be easily 
incorporated as a lagged variable w i t h i n a multilevel analysis, similar to that used i n 
Chapters 5 and 6. 
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Implic i t measures of response expectancies and motives/dispositions Because response-
expectancy theory exphcitly defines expectancies as consciously-accessible, all research 
into expectancy effects in placebos have relied upon verbal reports f rom participants. 
However, as Shanks and St John (1994) note, "Tests of verbal recall tend to be less 
sensitive to smaU amounts of knowledge than other behavioral measures" (p. 394). 
Thus, even i f one accepts the premise that expectancies must be conscious, the goal 
of measuring expectancies accurately demands that additional techniques are adopted. 
Additionally, verbal measurements of expectancies may be subject to a number of pre-
sentational biases, depending on the situation or context of a particular placebo. Taking 
the example of flower essences, participants drawn from a science-based undergraduate 
degree (or who are speaking to a scientifically-oriented researcher) might not wish to 
admit that they have positive response expectancies for what they perceive to be an 
'unscientific' treatment^ A n alternative explanation for the data presented in Chapters 
3, 5 and 6 follows from this—it might be the case that expectancies do mediate the effects 
of flower essence treatment, but that only participants high in dispositional spirituality 
are prepared to admit to having positive response-expectancies. 
As a consequence, non-verbal (i.e. behavioural or otherwise implicit) measures of 
expectancy are necessary to test response-expectancy in many relevant circumstances, 
although researchers may have to tolerate doubts over the status of such measurements 
as conscious constructs (Baeyens et al., 1994). To achieve this it may be desirable 
to adapt implicit measurement methodologies f rom social and cognitive research to 
obtain implicit measurements of expectancy. Behavioural measures, such as the amount 
participants would prepared to pay for a given placebo, might also capture variance in 
small (N = 25) pilot survey of attitudes to several therapies for depression, not presented here, 
indicated that Bach remedies were seen by University of Plymouth undergraduates as 'kind', 'spiritual' but 
not 'scientific'. 
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expectations not explained by verbal reports. 
Similar techniques could be employed to develop implicit measures of motives or 
values. Pakizeh et al. (2007) used a reaction-time task to confirm that the circumplex 
model of values was not dependent on semantic relatedness of SVS items, but this data 
d id not bear directly on relationship of implicit and explicit value measures. Researchers 
using other types of imphcit measures have begun to identify conditions under which 
implici t and exphcit measures wiU correlate (Hofmann et al., 2005), and this approach 
may be useful i n future work on values, helping to address some of the criticisms of the 
SVS (e.g. low discriminant validity and reliability, Perrinjaquet et al. 2007) 
Physiological outcomes Demonstrating effects w i t h physiological outcomes, as op-
posed to self report, would strengthen the claim of motivational concordance theory to 
be an important mechanism in real wor ld placebo effects. To demonstrate physiological 
effects might be difficult i n the type of studies presented here, in part because sample 
populations and conditions treated were so heterogeneous. Researchers might have 
improved success in the lab, perhaps using relatively sensitive measures such as facial 
E M G or startle eye-blink moderation (Wittenbrink and Schwarz, 2007) foUowing a 
motivationally concordant (or non-concordant) relaxation intervention. Disease models 
and clinical populations (see below) may also afford useful opportunities for objective 
measurements of outcome. 
Asthma patients are currently receiving increased attention as an interesting group 
w i t h which to conduct laboratory-based placebo research (Kaptchuk et al., 2008). This 
interest stems from the significant psychological component involved i n asthma (Lehrer 
et al., 2002) and the fact that accurate and objective measurements of lung function are 
relatively straightforward to obtain (e.g. wi th a cheap peak-flow device). Thus asthma 
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may also be suitable for further work on motivational concordance. 
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Studies i n other patient populations Subject to ethical constraints, researchers might 
use motivationally-concordant 'positive-psychology' type interventions in real chnical 
populations. Suitable groups might initially include m i l d or early-stage patients who 
would otherwise be offered little to no treatment, for example mildly depressed patients 
who would otherwise be offered only self-help or supported self-help interventions. 
Patients with chronic obstructive pulmonary disease (COPD) may also be suitable for 
this type of research. Psychological complaints are under-treated in COPD patients, and 
conventional treatments such as cognitive behavioural therapy (CBT) or antidepressant 
medications may be poorly tolerated (Yawn, in press). Irritable Bowel Syndrome 
may be another good candidate because it affects a relatively large number of people 
(Wilson et al., 2004), is responsive to placebo effects (Vase et al., 2003), and is suited 
to repeated measurements of both perceived improvement in symptoms and symptom 
frequency—symptom counts may be less susceptible to bias than self-report ratings of 
severity. 
Finally, a replication of the patient-treatment interaction methodology developed 
in Chapter 7 should also be attempted in clinical populations. Such a study might be 
combined wi th an existing RCT or open trial to compare, for example two different 
psychotherapies, or psychotherapy vs antidepressant medication, and would require very 
little additional effort to run with in this setting. 
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Conclusion 
I n conclusion, evidence f rom multiple sources suggests that motivational concordance is 
an additional psychological mechanism responsible for the real-world benefits of place-
bos. A motivational mechanism is compatible wi th earlier expectancy and conditioning 
accounts, but has some advantages, particularly when explaining generalised therapeutic 
benefits f r o m complex interventions. 
Appendix A 
Experimental materials 
A. 1 Participant information sheets from Chapter 2 
Briefing 
1. This is a study comparing the effectiveness of tv^o different pain reheving creams. 
2. These drugs have aheady been tested for safety in large clinical trials, and are in 
use in hospitals and chnics 
3. The first drug is called Ibuprofen, and you may have seen it available in Chemists' 
stores, or advertised on television. It is widely used, and an effective pain reliever. 
4. The second drug is called Trivaricaine. It is also widely used, primarily in hospitals 
and doctors' surgeries; it is not yet available over the counter, but has also been 
tested over many years and is an effective pain reliever. 
5. We need to test the drugs over period of several days, since this is how they are 
generally used by the public 
6. To provide a standardised stimulus to compare the drugs, we use a lever device, 
which wiU place pressure on one of your fingers. This produces no lasting damage, 
although it does hurt a moderate amount whilst the pressure is applied. 
7. For each drug, we w i l l be apply pressure to the treated finger, and an untreated 
finger for comparison. 
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8. Each tr ia l w i l l last 2 minutes, and you'll be asked to give a rating for how much the 
finger hurt immediately afterwards. 
9. You are free to leave the experiment AT A N Y T I M E - including during one of the 
trials. 
10. I f you do wish to leave the tr ial please teh a member of the team and we w i l l ensure 
all your data is destroyed. 
11. Your data wi l l remain anonymous at aU times. 
12. I f you have any concerns about the procedure, or feel distressed, please tell the 
experimenter, or call one of the help-line numbers below. 
UPSU Advice Line 01752 232281 
Samaritans 08457 90 90 90 
Debriefing 
Dear Participant, 
A t the start of this experiment I had to leave out some pieces of information. This 
decision was not taken lightly, and was necessary to investigate a phenomenon called the 
placebo effect. After reading this I hope you wiU understand and agree w i t h this decision. 
I 'm interested in whether some people consistently respond to placebos - that is, a piU 
or cream that has no active ingredient, but that is suggested to be effective. At present, it 
appears that we aU respond to suggestions of this k ind to some extent, and identifying a 
group that consistently responds is extremely difficult. 
This experiment was designed to answer that question by testing the same placebo 
creams over a number of days; the measure of placebo response was the difference in 
pain scores between your 'treated' and untreated fingers. Neither cream contained any 
active drug ingredients. 
We hope you w i l l understand why deception was necessary, and that you w i l l not be 
embarrassed i f you responded to one of the creams. The connection between mind and 
body is powerful , and it is to be expected that we can ' w i l l ' things to happen in this way. 
I f you have been upset or troubled by this experiment in any way, please do not 
hesitate to contact myself, my supervisor Professor Michael Hyland (01752 233144), or 
one of the members of the UPSU Advice Line (01752 232281). 
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I hope to publish the results of this study soon, and i f you are interested in the results 
please say so (either now or by email) and I w i l l be happy to send you a copy. I f you have 
any other questions please also feel free to ask. 
Regards, and many thanks, 
Ben Whalley 
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A.2 Bass Acquiescence Scale 
Instructions 
Please indicate whether you agree, disagree or are uncertain about each of the statements 
listed below: 
Scale items 
1. Success against the odds is the greatest of American ideals. 
2. Love is the greatest of the Arts. 
3. There is no satisfaction without a companion to share it. 
4. Love of the opposite sex makes the world go round. 
5. They never fail those who die i n a great cause. 
6. He that has many friends never fear disaster. 
7. Destroyers of tyranny have contributed most to mankind. 
8. You only injure yourself when you take not of despised critics. 
9. The only known cure for fear is faith. 
10. Our chief want i n life is somebody who w i l l make us do what we can. 
11. Never trust a flatterer. 
12. He who laughs last laughs longest. 
13. No principle is more noble or holy than that of true obedience. 
14. There is nothing which the body suffers which the soul may not profit by. 
15. One false friend can do more harm than one hundred enemies. 
16. N o gift is more precious than good advice. 
17. Obedience is the mother of success. 
18. The victory always remains w i t h those who admire rather than w i t h those who 
criticise. 
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19. The greatest fortunes are for those who leave the common path and blaze a new 
trail for themselves. 
20. 'Tis vain to quarrel w i t h our destiny. 
21. To be happy, always stay wi th in the law. 
22. You should give more than you want to give. 
23. Pity is the touch of god in human hearts. 
24. What we w i n through authority we lose; what we w i n through consideration we 
keep. 
25. A sense of duty is the basis of character. 
26. Next to love sympathy is the most divine passion of the human heart. 
27. Stay away from the proud man who is ashamed to weep. 
28. Sweet is the sleep of men w i t h virtue. 
29. One should feel the failures of friends as i f the failures were his own. 
30. Giving is always better than receiving. 
31. He that loses his conscience has nothing left that is worth keeping. 
32. Virtue is a struggle in which we overcome our weakness. 
33. He conquers all who conquers himself. 
34. It is difficult to do excellent work without greats strain. 
35. Only a statue's feelings are not easily hurt. 
36. Happiness must be won through great effort. 
37. The restless sleeper blames the couch. 
38. Seeing is believing. 
39. Still water runs deep. 
40. Make yourself honey and the flies w i l l eat you. 
41. The grass is always greener in the other feUow's yard. 
42. Most bog cows have little horns. 
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43. Every man is b l ind to his own defects. 
44. Jaws are the only part of the body that like to work. 
45. Those i n high places are in greater danger than those in lowly ones. 
46. Life is a struggle f rom beginning to end. 
47. W i l d colts make good horses. 
48. Empty heads go w i t h loud talk. 
49. You can't teach an old dog new tricks. 
50. Count your sheep and the wolf wiU eat them. 
51. Sleep is loved by everyone. 
52. The feeling of friendship is hke that of being comfortably filled w i t h roast beef. 
53. W h o does not love the opposite sex remains a fool the whole life long. 
54. Better one safe way than a hundred on which you are not sure. 
55. We like best that which lies beyond our reach. 
56. Amusement is the medicine for worry. 
Scoring 
Participants respond agreee, disagree or uncertain to all questions, and affirmative 
answers are summed to provide an overall score. A l l items are positively scored. 
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A.3 Tellegen absorption Scale 
Instructions 
This questionnaire consists of questions about experiences that you may have had in your 
hfe. We are interested in how often you have these experiences. It is important, however, 
that your answers show how often these experiences happen to you when you are not 
under the influence of alcohol or drugs. 
Scale items 
1. Sometimes I feel and experience things as I did when I was a child. 
2. I can be greatly moved by eloquent or poetic language. 
3. While watching a movie, a T V show, or a play, I may become so involved that I may 
forget about myself and my surroundings and experience the story as i f it were real 
and as i f I were taking part in it . 
4. I f I stare at a picture and then look away from it , I can sometimes "see" an image 
of the picture almost as i f I were still looking at it . 
5. Sometimes I feel as i f my m i n d could envelop the whole world. 
6. I like to watch cloud shapes change i n the sky. 
7. I f I wish I can imagine (or daydream) some things so vividly that they hold my 
attention as a good movie or story does. 
8. I think I really know what some people mean when they talk about mystical 
experiences. 
9. I sometimes "step outside" my usual self and experience an entirely different state 
of being. 
10. Textures - such as wool, sand, wood - sometimes remind me of colors or music. 
11. Sometimes I experience things as i f they were doubly real. 
12. When I listen to music I can get so caught up i n it that I don't notice anything else. 
13. I f I wish I can imagine that my body is so heavy that I could not move it i f I wanted 
to. 
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14. I can often somehow sense the presence of another person before I actually see or 
hear her/him. 
15. The crackle and flames of a wood fire stimulate my imagination 
16. It is sometimes possible for me to be completely immersed in nature or in art and 
to feel as i f my whole state of consciousness has somehow been temporarily altered. 
17. Different colors have distinctive and special meanings for me. 
18. I am able to wander off into my thoughts while doing a routine task and actually 
forget that I am doing the task, and then find a few minutes later that I have 
completed i t . 
19. I can sometimes recoUect certain past experiences i n my hfe w i t h such clarity and 
vividness that i t is like l iving them again or almost so. 
20. Things that might seem meaningless to others often make sense to me. 
21. Whi le acting i n a play I th ink I could really feel the emotions of the character and 
"become" her/him for the time being, forgetting both myself and the audience. 
22. M y thoughts often don't occur as words but as visual images. 
23. I often take delight i n small things (hke the five-pointed star shape that appears 
when you cut an apple across the core or the colors in soap bubbles). 
24. When listening to organ music or other powerful music I sometimes feel as i f I am 
being lifted into the air. 
25. Sometimes I can change noise into music by the way I listen to it. 
26. Some of my most v iv id memories are called up by scents and smells. 
27. Some music reminds me of pictures or changing color patterns. 
28. I often know what someone is going to say before he or she says it . 
29. I often have "physical memories"; for example, after I have been swimming I may 
still feel as i f I am in the water. 
30. The sound of a voice can be so fascinating to me that I can just go on listening to 
it . 
31. A t times I somehow feel the presence of someone who is not physically there. 
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32. Sometimes thoughts and images come to me without the shghtest effort on my 
part. 
33. I find that different odors have different colors. 
34. I can be deeply moved by a sunset. 
Scoring 
Participants respond yes or no to all questions. A l l items are positively scored. 
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A.4 The Spiritual Connection Questionnaire 
Instructions 
Below is a list of statements about the experience of spirituality. Please show to what 
extent these statements describe you by circling the number which best correspond to 
your experience. For example, i f the statement is very like you, then circle 3. I f it is only 
slightly like you, then circle 1. Do not spend to long over any statement. Just give the first 
answer that comes into your head. There are no right or wrong answers. 
Scale items 
1. Sometimes when I look at a person I feel a connection which is very special and 
different from usual human contact 
2. For me, happiness is achieved from pleasure, not spiritual fulfilment^''^"^"^'*^ 
3. I sometimes experience joy just from being in a beautiful place 
4. I do not feel connected to the universe in any spiritual way^ '^^ ^"'''^ ''^ " '^^ ^ 
5. I am very sensitive to the atmosphere of a house 
6. I never feel that I am making contact w i t h someone's soul^ '^ ^^^" '^') 
7. For me, spirituality gives me a feeling of ultimate happiness 
8. I never feel any special connection with a part of nature such as a flower, tree or 
mountain^'-^^^"'^'^) 
9. I can sometimes enter a state where I feel connected to the universe 
10. For me, places do not have a special atmosphere^''^"^"^''^ 
11. I am drawn to spiritual people 
12. Spirituality is not important to me^''"'""^^ 
13. For me, spirituality is a k i n d of love for everything 
14. I do not have a personal relationship wi th some power greater than myself^ '^ ''''^ '^''^ ''^ "'^ '^ ) 
15. I sometimes experience other people 'shining w i t h an inner light'^'"'^^^) 
16. It is not important to me to be connected with a spiritual being or force '^'^ ^^" '^^ ' 
A.4. SCQ 219 
17. I can sometimes feel love for living or non-l iving parts of nature (flowers, trees, 
stones, animals etc) 
18. The physical world as we know it is all there is^ ''^ ^^ "^ '^ ) 
19. There is something of the cosmos that binds all people together 
20. Spirituality does not contribute to my life(''^^^"^'') 
21. I feel there is a form of energy that binds ah hfe together^ '^^ ^^^^ 
22. I feel no spiritual connection to the wor ld around niet''^^^''''^^"^'^) 
23. I have a deep feeling of being connected to my family both past and future 
24. I have never had a spiritual experience that has changed my iife(sc?i4,reversed) 
25. We are all participating in something larger and greater than any of us 
26. I do not believe events in my life unfold according to a greater plan '^'^ "^"'^ '^ ) 
27. I can sometimes feel a connection w i t h those who are no longer w i t h us 
28. I am not much affected by my surroundings^'''^''^"^^^ 
29. I believe all hfe is connected 
30. I w i l l never have a spiritual bond w i t h another person^ '^^ ^^ '^''^ ^ "^^ '^ ^ 
31. I feel I have an inner spiritual strength^^"^^^ '^ 
32. I am not touched spiritually by beauty '^''^ ''^ "'^ '^ ) 
33. There is a larger plan to life^ '^^ ''^ ^^ 
34. I f ind spirituality in others rather off-putting^'"''^^"^'') 
35. M y spirituality makes life good for me''^ '^ ^^ ^^  
36. I never get completely immersed i n the beauty of my surroundings^'^^^^"^'^^ 
37. For me all life is connected 
38. I do not feel that there is a form of energy that binds people together^''^''^"^'^) 
39. I have joy in my life because of my spirituality 
40. The beauty of the universe fails to move me '^'^ "^ "^ '^ ) 
41. I feel an inner strength from a spiritual connection w i t h others^ "^^ ^^ '^) 
220 APPENDIX A. MATERIALS 
42. The cosmos (everything that exists) has only a physical dimension, not a spiritual 
43. M y connection to something spiritual makes me happy^"'^^^) 
44. I have no sense of awareness of those who w i l l come after me '^'^ ''^ " '^^ ' 
45. I feel that I am always protected by an ultimate principle, force or being^^ "^ ^^ )^ 
46. I have no feehng of being connected with the spirit world^''^''^"^'') 
47. M y feelings of a spiritual connection wi th the cosmos (everything that exists) are 
important to me 
48. Spiritual connections w i t h other people do not help me^''^^^"^^^ 
Scoring 
Participants respond by circling a number on a 7-point scale as follows: Unlike me -3 
- 2 - 1 0 1 2 3 Like me. Items marked ('•^ «^"^ '^ ) are reverse coded. Items marked are 
included i n the shorted SCQ-14. In both scales, scores are averaged such that higher 
scores indicate greater spirituality. 
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A.5 The Life Orientation Test - Revised (LOT-R) 
Instructions 
Please be as honest and accurate as you can throughout. Try not to let your response 
to one statement influence your responses to other statements. There are no 'correct' or 
'incorrect' answers. Answer according to your own feehngs, rather than how you th ink 
'most people' would answer. 
a) I agree a lot 
b) I agree a little 
c) I neither agree nor disagree 
d) I disagree a little 
e) I disagree a lot 
1. In uncertain times, I usually expect the best. 
2. h's easy for me to relax ^''"'''"^^ 
3. I f something can go wrong for me, it w i l l . 
4. I'm always optimistic about my future. 
5. I enjoy my friends a lot. '^'^ '"^" '^^ ) 
6. It's important for me to keep busy^''""^"^'') 
7. I hardly ever expect things to go my way. 
8. I don't get upset too easily 
9. I rarely count on good things happening to me. 
10. OveraU, I expect more good things to happen to me than bad. 
Scoring: 
Items 2, 5, 6, and 8 are fillers. Responses to 'scored' items are to be coded so that high 
values imply optimism. 
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A.6 Spiritual Involvement and Beliefs Scale - Revised (SIBS-R) 
Instructions 
Participants are asked how strongly they agree wi th the statements i n Table and circle 
one of the seven responses below: 
1. Strongly Disagree 
2. Disagree 
3. Neutral M i l d l y Disagree 
4. M i l d l y Agree 
5. Agree 
6. Strongly Agree 
Questionnaire items 
1. I set aside time for meditation and /or self-reflection. 
2. I can f ind meaning in times of hardship. 
3. A person can be fulfi l led without pursuing an active spiritual Hfe/''^^^"^'') 
4. I f ind serenity by accepting things as they are. 
5. I have a relationship w i t h someone I can turn to for spiritual guidance. 
6. Prayers do not really change what happens.^ ''^ "^" '^^ ^ 
7. I n times of despair, I can find little reason to hope.^ ''^ ''^ " '^^ ) 
8. I have a personal relationship w i t h a power greater than myself. 
9. I have had a spiritual experience that greatly changed my life. 
10. When I help others , I expect nothing in return. 
11. I don't take time to appreciate nature. '^'^ *'^ " '^'^  
12. I have joy in my life because of my spirituality. 
13. M y relationship w i t h a higher power helps me love others more completely. 
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15. 
14. 
17. 
16. 
Spiritual writings enrich my life. 
I have experienced healing after prayer. 
My spiritual understanding continues to grow. 
I focus on what needs to be changed in me, not on what needs to be changed i n 
others. 
18. In difficult times, I am still grateful. 
19. I have been through a time of suffering that led to spiritual growth. 
20. I solve my problems without using spiritual resources. (reversed) 
21. I examine my actions to see i f they reflect my values. 
22. How spiritual a person do you consider yourself? (with '7' being the most spiritual) 
Scoring instructions 
A l l negatively worded items (3, 6, 7, 11, 20) are reverse scored, i.e. strongly agree = 1, 
agree = 2,... strongly disagree = 7. For all other items the score is the number circled by 
the subject. 
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A.7 Love, compassion and tolerance. 
By the Dalai Lama The essence of ah religions is love, compassion, and tolerance. 
Kindness is my true religion. No matter whether you are learned or not, whether you 
believe i n the next life or not, whether you beheve in God or Buddha or some other 
religion or not, i n day-to-day life you must be a k i n d person. When you are motivated 
by kindness, i t doesn't matter whether you are a practitioner, a lawyer, a politician, an 
administrator, a worker, or an engineer: whatever your profession or field, deep down 
you are a k i n d person. Love, compassion, and tolerance are necessities, not luxuries. 
Without them, humanity cannot survive. I f you have a particular faith or religion, that 
is good. But you can survive without i t i f you have love, compassion, and tolerance. 
The dear proof of a person's love of God is i f that person genuinely shows love to fellow 
human beings. To have strong consideration for others' happiness and welfare, we must 
have a special altruistic attitude i n which we take upon ourselves the burden of helping 
others. To generate such an unusual attitude, we must have great compassion - caring 
about the suffering of others and wanting to do something about it. To have such a strong 
force of compassion, we must have a strong sense of love that, upon observing sentient 
beings, wishes that they have happiness - finding a pleasantness in everyone and wishing 
happiness for everyone, just as a mother does for her sole sweet child. To have a sense 
of closeness and dearness for others, use as a model a person in this hfetime who was 
very k i n d to you. Then extend this sense of gratitude to all beings. Deep down we must 
have real affection for each other, a dear realisation or recognition of our shared human 
status. At the same time, we must openly accept all ideologies and systems as a means 
of solving humanity's problems. One country, one nation, one ideology, one system is 
not sufficient. It is helpful to have a variety of different approaches on the basis of a deep 
feeling of the basic sameness of humanity. We can then make a joint effort to solve the 
problems of the whole of humankind. 
Every major religion has similar ideas of love, the same goal of benefiting through 
spiritual practice, and the same effect of making its foUowers into better human beings. 
A l l religions teach moral precepts for perfecting the functions of mind, body, and speech. 
A l l teach us not to lie or steal or take others' lives, and so on. The common goal of 
aU moral precepts laid down by the great teachers of humanity is unselfishness. Those 
teachers wanted to lead their followers away from the paths of negative deeds caused by 
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ignorance and to introduce them to paths of goodness. A h religions can learn from one 
another; their ultimate goal is to produce better human beings who w i l l be more tolerant, 
more compassionate, and less selfish. 
Human beings need spiritual as well as material sustenance. Without spiritual 
sustenance, it is difficult to get and maintain peace of mind. The purpose of religion is 
not to argue which one is the best. Over the past centuries, each great teaching has served 
humanity, so it's much better to make friends, understand each other, and make an effort 
to serve humanity than to criticise or argue. Buddha, Jesus Christ, and all other great 
teachers created their ideas and teachings w i t h sincere motivation, love, and kindness 
toward humanity, and they shared it for the benefit of humanity, I do not think those great 
teachers created differences to make trouble. Our human m i n d always likes diff^erent 
approaches. There is a richness i n the fact that there are so many different presentations of 
the way. There are two ways to enter into Buddhism; one through faith and one through 
reasoning. Faith alone may not be sufficient, Buddha always emphasised a balance of 
wisdom and compassion: a good brain and a good heart should work together. Placing 
importance on just the intellect and ignoring the heart can create more problems and 
more suffering in the world. On the other hand, i f we emphasise only the heart, and 
ignore the brain, then there is not much difference between humans and animals. These 
two must be developed in balance, and when they are, the result is material progress, 
accompanied by good spiritual development. Heart and mind working in harmony w i l l 
yield a truly peaceful and friendly human family. I feel that my mission is, wherever I 
am, to express my feehng about the importance of kindness, compassion, and the true 
sense of brotherhood. I practice these things. It gives me more happiness, more success. 
I f I practice anger or jealousy or bitterness, no doubt my smile would disappear. The real 
troublemakers are anger, jealousy, impatience, and hatred. W i t h them, problems cannot 
be solved. Though we may have temporary success, ultimately our hatred or anger wiU 
create further difficulties. Anger makes for swift solutions. Yet, when we face problems 
with compassion, sincerity, and good motivation, our solutions may take longer, but 
ultimately they are better. 
When I meet new people, in my mind there is no barrier, no curtain. As human 
beings you are my brothers and sisters; there is no difference i n substance. I can talk 
with you as I would to old friends. W i t h this feeling we can communicate without any 
difficulty and can make heart-to-heart contact. Based on such genuine human relations 
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- real feeling for each other, understanding each other - we can develop mutual trust and 
respect. From that, we can share other peoples suffering and build harmony in human 
society. 
/ 
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A.8 'The Moon Under Water 
By George Orwel l M y favourite public-house, the M o o n Under Water, is only two 
minutes from a bus stop, but it is on a side-street, and drunks and rowdies never 
seem to f ind their way there, even on Saturday nights. Its clientele, though fairly large, 
consists mostly of "regulars" who occupy the same chair every evening and go there for 
conversation as much as for the beer. I f you are asked why you favour a particular public-
house, it would seem natural to put the beer first, but the thing that most appeals to me 
about the Moon Under Water is what people caU its "atmosphere." To begin with, its 
whole architecture and fittings are uncompromisingly Victorian. It has no glass-topped 
tables or other modern miseries, and, on the other hand, no sham roof-beams, ingle-
nooks or plastic panels masquerading as oak. The grained woodwork, the ornamental 
mirrors behind the bar, the cast-iron fireplaces, the f lor id ceiling stained dark yellow by 
tobacco-smoke, the stuffed bull's head over the mantelpiece-everything has the solid, 
comfortable ugliness of the nineteenth century. In winter there is generally a good fire 
burning in at least two of the bars, and the Victorian lay-out of the place gives one plenty 
of elbow-room. There are a pubhc bar, a saloon bar, a ladies' bar, a bottle-and-jug for 
those who are too bashful to buy their supper beer publicly, and, upstairs, a dining-room. 
Games are only played in the public, so that in the other bars you can walk about without 
constantly ducking to avoid flying darts. I n the Moon Under Water it is always quiet 
enough to talk. The house possesses neither a radio nor a piano, and even on Christmas 
Eve and such occasions the singing that happens is of a decorous k ind. The barmaids 
know most of their customers by name, and take a personal interest i n everyone. They are 
aU middle-aged women-two of them have theii- hair dyed in quite surprising shades-and 
they call everyone "dear," irrespective of age or sex. ("Dear," not "Ducky": pubs where 
the barmaid calls you "ducky" always have a disagreeable raffish atmosphere.) Unlike 
most pubs, the Moon Under Water seUs tobacco as well as cigarettes, and it also seUs 
aspirins and stamps, and is obliging about Jetting you use the telephone. You cannot 
get dinner at the Moon Under Water, but there is always the snack counter where you 
can get liver-sausage sandwiches, mussels (a speciality of the house), cheese, pickles and 
those large biscuits w i t h caraway seeds in them which only seem to exist in public-houses. 
Upstairs, six days a week, you can get a good, solid lunch-for example, a cut off the joint, 
two vegetables and boiled jam rol l - for about three shillings. The special pleasure of this 
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lunch is that you can have draught stout w i t h it. I doubt whether as many as 10 per cent of 
London pubs serve draught stout, but the Moon Under Water is one of them. It is a soft, 
creamy sort of stout, and it goes better in a pewter pot. They are particular about their 
dr ink ing vessels at the M o o n Under Water, and never, for example, make the mistake 
of serving a pint of beer i n a handleless glass. Apart from glass and pewter mugs, they 
have some of those pleasant strawberry-pink china ones which are now seldom seen in 
London. China mugs went out about 30 years ago, because most people like their dr ink 
to be transparent, but i n my opinion beer tastes better out of china. The great surprise 
of the M o o n Under Water is its garden. You go through a narrow passage leading out of 
the saloon, and find yourself in a fairly large garden w i t h plane trees, under which there 
are little green tables w i t h iron chairs round them. Up at one end of the garden there are 
swings and a chute for the children. O n summer evenings there are family parties, and 
you sit under the plane trees having beer or draught cider to the tune of delighted squeals 
f r o m children going down the chute. The prams w i t h the younger children are parked 
near the gate. Many as are the virtues of the Moon Under Water, I th ink that the garden 
is its best feature, because i t allows whole families to go there instead of M u m having to 
stay at home and m i n d the baby while Dad goes out alone. A n d though, strictly speaking, 
they are only allowed in the garden, the children tend to seep into the pub and even to 
fetch drinks for their parents. This, I believe, is against the law, but it is a law that deserves 
to be broken, for it is the puritanical nonsense of excluding children-and therefore, to 
some extent, w o m e n - f r o m pubs that has turned these places into mere boozing-shops 
instead of the family gathering-places that they ought to be. The Moon Under Water is 
my ideal of what a pub should be-at any rate, in the London area. (The qualities one 
expects of a country pub are slightly different.) But now is the time to reveal something 
which the discerning and disillusioned reader wiU probably have guessed already. There 
is no such place as the M o o n Under Water. That is to say, there may weh be a pub of 
that name, but I don't know of i t , nor do I know any pub w i t h just that combination of 
qualities. I know pubs where the beer is good but you can't get meals, others where you 
can get meals but which are noisy and crowded, and others which are quiet but where 
the beer is generally sour. As for gardens, offhand I can only think of three London pubs 
that possess them. But, to be fair, I do know of a few pubs that almost come up to the 
M o o n Under Water. I have mentioned above ten quahties that the perfect pub should 
have and I know one pub that has eight of them. Even there, however, there is no draught 
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stout, and no china mugs. A n d i f anyone knows of a pub that has draught stout, open 
fires, cheap meals, a garden, motherly barmaids and no radio, I should be glad to hear of 
it , even though its name were something as prosaic as the Red Lion or the Railway Arms. 
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A.9 System used to build online questionnaires 
A series of scripts and functions were written in the PHP programming language to 
facilitate quick, reliable and secure creation of online questionnaires. A series of 'screen 
grabs' are included below demonstrating the key functions f rom the user's perspective. 
Security was maintained using standard open source tools and protocols. Data was stored 
i n a flat file, and could be exported to a Stata-compatible format by requesting a specific 
password protected URL. 
Additionally, Figure A.4 shows the current (retrieved 22nd July 2008) state of the 
research group website created to promote studies, provide information to potential 
participants, and provide an attractive 'orienting point' for users who arrived via online-
advertising or f r o m media coverage. 
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Figure A . l ; User required to enter a pre-defined study ID number (access blocked 
without a valid ID) 
Pkase enter yoor study ID (use 1U1 for demo) 
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Figure A.2: System requires user to select a checkbox (used to ensure consent given 
for online studies) 
-org. uk/qm ]/tmto.p»ipTq-dt«no 
OBlMa RMMTck m 
Some checld)oxes 
2 Thli one is required 
• This one isn't 
This one Is pre-ddced 
This one b required 
Iht j one isn't 
Tfalsonelspre-Ucked j 
j 
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Figure A.3: Various question formats allowed by the system (custom question formats 
or scoring systems were easily created on an ad-hoc basis) 
Study tide 
Some Initial Instnictlons 
TtnquMdoa: I I 
TntqanUni: | 
Tolquallon: | 
J i 
File Inserted to gtve Instructions 
niHtarnnupilnM] 
*2 *3 
Some multiple choice options 
A Ulten type question 
A list of options - one a pre-set 
0-1 
0-1 
0-1 
• Nnel 
0 « l 
O . J 
A pulldown Ust - one Is pre-sct ( n 
A pulldown bst - not Inline 
r 
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Figure A.4: Research group website useci to promote stuciies (retrieved 22 July 2008) 
a a a 
holistichealthresearch.org.uk 
Ttw links b«twMn physical and psychologtcal 
hMlth 
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A. 10 Text of automated telephone system described in Chap-
ter 5 
Calls in 
Note, a flow diagram indicating a participant's flow through the call system can be found 
on page 113. 
Welcome Hello, this is the University of Plymouth research line. 
I D number? Please enter the I D number which was sent to you w i t h the flower essence 
pack (it should be a four digit number). 
Check number? Was that [repeat entered number] ? Press 1 for yes or 2 for no. 
Bad I D number That didn't seem to be a valid study I D code. Please t ry again 
Registered You're now ready to start the study. 
Reminder Remember to take 3 drops of the essence twice each day, in the morning and 
evening. 
Aflftrmation (positive/spiritual) Flower essences work best i f you picture that they are 
doing you good as you take them / Flower essences work best i f you picture the 
spirit of the flower connecting you to a pool of universal healing and love. 
Goodbye We'll cafl you tomorrow to find out how you are getting on. Thank you and 
goodbye. 
Calls out 
Note, a flow diagram indicating a participant's flow through the call system can be found 
on page 114. 
Hello Hello, this is an automatic call from the University of Plymouth to find out how 
you're getting on w i t h your flower essences - this w i l l only take around 2 minutes. 
Can you talk? I f now is a good time to answer the questions please press 1. I f you would 
prefer us to caU back later today press 2. I f you don't want to be called again today 
press 3. 
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Change? H o w much better do you feel f rom taking the flower essence? Press a number 
f r o m one to nine, where FIVE means you feel the same, ONE means you feel much 
worse, and N I N E means you feel much better. 
Compliance? D i d you take the flower essence this morning? Press ONE for no, or N I N E 
for yes. I f you can't remember, press FIVE. 
Ease? (spiritual/positive) When you were taking the flower essences, how easy was it to 
picture the spirit of the flower connecting you to a pool of universal healing and 
love? / When you were taking the flower essences, how easy was it to picture the 
flower essences helping you? Press a number from ONE to N I N E , where N I N E 
means very easy, and ONE means very difficult. 
A f f i r m a t i o n (spiritual/positive) Flower essences work best i f you picture the spirit of 
the flower connecting you to a pool of universal healing and love / Flower essences 
w o r k best i f you picture that they are doing you good as you take them. 
Reminder We're finished now, but remember to take 3 drops of the essence twice a day, 
m o r n i n g and evening. 
Goodbye We w i l l call again soon to f ind out how you are getting on. Goodbye. 
Thankyou/goodbye Thanks for your help - we hope you have enjoyed participating i n 
the study. I f you would hke any more information about our work please email 
Ben Whalley at ben dot whalley (that's W H A L L E Y) at plymouth dot ac dot uk. 
We'U hang up now, so thanks, and good-bye. 
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A. 11 Text of automated telephone system described in Chap-
ter 6 
Calls in 
Note, a flow diagram indicating a participant's flow through the call system can be found 
on page 141. 
Welcome Hello, this is the University of Plymouth research line. 
I D number? Please enter the I D number you were given on our website to register for 
the study. 
OK Thanks, 
Telephone number? ...please enter the telephone number you would like us to call you 
on over the next few weeks, followed by the hash key. This must be your own 
mobile phone number and not a landline. 
Registered Thanks - you've now registered for the study. We'll send you a pack 
containing the flower essence i n the post, but i t is important you don't use it before 
the date marked on the pack. The reason is that we would like to find out about 
your child's tantrums before taking the essence. As soon as this call is finished, 
we'll call you straight back to ask you the first of the questions about your child's 
tantrums. Goodbye for now. 
Bad I D number That didn't seem to be a valid study I D code. Please try again 
Bad phone number That didn't seem to be a valid mobile phone number. U K mobile 
phone numbers have 11 digits, and begin w i t h the numbers 0 and 7. 
Check number? Was that [repeat entered number] ? Press 1 for yes or 2 for no. 
Major problem We're sorry but this doesn't seem to be working out. Please contact Ben 
Whalley via the study website i f you are having problems w i t h this system. 
Calls out 
Note, a flow diagram indicating a participant's flow through the cafl system can be found 
on page 142. 
238 APPENDIX A. MATERIALS 
Hello Hello, this is an automated call f rom the University of Plymouth to find out how 
your child is getting on w i t h the flower essence. 
Can y o u talk? I f you can talk now please press 1. I f now is not a good time but you would 
like us to caU back later press 2. I f you don't want us to cafl again today please press 
3. 
Ca l lback I f you want us to call back in about 15 minutes please press 0. I n about an 
hour, press 1. I n 2 hours press 2. I n three hours press 3. I n four hours press 4. I f 
you have changed your m i n d and don't want a call today please press 9. 
W i l l call back soon Ok, we'll cafl back soon. Goodbye. 
Won't caU again today Don't worry. We won't call again today, but you'll receive your 
next call as usual in a few days. Goodbye. 
Received essence? Have you received the flower essence yet? Press 1 for yes, 0 for no. 
N o essence yet Ok, we'll call again tomorrow - hopefully you w i l l have received the 
essence by then and we can find out how you're getting on w i t h it . Goodbye. 
Started taking yet? Have you begun to give the essence to your child? Press 1 for yes, 0 
for no. 
Please start taking Ok, we'll call again tomorrow. Please start giving the essence to your 
child, either this evening or tomorrow morning. I f you don't wish to give the 
essence to your child, please contact Ben Whalley via the study website to withdraw 
f rom the study. Goodbye. 
H a d a tantrum? Has your child had a temper tantrum in the past 24 hours? Press a 
number on your keypad f rom 0 to 9 to indicate how many, or the star key i f it has 
been more than 9. 
T h i n k o f worst t an t rum Please th ink about the worst of the tantrums when answering 
the following questions. 
T a n t r u m length? Approximately how long did the tantrum last for? Press 1 for less than 
a minute. Press 2 for less than 2 minutes. Press 3 for less than 3 minutes. Press 4 
for less than 4 minutes. Press 5 for less than 5 minutes. Press 6 for between 5 and 
10 minutes. Press 7 for 10 minutes or more. 
Extra questions Now we'll ask a few questions to get a better picture of the tantrum. 
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Tantrum severity? On a scale of 1 to 9, how bad was the tantrum, where 1 is not bad at 
all, 9 is very bad, and 5 is about average. 
Whining? During the tantrum, did your child whine? Press a number from 1, which 
means no whining, to 9, which means lots of whining. 
Crying? [As for Whining above] 
Screaming? [As for Whin ing above] 
Kicking or hitting? [As for Whining above] 
Hold breath? D i d your child hold their breath? Press 0 for no. Press 1 for yes. 
O n floor? D i d your child get down on the floor? Press 0 for no. Press 1 for crouching 
down. Press 2 for properly lying on the floor. 
Compliance? How many times did your child take the essence yesterday. Press 1 for 
once, 2 for twice, or 0 for not at all. 
Parent mood? O n a scale of one to nine, how happy are you today, where 9 is much 
happier than normal, 5 is about normal, and 1 means much more unhappy than 
normal. 
Reminder Remember to give your child the essence twice each day. The makers of this 
essence th ink that flower essence work because the essence connects your child to 
a universal pool of healing and love. Many people find it best to give it first thing 
in the morning and last thing at night. 
Goodbye 
Start taking i f you have i t I f you have the essence, please start giving it to your child 
tomorrow. 
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We didn't tell our little boy about the esences - he wasn't even 2 and a half 
when we started, however, fingers crossed the tantrums and hitt ing has 
reduced by about 80% so I would say a definite success for us. 
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Please feel free to use my comments i have told so many people about this 
and they cant wait for it to come out on the market. Please let me know 
where i can purchase some more 4 my son A. 
A has one tablet a day now, you can tell the difference in his behavior i f we 
have forgotton to give h i m one. I think this stuffis amaizing. 
Note, the same mother had previously emailed to say: 
Dear Ben, Thankyou my families life has changed so much since my son A 
has been taking his happy pi l l . A was told that this was his happy pi l l . He 
sleeps better, he is a different child altogether and my parents have noticed a 
difference too. Please please let me purchase some more i dont care what i t 
cost. 
The first time I gave the flower essence I caused a tantrum - he took the 
capsule and then asked for 'more sweetie'. When I said 'no' he had a tantrum 
shouting 'MORE SWEETIE'!!! He did eventually accept he was only going 
to get one at a time. 
i d id not tell my child, infact i told her it was a v i tamin . . . i stopped the 
"viamins" about 6 weeks ago and found little tantrums coming back, not 
as long as before though, and mostly when shes tired. 
I can quite honestly say that these remedies changed our life! It took two 
weeks. After the first 10 days or so my daughter started to have problems 
sleeping. She wasn't unhappy, just very awake. So i reduced the pills to just 
one in the morning and instantly she slept better at night. 
The first remedy I gave her changed her instantly, but this only lasted for 
about 3/4 of an hour - but i t was the first time I'd seen my daughter actually 
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relax - I could see it in her face, I'd never seen it before - only in her older 
sister who seems relaxed all the time! After that had worn off i t took a couple 
of days for her to find out for herself how she should be, she seemed to be 
allowed to learn that being more placid was a happier and greater place to 
be. 
After two weeks she didn't need them anymore. However, about 7 weeks or 
so later she was very i l l w i t h flu like symptoms for just over a week, and as 
she recovered from that she started to resort back to her old ways again of 
anger and frustration. I started giving her a remedy in the morning for 3 
days and she settled down instantly. That was the 2nd - 3rd week of October 
and she hasn't needed anything since. 
I'd love to know what's i n them. But, whatever it was, please take it f rom a 
mother who was at her limits - they work. A n d you are brill iant to want to 
concentrate on this as part of your studies. 
Well done and good luck in whatever else you choose to do. 
We have been thril led at the results the pflls had on our 4 year old son James. 
Not sure i f it was a combination of starting school along w i t h the pills that 
made them especially effective but we are definitely intending to buy some 
more as we are now near the end of the supply! 
Love these three questions, as the one comment I wanted to make was ( 
relevant and )that the tablets seemed to help w i t h my childs tantrums. I 
feel that this C O U L D have been purely through placebo effect as I had 
told h i m they were going to help. O r it could have been because they had 
an ingredient that calmed him??. Nevertheless-does this really matter too 
much? The desired effect is to cease or reduce the child's tantrum/s. As a 
parent, I don't really care too much how this is achieved i f it involves an 
unharmful substance. I feel children ( or in any case my child) tantrum/s 
primarily to gain attention from their carer. I f a parent taking the time to 
242 APPENDIX A. MATERIALS 
administer a herbal tablet to the child satisfies that childs need for attention 
( thus ceasing the tantrum) then greatJf it works because of it's specially 
selected ingredients then great too. But it does make a difference. 
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